PKACA
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NIH7 | S229 | Sugiyama | UNC119B | QLSEDVIRLMIENPYETRSDsFYFVDNKLIMHNKADYAYNG |
| O00141 | T369 | ELM|EPSD|PSP | SGK1 SGK | IKSHVFFSLINWDDLINKKItPPFNPNVsGPNDLRHFDPEF |
| O00168 | S83 | ELM|EPSD|PSP | FXYD1 PLM | KFNQQQRTGEPDEEEGtFRssIRRLstRRR___________ |
| O00168 | S88 | EPSD|PSP | FXYD1 PLM | QRTGEPDEEEGtFRssIRRLstRRR________________ |
| O00231 | S14 | EPSD|PSP | PSMD11 | _______MAAAAVVEFQRAQsLLstDREAsIDILHsIVKRD |
| O00232 | S332 | Sugiyama | PSMD12 | MELMRWSTLVEDYGMELRKGsLEsPAtDVFGsTEEGEKRWK |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00299 | S211 | Sugiyama | CLIC1 G6 NCC27 | CKKYRGFTIPEAFRGVHRYLsNAyAREEFAstCPDDEEIEL |
| O00418 | S366 | iPTMNet|EPSD | EEF2K | AKtILRGtEEKCGsPQVRTLsGSRPPLLRPLsENSGDENMS |
| O00418 | S500 | iPTMNet|EPSD | EEF2K | RVCVEKWNLLNssRLHLPRAsAVALEVQRLNALDLEKKIGK |
| O00429 | S637 | ELM|EPSD|PSP | DNM1L DLP1 DRP1 | PQKGHAVNLLDVPVPVARKLsAREQRDCEVIERLIKSYFLI |
| O00482 | S510 | EPSD|PSP | NR5A2 B1F CPF FTF | PQQTEKFGQLLLRLPEIRAIsMQAEEYLYYKHLNGDVPYNN |
| O00571 | S83 | Sugiyama | DDX3X DBX DDX3 | sKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsD |
| O14558 | S16 | EPSD|PSP | HSPB6 | _____MEIPVPVQPSWLRRAsAPLPGLSAPGRLFDQRFGEG |
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14649 | S393 | EPSD|PSP | KCNK3 TASK TASK1 | sVsTGLHSLStFRGLMKRRssV___________________ |
| O14813 | S153 | EPSD|PSP | PHOX2A ARIX PMX2A | RVQVWFQNRRAKFRKQERAAsAKGAAGAAGAKKGEARCSSE |
| O14921 | T41 | EPSD|PSP | RGS13 | SNLTLEEVLQWAQSFENLMAtKYGPVVYAAYLKMEHSDENI |
| O14965 | T288 | ELM|iPTMNet|EPSD|PSP | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 | GELKIADFGWsVHAPssRRttLCGTLDYLPPEMIEGRMHDE |
| O14974 | S692 | Sugiyama | PPP1R12A MBS MYPT1 | PVRDEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIG |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15013 | S1232 | Sugiyama | ARHGEF10 KIAA0294 | VKFIVLATALHEKDKDKsRDsLAPGPEPQDEDQKDALPSGG |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15217 | S189 | EPSD|PSP | GSTA4 | EKIPNILSAFPFLQEYTVKLsNIPtIKRFLEPGSKKKPPPD |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15357 | S1176 | Sugiyama | INPPL1 SHIP2 | RGLPsDyGRPLsFPPPRIREsIQEDLAEEAPCLQGGRASGL |
| O15357 | S43 | Sugiyama | INPPL1 SHIP2 | HRDLSRAAAEELLARAGRDGsFLVRDSESVAGAFALCVLYQ |
| O15392 | S20 | EPSD|PSP | BIRC5 API4 IAP4 | _MGAPTLPPAWQPFLKDHRIstFKNWPFLEGCACtPERMAE |
| O15551 | T192 | iPTMNet|EPSD|PSP | CLDN3 C7orf1 CPETR2 | LQLLGGALLCCSCPPREKKYtATKVVysAPRstGPGAsLGt |
| O15554 | S334 | EPSD|PSP | KCNN4 IK1 IKCA1 KCA4 SK4 | SAARVLQEAWMFYKHtRRKEsHAARRHQRKLLAAINAFRQV |
| O43164 | S342 | EPSD|PSP | PJA2 KIAA0438 RNF131 | IsssQVDQETGFNRHEAKQRsVQRWREALEVEESGSDDLLI |
| O43164 | T389 | EPSD|PSP | PJA2 KIAA0438 RNF131 | GEHDCMFLDPPYSRVITQREtENNQMTSESGATAGRQEVDN |
| O43181 | S173 | EPSD|PSP | NDUFS4 | PKPKSKSYGANFSWNKRTRVsTK__________________ |
| O43390 | S428 | Sugiyama | HNRNPR HNRPR | LAKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRG |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43511 | T717 | PSP | SLC26A4 PDS | DYVIEKLEQCGFFDDNIRKDtFFLTVHDAILYLQNQVKSQE |
| O43521 | S87 | GPS6 | BCL2L11 BIM | PAsPGPFATRsPLFIFMRRSsLLSRsssGYFsFDTDRsPAP |
| O43566 | S260 | ELM|iPTMNet|EPSD | RGS14 | LRKSFRRELGGTANAALRREsQGSLNSSASLDLGFLAFVSS |
| O43566 | T495 | iPTMNet|EPSD | RGS14 | PPAsPSSLVKVPSSATGKRQtCDIEGLVELLNRVQSSGAHD |
| O43665 | S176 | PSP | RGS10 | KRTEEEEEDLPDAQTAAKRAsRIYNT_______________ |
| O43747 | S348 | Sugiyama | AP1G1 ADTG CLAPG1 | ALTSLLKTVQTDHNAVQRHRstIVDCLKDLDVSIKRRAMEL |
| O43747 | T349 | Sugiyama | AP1G1 ADTG CLAPG1 | LTSLLKTVQTDHNAVQRHRstIVDCLKDLDVSIKRRAMELs |
| O43768 | S109 | PSP | ENSA | KNLVtGDHIPTPQDLPQRKssLVtsKLAGGQVE________ |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60240 | S81 | iPTMNet|EPSD | PLIN1 PERI PLIN | GVQSASSLAAWSMEPVVRRLstQFTAANELACRGLDHLEEK |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S485 | Sugiyama | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60343 | T488 | Sugiyama | TBC1D4 AS160 KIAA0603 | IEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVSDQ |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60343 | T752 | Sugiyama | TBC1D4 AS160 KIAA0603 | IRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISW |
| O60479 | S10 | EPSD|PSP | DLX3 | ___________MSGSFDRKLsSILTDISSSLSCHAGSKDSP |
| O60566 | S509 | Sugiyama | BUB1B BUBR1 MAD3L SSK1 | IPGMTLSSSVCQVNCCARETsLAENIWQEQPHSKGPsVPFS |
| O60658 | S359 | PSP | PDE8A | VQSDTHTDNQTGKHKDRRKGsLDVKAVASRATEVSSQRRHS |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60825 | S466 | iPTMNet|EPSD|PSP | PFKFB2 | RDKPTNNFPKNQTPVRMRRNsFtPLsssNtIRRPRNYsVGs |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O60928 | S287 | EPSD|PSP | KCNJ13 | LVVFLSAMQEGTGEICQRRTsYLPSEIMLHHCFASLLTRGS |
| O60941 | T11 | EPSD|PSP | DTNB | __________MIEESGNKRKtMAEKRQLFIEMRAQNFDVIR |
| O60941 | T424 | EPSD|PSP | DTNB | LIARYAARLAAEAGNVTRPPtDLsFNFDANKQQRQLIAELE |
| O75151 | S1056 | PSP | PHF2 CENP-35 KIAA0662 | QAGRTSQPMAPGVFLtQRRPsAssPNNNTAAKGKRTKKGMA |
| O75151 | S757 | PSP | PHF2 CENP-35 KIAA0662 | GSLHIDTDTKPGRNARVKKEsGSSAAGILDLLQASEEVGAL |
| O75151 | S899 | PSP | PHF2 CENP-35 KIAA0662 | sLEsDEDNPIFKSRSKKRKGsDDAPYsPtARVGPSVPRQDR |
| O75151 | S954 | PSP | PHF2 CENP-35 KIAA0662 | LAAAAAKLsQQEEQKSKKKKsAKRKLTPNTTSPSTSTSISA |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75376 | S70 | EPSD|PSP | NCOR1 KIAA1047 | VSQASQLLQQQQQQQLRRRPsLLSEFHPGSDRPQERRtsyE |
| O75390 | S97 | Sugiyama | CS | GLVyEtsVLDPDEGIRFRGFsIPECQKLLPKAKGGEEPLPE |
| O75396 | S137 | Sugiyama | SEC22B SEC22L1 | TFIQKTKKLYIDSRARRNLGsINtELQDVQRIMVANIEEVL |
| O75581 | T1548 | EPSD|PSP | LRP6 | PtTPCSTDVCDsDyAPsRRMtSVATAKGYTSDLNyDSEPVP |
| O75665 | S735 | PSP | OFD1 CXorf5 | EALTGsAAsRLRGGTSSRRLsSTPLPKAKRsLESEMyLEGL |
| O75665 | S899 | PSP|Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O75688 | S195 | EPSD|PSP | PPM1B PP2CB | REKERIQNAGGsVMIQRVNGsLAVSRALGDYDYKCVDGKGP |
| O75717 | S374 | Sugiyama | WDHD1 AND1 | INDDEDDEDLMMAsGRPRQRsHILEDDENsVDIsMLKtGss |
| O75762 | S317 | EPSD|PSP | TRPA1 ANKTM1 | GSVDIVNTTDGCHETMLHRAsLFDHHELADYLISVGADINK |
| O75762 | S428 | EPSD|PSP | TRPA1 ANKTM1 | DEDNDGCTPLHYACRQGGPGsVNNLLGFNVSIHSKSKDKKS |
| O75762 | S86 | EPSD|PSP | TRPA1 ANKTM1 | FLHYAAAEGQIELMEKITRDsSLEVLHEMDDYGNTPLHCAV |
| O75762 | S972 | EPSD|PSP | TRPA1 ANKTM1 | LMNLLIGLAVGDIAEVQKHAsLKRIAMQVELHTSLEKKLPL |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O76054 | S289 | EPSD|PSP | SEC14L2 C22orf6 KIAA1186 KIAA1658 | YVRDQVKQQYEHSVQISRGSsHQVEYEILFPGCVLRWQFMS |
| O76074 | S102 | ELM|EPSD|PSP | PDE5A PDE5 | PLQQsPRADNSAPGTPTRKIsAsEFDRPLRPIVVKDSEGTV |
| O94763 | S372 | EPSD|PSP | URI1 C19orf2 NNX3 PPP1R19 RMP URI | KNTTLKFSEKKEEAKRKRKNstGsGHsAQELPTIRTPADIY |
| O94808 | S202 | ELM | GFPT2 | FALVFKSVHYPGEAVATRRGsPLLIGVRSKYKLSTEQIPIL |
| O94811 | S159 | EPSD|PSP | TPPP TPPP1 | EVHRLIEGKAPIISGVTKAIssPtVSRLTDTTKFTGSHKER |
| O94811 | S32 | EPSD|PSP | TPPP TPPP1 | NRtPPKsPGDPsKDRAAKRLsLEsEGAGEGAAAsPELSALE |
| O94811 | T92 | EPSD|PSP | TPPP TPPP1 | HGKNWSKLCKDCQVIDGRNVtVTDVDIVFSKIKGKsCRTIT |
| O94875 | S259 | PSP | SORBS2 ARGBP2 KIAA0777 | sLERPMssAsMASDFRKRRKsEPAVGPPRGLGDQsAsRtsP |
| O94888 | S280 | Sugiyama | UBXN7 KIAA0794 UBXD7 | EHGQLDGLsssPPKKCARsEsLIDAsEDsQLEAAIRASLQE |
| O94992 | S158 | PSP | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EEEWGQQQRQLGKKKHRRRPsKKKRHWKPYYKLTWEEKKKF |
| O94992 | S268 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EDGGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELI |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95140 | S442 | PSP | MFN2 CPRP1 KIAA0214 | ITEEVERQVSTAMAEEIRRLsVLVDDYQMDFHPSPVVLKVY |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95180 | S1107 | EPSD|PSP | CACNA1H | TPKSsPFLDAAPsLPDSRRGsSSSGDPPLGDQKPPASLRSS |
| O95239 | S801 | Sugiyama | KIF4A KIF4 | LKEKKESGENPPPKLRRRtFsLtEVRGQVsEsEDsItKQIE |
| O95295 | S50 | iPTMNet|EPSD|PSP | SNAPIN BLOC1S7 SNAP25BP SNAPAP | LEFLRPAVQQLDSHVHAVREsQVELREQIDNLATELCRINE |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95477 | S1042 | ELM|iPTMNet|EPSD|PSP | ABCA1 ABC1 CERP | PSSKLKSKTSQLSGGMQRKLsVALAFVGGSKVVILDEPTAG |
| O95477 | S2054 | ELM|iPTMNet|EPSD|PSP | ABCA1 ABC1 CERP | LVKYGEKYAGNYSGGNKRKLsTAMALIGGPPVVFLDEPTTG |
| O95571 | S19 | Sugiyama | ETHE1 HSCO | __MAEAVLRVARRQLsQRGGsGAPILLRQMFEPVSCTFTYL |
| O95613 | S1814 | Sugiyama | PCNT KIAA0402 PCNT2 | AALEAKEALSRLLADQERRHsQALEALQQRLQGAEEAAELQ |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95644 | S245 | ELM|EPSD|PSP | NFATC1 NFAT2 NFATC | LGACtLLGsPRHsPstsPRAsVTEESWLGARssRPAsPCNK |
| O95644 | S269 | ELM|EPSD|PSP | NFATC1 NFAT2 NFATC | ESWLGARssRPAsPCNKRKYsLNGRQPPysPHHsPtPSPHG |
| O95644 | S294 | ELM|EPSD|PSP | NFATC1 NFAT2 NFATC | QPPysPHHsPtPSPHGsPRVsVTDDSWLGNTTQYTSSAIVA |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95817 | S195 | Sugiyama | BAG3 BIS | AAsDCsssSsSAsLPssGRssLGsHQLPRGyISIPVIHEQN |
| O95863 | S11 | EPSD|PSP | SNAI1 SNAH | __________MPRSFLVRKPsDPNRKPNYSELQDSNPEFTF |
| O96001 | T119 | iPTMNet|EPSD | PPP1R17 C7orf16 GSBS | KMIPVLHNTDLEQKKPRRKDtPALHMSPFAAGVTLLRDERP |
| O96001 | T68 | iPTMNet|EPSD | PPP1R17 C7orf16 GSBS | KNVQATLNVESDQKKPRRKDtPALHIPPFIPGVFSEHLIKR |
| O96004 | S109 | ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | GGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPADTK |
| O96004 | S98 | ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | PGQSPGRLEALGGRLGRRKGsGPKKERRRtEsINSAFAELR |
| O96004 | T107 | ELM|iPTMNet|EPSD | HAND1 BHLHA27 EHAND | ALGGRLGRRKGsGPKKERRRtEsINSAFAELRECIPNVPAD |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00439 | S16 | ELM|EPSD|PSP | PAH | _____MSTAVLENPGLGRKLsDFGQETSYIEDNCNQNGAIS |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P01023 | S273 | Sugiyama | A2M CPAMD5 FWP007 | LYTYGKPVPGHVTVSICRKYsDAsDCHGEDSQAFCEKFSGQ |
| P01100 | S362 | iPTMNet|EPSD | FOS G0S7 | VFTYPEADSFPSCAAAHRKGsSsNEPSSDSLSsPTLLAL__ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S458 | Sugiyama | LMNA LMN1 | GRVAVEEVDEEGKFVRLRNKsNEDQsMGNWQIKRQNGDDPL |
| P02671 | S460 | ELM | FGA | KELRTGKEKVTSGSTTTTRRsCSKTVTKTVIGPDGHKEVTK |
| P02686 | S141 | EPSD | MBP | QEDSAATSESLDVMASQKRPsQRHGsKyLATAstMDHARHG |
| P02686 | S146 | EPSD | MBP | ATSESLDVMASQKRPsQRHGsKyLATAstMDHARHGFLPRH |
| P02686 | S190 | EPSD | MBP | GILDsIGRFFGGDRGAPKRGsGKDSHHPARTAHyGsLPQKS |
| P02686 | S266 | EPSD | MBP | SRFsWGAEGQRPGFGYGGRAsDYKSAHKGFKGVDAQGtLsK |
| P02686 | S295 | EPSD | MBP | FKGVDAQGtLsKIFKLGGRDsRSGsPMARR___________ |
| P02686 | T169 | EPSD | MBP | LATAstMDHARHGFLPRHRDtGILDsIGRFFGGDRGAPKRG |
| P03372 | S236 | ELM|EPSD|PSP | ESR1 ESR NR3A1 | HNDyMCPATNQCTIDKNRRKsCQACRLRKCYEVGMMKGGIR |
| P03372 | S305 | EPSD|PSP | ESR1 ESR NR3A1 | DMRAANLWPsPLMIKRSKKNsLALSLtADQMVSALLDAEPP |
| P04004 | S397 | ELM|iPTMNet|EPSD|PSP | VTN | KGYRsQRGHsRGRNQNsRRPsRAtWLsLFssEEsNLGANNY |
| P04035 | S872 | iPTMNet|EPSD | HMGCR | SLMAALAAGHLVKSHMIHNRsKINLQDLQGACTKKTA____ |
| P04049 | S233 | iPTMNet|EPSD | RAF1 RAF | TMRRMRESVSRMPVssQHRystPHAFtFNtssPSSEGSLSQ |
| P04049 | S259 | ELM|iPTMNet|EPSD|PSP | RAF1 RAF | tFNtssPSSEGSLSQRQRststPNVHMVsttLPVDSRMIED |
| P04049 | S43 | ELM|iPTMNet|EPSD|PSP | RAF1 RAF | DGssCIsPtIVQQFGYQRRAsDDGKLtDPSKTSNTIRVFLP |
| P04049 | S621 | ELM|iPTMNet|EPSD|PSP | RAF1 RAF | QILssIELLQHsLPKINRsAsEPsLHRAAHtEDINACtLtt |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S346 | Sugiyama | ALDOA ALDA | EEYVKRALANsLACQGKytPsGQAGAAAsEsLFVsNHAy__ |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | T216 | ELM|EPSD|PSP | ANXA1 ANX1 LPC1 | EDLADsDARALyEAGERRKGtDVNVFNtILttRSyPQLRRV |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04439 | S336 | ELM | HLA-A HLAA | VLLGAVITGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGS |
| P04439 | S337 | ELM|PSP | HLA-A HLAA | LLGAVITGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGSD |
| P04439 | S343 | ELM|PSP | HLA-A HLAA | TGAVVAAVMWRRKssDRKGGsyTQAASSDSAQGSDVsLTAC |
| P04626 | T686 | EPSD|PSP | ERBB2 HER2 MLN19 NEU NGL | VLGVVFGILIKRRQQKIRKYtMRRLLQETELVEPLtPsGAM |
| P04637 | S378 | EPSD|PSP | TP53 P53 | EPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD_____ |
| P04792 | S78 | EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T143 | EPSD|PSP | HSPB1 HSP27 HSP28 | KHEERQDEHGyIsRCFTRKYtLPPGVDPTQVSSsLsPEGtL |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05023 | S943 | EPSD|PSP | ATP1A1 | FVSIVVVQWADLVICKTRRNsVFQQGMKNKILIFGLFEETA |
| P05067 | S679 | PSP | APP A4 AD1 | TNIKTEEISEVKMDAEFRHDsGYEVHHQKLVFFAEDVGsNK |
| P05093 | S258 | EPSD|PSP | CYP17A1 CYP17 S17AH | IRNDLLNKILENYKEKFRSDsITNMLDTLMQAKMNSDNGNA |
| P05114 | S21 | ELM|iPTMNet|EPSD | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | ELM|iPTMNet|EPSD | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05114 | S7 | iPTMNet|EPSD | HMGN1 HMG14 | ______________MPKRKVssAEGAAKEEPKRRsARLsAK |
| P05204 | S25 | iPTMNet|EPSD | HMGN2 HMG17 | KAEGDAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAP |
| P05204 | S29 | iPTMNet|EPSD | HMGN2 HMG17 | DAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAPAKKG |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05549 | S239 | EPSD|PSP | TFAP2A AP2TF TFAP2 | sLLsstsKYKVTVAEVQRRLsPPECLNASLLGGVLRRAKsK |
| P05783 | S305 | Sugiyama | KRT18 CYK18 PIG46 | QSAEVGAAETTLTELRRtVQsLEIDLDsMRNLKAsLENsLR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P06239 | S42 | iPTMNet|EPSD|PSP | LCK | NCHYPIVPLDGKGTLLIRNGsEVRDPLVTYEGsNPPAsPLQ |
| P06241 | S21 | EPSD|PSP | FYN | MGCVQCKDKEAtKLtEERDGsLNQssGyRyGTDPTPQHyPS |
| P06400 | S780 | EPSD|PSP | RB1 | FMQRLKtNILQyAstRPPtLsPIPHIPRsPyKFPssPLRIP |
| P06737 | S430 | Sugiyama | PYGL | KHLDRIVALFPKDVDRLRRMsLIEEEGSKRINMAHLCIVGS |
| P06744 | S107 | Sugiyama | GPI | GEKINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLD |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P07101 | S40 | iPTMNet|EPSD|PSP | TH TYH | ELDAKQAEAIMVRGQGAPGPsLTGsPWPGTAAPAASYTPTP |
| P07101 | S71 | ELM|EPSD|PSP | TH TYH | APAASYTPTPRsPRFIGRRQsLIEDARKEREAAVAAAAAAV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07384 | S255 | EPSD|PSP | CAPN1 CANPL1 PIG30 | YQIILKALERGSLLGCSIDIssVLDMEAITFKKLVKGHAYS |
| P07384 | S256 | EPSD|PSP | CAPN1 CANPL1 PIG30 | QIILKALERGSLLGCSIDIssVLDMEAITFKKLVKGHAYSV |
| P07384 | S415 | EPSD|PSP | CAPN1 CANPL1 PIG30 | PQFKIRLDETDDPDDyGDREsGCsFVLALMQKHRRRERRFG |
| P07384 | S418 | EPSD|PSP | CAPN1 CANPL1 PIG30 | KIRLDETDDPDDyGDREsGCsFVLALMQKHRRRERRFGRDM |
| P07384 | S474 | EPSD|PSP|Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07550 | S261 | EPSD|PSP | ADRB2 ADRB2R B2AR | HVQNLsQVEQDGRTGHGLRRssKFCLKEHKALKTLGIIMGT |
| P07550 | S262 | ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | VQNLsQVEQDGRTGHGLRRssKFCLKEHKALKTLGIIMGTF |
| P07550 | S345 | ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | IyCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsG |
| P07550 | S346 | ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | yCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsGY |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | S138 | PSP | PFN1 | GVHGGLINKKCyEMAsHLRRsQY__________________ |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S72 | PSP | PFN1 | VGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFsMDLRtKs |
| P07814 | S1336 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | SEEDKEALIAKCNDYRRRLLsVNIRVRADLRDNysPGWKFN |
| P07814 | S330 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KHRKNPIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGC |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | T90 | EPSD|PSP | HSP90AA1 HSP90A HSPC1 HSPCA | LDsGKELHINLIPNKQDRtLtIVDtGIGMTKADLINNLGtI |
| P07942 | S1115 | Sugiyama | LAMB1 | SCNEFTGQCQCMPGFGGRTCsECQELFWGDPDVECRACDCD |
| P07949 | S696 | EPSD|PSP | RET CDHF12 CDHR16 PTC | FRRPAQAFPVsysssGARRPsLDSMENQVSVDAFKILEDPK |
| P08034 | S233 | ELM|iPTMNet|EPSD | GJB1 CX32 | IIRACARRAQRRSNPPsRKGsGFGHRLSPEyKQNEINKLLS |
| P08138 | S303 | ELM | NGFR TNFRSF16 | QGANsRPVNQtPPPEGEKLHsDsGIsVDsQsLHDQQPHTQT |
| P08151 | S544 | EPSD|PSP | GLI1 GLI | HTGtTVSRRVGPPVSLERRssSSSSIsSAYtVSRRssLASP |
| P08151 | S560 | EPSD|PSP | GLI1 GLI | ERRssSSSSIsSAYtVSRRssLASPFPPGsPPENGASSLPG |
| P08151 | S640 | EPSD|PSP | GLI1 GLI | WRSRAEyPGYNPNAGVTRRAsDPAQAADRPAPARVQRFKSL |
| P08151 | T374 | EPSD|PSP | GLI1 GLI | RTHSNEKPYVCKLPGCTKRYtDPSSLRKHVKTVHGPDAHVt |
| P08174 | S106 | Sugiyama | CD55 CR DAF | QWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVGtVVE |
| P08174 | S108 | Sugiyama | CD55 CR DAF | SDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVGtVVEyE |
| P08183 | S667 | ELM|EPSD|PSP | ABCB1 MDR1 PGY1 | EIDALEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEA |
| P08183 | S671 | EPSD|PSP | ABCB1 MDR1 PGY1 | LEMssNDsRssLIRKRsTRRsVRGSQAQDRKLsTKEALDES |
| P08183 | S683 | ELM|EPSD|PSP | ABCB1 MDR1 PGY1 | IRKRsTRRsVRGSQAQDRKLsTKEALDESIPPVSFWRIMKL |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | S206 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEREKEIs |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S615 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tyGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIV |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08588 | S312 | EPSD|PSP | ADRB1 ADRB1R B1AR | PAAAAATAPLANGRAGKRRPsRLVALREQKALKTLGIIMGV |
| P08670 | S25 | iPTMNet|EPSD | VIM | sVssssYRRMFGGPGtAsRPsssRsYVttsTRtYsLGsALR |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08670 | S39 | iPTMNet|EPSD|PSP | VIM | GtAsRPsssRsYVttsTRtYsLGsALRPstsRsLyAssPGG |
| P08670 | S47 | iPTMNet|EPSD | VIM | sRsYVttsTRtYsLGsALRPstsRsLyAssPGGVyAtRssA |
| P08670 | S7 | iPTMNet|EPSD | VIM | ______________MstRsVssssYRRMFGGPGtAsRPsss |
| P08670 | S72 | EPSD|PSP | VIM | LyAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAI |
| P08670 | S73 | EPSD|PSP | VIM | yAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAIN |
| P08684 | S116 | EPSD|PSP | CYP3A4 CYP3A3 | KECYsVFtNRRPFGPVGFMKsAIsIAEDEEWKRLRsLLsPt |
| P08684 | S119 | EPSD|PSP | CYP3A4 CYP3A3 | YsVFtNRRPFGPVGFMKsAIsIAEDEEWKRLRsLLsPtFts |
| P08684 | S134 | EPSD|PSP | CYP3A4 CYP3A3 | MKsAIsIAEDEEWKRLRsLLsPtFtsGKLKEMVPIIAQYGD |
| P08684 | S259 | EPSD|PSP | CYP3A4 CYP3A3 | CVFPREVTNFLRKSVKRMKEsRLEDtQKHRVDFLQLMIDSQ |
| P08684 | S478 | EPSD|PSP | CYP3A4 CYP3A3 | RVLQNFSFKPCKETQIPLKLsLGGLLQPEKPVVLKVESRDG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P08833 | S126 | PSP | IGFBP1 IBP1 | QESDASAPHAAEAGSPEsPEsTEITEEELLDNFHLMAPsEE |
| P08833 | S144 | PSP | IGFBP1 IBP1 | PEsTEITEEELLDNFHLMAPsEEDHSILWDAISTYDGSKAL |
| P08833 | S194 | PSP | IGFBP1 IBP1 | EPCRIELYRVVESLAKAQETsGEEIsKFYLPNCNKNGFYHS |
| P08833 | S199 | PSP | IGFBP1 IBP1 | ELYRVVESLAKAQETsGEEIsKFYLPNCNKNGFYHSRQCET |
| P09651 | S199 | ELM | HNRNPA1 HNRPA1 | KALSKQEMAsAsssQRGRsGsGNFGGGRGGGFGGNDNFGRG |
| P09874 | S465 | PSP | PARP1 ADPRT PPOL | EVKEANIRVVsEDFLQDVsAstKSLQELFLAHILSPWGAEV |
| P09874 | S782 | PSP | PARP1 ADPRT PPOL | VEMLDNLLDIEVAySLLRGGsDDssKDPIDVNyEKLKTDIK |
| P09874 | S785 | PSP | PARP1 ADPRT PPOL | LDNLLDIEVAySLLRGGsDDssKDPIDVNyEKLKTDIKVVD |
| P09917 | S272 | ELM|EPSD|PSP | ALOX5 LOG5 | LPEKLPVtTEMVECSLERQLsLEQEVQQGNIFIVDFELLDG |
| P09917 | S448 | PSP | ALOX5 LOG5 | TGGGGHVQMVQRAMKDLTyAsLCFPEAIKARGMESKEDIPY |
| P09917 | S524 | ELM|EPSD|PSP | ALOX5 LOG5 | PELQDFVNDVYVYGMRGRKSsGFPKSVKSREQLSEYLTVVI |
| P09917 | S671 | PSP | ALOX5 LOG5 | ERNKKKQLPYYYLsPDRIPNsVAI_________________ |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0C0L4 | S1567 | Sugiyama | C4A CO4 CPAMD2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0C0L5 | S1567 | Sugiyama | C4B CO4 CPAMD3; C4B_2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DMV8 | S418 | EPSD|PSP | HSPA1A HSP72 HSPA1 HSX70 | PLSLGLETAGGVMTALIKRNsTIPTKQTQIFTTYSDNQPGV |
| P0DN86 | S116 | ELM | CGB3 CGB; CGB5; CGB8 | VNPVVSYAVALSCQCALCRRstTDCGGPKDHPLTCDDPRFQ |
| P0DN86 | S86 | ELM | CGB3 CGB; CGB5; CGB8 | QGVLPALPQVVCNYRDVRFEsIRLPGCPRGVNPVVSYAVAL |
| P0DN86 | T117 | ELM | CGB3 CGB; CGB5; CGB8 | NPVVSYAVALSCQCALCRRstTDCGGPKDHPLTCDDPRFQD |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10071 | S1006 | EPSD|PSP | GLI3 | GYGRRHLQPHDAPGHGVRRAsDPVRTGSEGLALPRVPRFSS |
| P10071 | S849 | EPSD|PSP | GLI3 | GRSDLSGVDVTMLNMLNRRDssASTISSAYLSSRRssGISP |
| P10071 | S865 | EPSD|PSP | GLI3 | NRRDssASTISSAYLSSRRssGISPCFSSRRSsEAsQAEGR |
| P10071 | S877 | EPSD|PSP | GLI3 | AYLSSRRssGISPCFSSRRSsEAsQAEGRPQNVSVADSYDP |
| P10071 | S907 | EPSD|PSP | GLI3 | QNVSVADSYDPISTDASRRssEASQSDGLPsLLSLTPAQQY |
| P10071 | S980 | EPSD|PSP | GLI3 | LGDALEPGVALPPVHAPRRCsDGGAHGYGRRHLQPHDAPGH |
| P10276 | S219 | EPSD|PSP | RARA NR1B1 | FPALCQLGKYTTNNSSEQRVsLDIDLWDKFSELSTKCIIKT |
| P10276 | S369 | EPSD|PSP | RARA NR1B1 | DMLQEPLLEALKVYVRKRRPsRPHMFPKMLMKITDLRSISA |
| P10412 | S36 | EPSD|PSP|Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10636 | S214 | EPSD | MAPT MAPTL MTBT1 TAU | GDLHQEGPPLKGAGGKERPGsKEEVDEDRDVDESsPQDsPP |
| P10636 | S512 | EPSD | MAPT MAPTL MTBT1 TAU | tPPAPKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsL |
| P10636 | S515 | EPSD | MAPT MAPTL MTBT1 TAU | APKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtP |
| P10636 | S516 | EPSD | MAPT MAPTL MTBT1 TAU | PKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPP |
| P10636 | S531 | ELM|EPSD|PSP | MAPT MAPTL MTBT1 TAU | RsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPK |
| P10636 | S579 | EPSD|PSP | MAPT MAPTL MTBT1 TAU | RLQTAPVPMPDLKNVKsKIGstENLKHQPGGGKVQIINKKL |
| P10636 | S673 | EPSD|PSP | MAPT MAPTL MTBT1 TAU | QVEVKSEKLDFKDRVQsKIGsLDNITHVPGGGNKKIEtHKL |
| P10636 | S726 | EPSD|PSP | MAPT MAPTL MTBT1 TAU | GAEIVyKsPVVsGDtsPRHLsNVsstGsIDMVDsPQLAtLA |
| P10636 | T173 | iPTMNet|EPSD | MAPT MAPTL MTBT1 TAU | MPGAPLLPEGPREATRQPsGtGPEDTEGGRHAPELLKHQLL |
| P10636 | T529 | EPSD | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10636 | T548 | EPSD | MAPT MAPTL MTBT1 TAU | RtPsLPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMP |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11137 | S1675 | EPSD | MAP2 | AtPKQLRLINQPLPDLKNVKsKIGsTDNIKYQPKGGQVQIV |
| P11137 | S1679 | EPSD|PSP | MAP2 | QLRLINQPLPDLKNVKsKIGsTDNIKYQPKGGQVQIVTKKI |
| P11137 | S1710 | EPSD|PSP | MAP2 | GQVQIVTKKIDLSHVTSKCGsLKNIRHRPGGGRVKIESVKL |
| P11137 | S1782 | EPSD|PSP | MAP2 | LNFREHAKARVDHGAEIItQsPGRssVAsPRRLsNVsssGs |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11168 | S491 | ELM|iPTMNet|EPSD | SLC2A2 GLUT2 | GVLLAFTLFTFFKVPETKGKsFEEIAAEFQKKsGsAHRPKA |
| P11168 | S503 | ELM|iPTMNet|EPSD | SLC2A2 GLUT2 | KVPETKGKsFEEIAAEFQKKsGsAHRPKAAVEMKFLGATET |
| P11168 | S505 | ELM|iPTMNet|EPSD | SLC2A2 GLUT2 | PETKGKsFEEIAAEFQKKsGsAHRPKAAVEMKFLGATETV_ |
| P11413 | S106 | Sugiyama | G6PD | PFFKATPEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMN |
| P11413 | Y107 | Sugiyama | G6PD | FFKATPEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMNA |
| P11473 | S182 | ELM|EPSD|PSP | VDR NR1I1 | GGGSHPSRPNsRHtPSFSGDsSSSCSDHCITSSDMMDSSSF |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11586 | S490 | Sugiyama | MTHFD1 MTHFC MTHFD | QTDKALFNRLVPSVNGVRRFsDIQIRRLKRLGIEKTDPTTL |
| P11717 | S1378 | Sugiyama | IGF2R MPRI | QYACPPFDLTECSFKDGAGNsFDLsSLSRYSDNWEAITGTG |
| P11831 | T159 | EPSD|PSP | SRF | KTRGRVKIKMEFIDNKLRRYttFsKRKTGIMKKAYELSTLT |
| P11940 | S51 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | FSPAGPILsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12268 | S496 | Sugiyama | IMPDH2 IMPD2 | LTQVRAMMYSGELKFEKRtssAQVEGGVHsLHsyEKRLF__ |
| P12270 | S2108 | EPSD|PSP | TPR | HAPPQELGPPVQRIQMTRRQsVGRGLQLtPGIGGMQQHFFD |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P12931 | S17 | ELM|iPTMNet|EPSD|PSP | SRC SRC1 | ____MGSNKSKPKDAsQRRRsLEPAENVHGAGGGAFPAsQt |
| P12931 | Y419 | EPSD|PSP | SRC SRC1 | ENLVCKVADFGLARLIEDNEytARQGAKFPIKWTAPEAALy |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13224 | S191 | ELM|iPTMNet|EPSD | GP1BB | LLCRLRRLRARARARAAARLsLtDPLVAERAGtDEs_____ |
| P13569 | S660 | ELM|EPSD|PSP | CFTR ABCC7 | FsSKLMGCDSFDQFSAERRNsILTETLHRFsLEGDAPVSWT |
| P13569 | S670 | PSP | CFTR ABCC7 | FDQFSAERRNsILTETLHRFsLEGDAPVSWTEtKKQsFKQT |
| P13569 | S700 | ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | TEtKKQsFKQTGEFGEKRKNsILNPINsIRKFsIVQKTPLQ |
| P13569 | S712 | EPSD|PSP | CFTR ABCC7 | EFGEKRKNsILNPINsIRKFsIVQKTPLQMNGIEEDSDEPL |
| P13569 | S737 | ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | TPLQMNGIEEDSDEPLERRLsLVPDSEQGEAILPRIsVIST |
| P13569 | S753 | ELM|EPSD|PSP | CFTR ABCC7 | ERRLsLVPDSEQGEAILPRIsVISTGPTLQARRRQsVLNLM |
| P13569 | S768 | ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | ILPRIsVISTGPTLQARRRQsVLNLMTHSVNQGQNIHRKTT |
| P13569 | S795 | ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | HSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsRRLsQE |
| P13569 | S813 | ELM|iPTMNet|EPSD|PSP | CFTR ABCC7 | KVsLAPQANLTELDIYsRRLsQEtGLEISEEINEEDLKECF |
| P13612 | S1021 | iPTMNet|EPSD|PSP | ITGA4 CD49D | KAGFFKRQYKsILQEENRRDsWsyINsKSNDD_________ |
| P13612 | S1027 | ELM | ITGA4 CD49D | RQYKsILQEENRRDsWsyINsKSNDD_______________ |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13688 | S461 | PSP | CEACAM1 BGP BGP1 | VALIAVALACFLHFGKtGRAsDQRDLtEHKPsVSNHTQDHS |
| P13688 | S472 | PSP | CEACAM1 BGP BGP1 | LHFGKtGRAsDQRDLtEHKPsVSNHTQDHSNDPPNKMNEVt |
| P13688 | S512 | PSP | CEACAM1 BGP BGP1 | tysTLNFEAQQPTQPTsASPsLTATEIIySEVKKQ______ |
| P13796 | S5 | ELM|iPTMNet|EPSD|PSP | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P13796 | S7 | ELM | LCP1 PLS2 | ______________MARGsVsDEEMMELREAFAKVDtDGNG |
| P13798 | S27 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | LsEPEEAAALyRGLSRQPALsAACLGPEVtTQyGGQyRTVH |
| P13807 | S710 | iPTMNet|EPSD | GYS1 GYS | APEWPRRAsCTsSTSGSKRNsVDtAtsssLstPsEPLsPts |
| P13807 | S8 | iPTMNet|EPSD | GYS1 GYS | _____________MPLNRTLsMssLPGLEDWEDEFDLENAV |
| P13861 | S58 | Sugiyama | PRKAR2A PKR2 PRKAR2 | TRLREARAPAsVLPAAtPRQsLGHPPPEPGPDRVADAKGDs |
| P13861 | S99 | ELM|Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14136 | S13 | iPTMNet|EPSD|PSP | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S17 | iPTMNet|EPSD | GFAP | ____MERRRItsAARRsYVssGEMMVGGLAPGRRLGPGTRL |
| P14136 | S38 | iPTMNet|EPSD|PSP | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14136 | S8 | EPSD|PSP | GFAP | _____________MERRRItsAARRsYVssGEMMVGGLAPG |
| P14136 | T7 | EPSD|PSP | GFAP | ______________MERRRItsAARRsYVssGEMMVGGLAP |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14410 | S7 | ELM|iPTMNet|EPSD | SI | ______________MARKKFsGLEISLIVLFVIVTIIAIAL |
| P14598 | S303 | ELM | NCF1 NOXO2 SH3PXD1A | sGQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDA |
| P14598 | S320 | ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S328 | ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14598 | S348 | ELM | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14598 | S359 | ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | ELM|EPSD|PSP | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14859 | S385 | ELM | POU2F1 OCT1 OTF1 | PsALNsPGIEGLSRRRKKRtsIETNIRVALEKSFLENQKPT |
| P14866 | S539 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | EICDELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETL |
| P14866 | S542 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | DELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFL |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15056 | S429 | ELM | BRAF BRAF1 RAFB1 | SLTNVKALQKsPGPQRERKsssssEDRNRMKtLGRRDssDD |
| P15056 | S430 | iPTMNet|EPSD | BRAF BRAF1 RAFB1 | LTNVKALQKsPGPQRERKsssssEDRNRMKtLGRRDssDDW |
| P15311 | S66 | EPSD|PSP | EZR VIL2 | GLHYVDNKGFPTWLKLDKKVsAQEVRKENPLQFKFRAKFyP |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P15924 | S2849 | ELM|iPTMNet|EPSD|PSP | DSP | sRsGsRSGsRsGsRsGsRRGsFDAtGNssYsYSYSFSsssI |
| P16066 | S529 | ELM|EPSD|PSP | NPR1 ANPRA | RVRWEDVEPSsLERHLRSAGsRLtLsGRGsNyGsLLtTEGQ |
| P16070 | S43 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLNITCRFAGVFHVEKNGRYsIsRtEAADLCKAFNSTLPTM |
| P16070 | S697 | EPSD|PSP | CD44 LHR MDU2 MDU3 MIC4 | GQKKKLVINsGNGAVEDRKPsGLNGEAsKsQEMVHLVNKEs |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16144 | S1364 | EPSD|PSP | ITGB4 | DSFLMYSDDVLRsPSGsQRPsVSDDTGCGWKFEPLLGEELD |
| P16220 | S119 | PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16333 | S85 | Sugiyama | NCK1 NCK | ASIVKNLKDTLGIGKVKRKPsVPDsAsPADDsFVDPGERLy |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16452 | S248 | ELM | EPB42 E42P | LPTPQTQATQEGALLNKRRGsVPILRQWLTGRGRPVYDGQA |
| P16949 | S16 | iPTMNet|EPSD|PSP|Sugiyama | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P16949 | S63 | ELM|iPTMNet|EPSD|PSP | STMN1 C1orf215 LAP18 OP18 | KDLsLEEIQKKLEAAEERRKsHEAEVLKQLAEKREHEKEVL |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17302 | S364 | PSP | GJA1 GJAL | sKKLAAGHELQPLAIVDQRPssRAssRAssRPRPDDLEI__ |
| P17302 | S365 | PSP | GJA1 GJAL | KKLAAGHELQPLAIVDQRPssRAssRAssRPRPDDLEI___ |
| P17302 | S369 | EPSD|PSP | GJA1 GJAL | AGHELQPLAIVDQRPssRAssRAssRPRPDDLEI_______ |
| P17302 | S373 | EPSD|PSP | GJA1 GJAL | LQPLAIVDQRPssRAssRAssRPRPDDLEI___________ |
| P17542 | S172 | ELM|EPSD|PSP | TAL1 BHLHA17 SCL TCL5 | FGEPDAFPMFTTNNRVKRRPsPYEMEITDGPHTKVVRRIFT |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17600 | S9 | iPTMNet|EPSD | SYN1 | ____________MNYLRRRLsDSNFMANLPNGYMTDLQRPQ |
| P17612 | S11 | GPS6 | PRKACA PKACA | __________MGNAAAAKKGsEQEsVKEFLAKAKEDFLKKW |
| P17612 | S140 | GPS6 | PRKACA PKACA | VMEYVPGGEMFSHLRRIGRFsEPHARFYAAQIVLTFEYLHS |
| P17612 | S15 | GPS6 | PRKACA PKACA | ______MGNAAAAKKGsEQEsVKEFLAKAKEDFLKKWESPA |
| P17612 | S213 | GPS6 | PRKACA PKACA | KGRtWtLCGtPEYLAPEIILsKGYNKAVDWWALGVLIYEMA |
| P17612 | S260 | GPS6 | PRKACA PKACA | FADQPIQIYEKIVSGKVRFPsHFSSDLKDLLRNLLQVDLTK |
| P17612 | S326 | GPS6 | PRKACA PKACA | IYQRKVEAPFIPKFKGPGDTsNFDDyEEEEIRVsINEKCGK |
| P17612 | S339 | GPS6|PSP | PRKACA PKACA | FKGPGDTsNFDDyEEEEIRVsINEKCGKEFSEF________ |
| P17612 | S54 | GPS6 | PRKACA PKACA | PAQNTAHLDQFERIKtLGtGsFGRVMLVKHKETGNHyAMKI |
| P17612 | T198 | GPS6|EPSD|PSP | PRKACA PKACA | QGYIQVTDFGFAKRVKGRtWtLCGtPEYLAPEIILsKGYNK |
| P17612 | T49 | GPS6 | PRKACA PKACA | KKWESPAQNTAHLDQFERIKtLGtGsFGRVMLVKHKETGNH |
| P17655 | S369 | ELM|EPSD|PSP | CAPN2 CANPL2 | TSDTYKKWKLTKMDGNWRRGstAGGCRNYPNTFWMNPQYLI |
| P17655 | T370 | ELM|EPSD|PSP | CAPN2 CANPL2 | SDTYKKWKLTKMDGNWRRGstAGGCRNYPNTFWMNPQYLIK |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P17661 | S12 | EPSD|PSP | DES | _________MSQAYSSsQRVssYRRtFGGAPGFPLGsPLss |
| P17661 | T17 | EPSD|PSP | DES | ____MSQAYSSsQRVssYRRtFGGAPGFPLGsPLssPVFPR |
| P17661 | T76 | EPSD|PSP | DES | VSRtsGGAGGLGsLRAsRLGttRtPssyGAGELLDFsLADA |
| P17676 | S288 | ELM|EPSD|PSP | CEBPB TCF5 PP9092 | DKHSDEYKIRRERNNIAVRKsRDKAKMRNLETQHKVLELTA |
| P17752 | S260 | PSP | TPH1 TPH TPRH TRPH | DFLSGLAFRVFHCTQYVRHSsDPFYTPEPDTCHELLGHVPL |
| P17752 | S58 | ELM|iPTMNet|EPSD|PSP | TPH1 TPH TPRH TRPH | FQEKHVNLLHIESRKSKRRNsEFEIFVDCDINREQLNDIFH |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17812 | T455 | ELM|EPSD|PSP | CTPS1 CTPS | DMPEHNPGQMGGTMRLGKRRtLFQTKNsVMRKLyGDADyLE |
| P17858 | T773 | ELM | PFKL | QYRISMAAYVsGELEHVTRRtLsMDKGF_____________ |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18505 | S434 | ELM | GABRB1 | YGRALDRHGVPSKGRIRRRAsQLKVKIPDLTDVNSIDKWSR |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18846 | S63 | iPTMNet|EPSD | ATF1 | DsSDsIGssQKAHGILARRPsYRKILKDLsSEDTRGRKGDG |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19174 | S1248 | ELM|EPSD|PSP | PLCG1 PLC1 | LRERGsDASGQLFHGRAREGsFEsRyQQPFEDFRIsQEHLA |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19429 | S166 | EPSD|PSP | TNNI3 TNNC1 | RVRIsADAMMQALLGARAKEsLDLRAHLKQVKKEDTEKENR |
| P19429 | S23 | ELM|EPSD|PSP | TNNI3 TNNC1 | DGSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsA |
| P19429 | S24 | ELM|EPSD|PSP | TNNI3 TNNC1 | GSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAs |
| P19429 | S39 | EPSD|PSP | TNNI3 TNNC1 | IRRRssNyRAYAtEPHAKKKsKIsAsRKLQLKtLLLQIAKQ |
| P19438 | T411 | PSP | TNFRSF1A TNFAR TNFR1 | QNGRCLREAQySMLATWRRRtPRREAtLELLGRVLRDMDLL |
| P19438 | T417 | PSP | TNFRSF1A TNFAR TNFR1 | REAQySMLATWRRRtPRREAtLELLGRVLRDMDLLGCLEDI |
| P19544 | S365 | ELM|EPSD|PSP | WT1 | RKHTGEKPYQCDFKDCERRFsRSDQLKRHQRRHTGVKPFQC |
| P19544 | S393 | ELM|EPSD|PSP | WT1 | HQRRHTGVKPFQCKTCQRKFsRSDHLKTHTRTHTGKTSEKP |
| P19793 | S27 | EPSD|PSP | RXRA NR2B1 | LPLDFSTQVNSSLtsPtGRGsMAAPsLHPSLGPGIGSPGQL |
| P19838 | S337 | ELM|EPSD|PSP | NFKB1 | KYKDINITKPAsVFVQLRRKsDLETSEPKPFLYYPEIKDKE |
| P20020 | S1178 | ELM|iPTMNet|EPSD | ATP2B1 PMCA1 | HIPLIDDTDAEDDAPTKRNSsPPPSPNKNNNAVDSGIHLTI |
| P20265 | S360 | EPSD|PSP | POU3F2 BRN2 OCT7 OTF7 | GsPtSIDKIAAQGRKRKKRTsIEVSVKGALESHFLKCPKPS |
| P20290 | S173 | Sugiyama | BTF3 NACB OK/SW-cl.8 | QLGADsLtsLRRLAEALPKQsVDGKAPLAtGEDDDDEVPDL |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P20941 | S73 | iPTMNet|EPSD | PDC | MsSPQSRNGKDSKERVSRKMsIQEYELIHKEKEDENCLRKY |
| P21281 | T115 | Sugiyama | ATP6V1B2 ATP6B2 VPP3 | VVQVFEGTSGIDAKKTSCEFtGDILRTPVSEDMLGRVFNGS |
| P21333 | S2152 | EPSD|PSP | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21731 | S324 | PSP | TBXA2R | DPWVYILFRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ_ |
| P21731 | S329 | EPSD|PSP | TBXA2R | ILFRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ______ |
| P21731 | S331 | PSP|Sugiyama | TBXA2R | FRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ________ |
| P21817 | S2843 | iPTMNet|EPSD | RYR1 RYDR | IEKAREGEEEKTEKKKTRKIsQsAQtyDPREGYNPQPPDLS |
| P21980 | S215 | EPSD|PSP | TGM2 | ILLDVNPKFLKNAGRDCsRRssPVYVGRVVsGMVNCNDDQG |
| P21980 | S216 | EPSD|PSP | TGM2 | LLDVNPKFLKNAGRDCsRRssPVYVGRVVsGMVNCNDDQGV |
| P22033 | S481 | Sugiyama | MMUT MUT | EGIPKLRIEECAARRQARIDsGSEVIVGVNKYQLEKEDAVE |
| P22059 | T377 | Sugiyama | OSBP OSBP1 | NEFFDAPEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQ |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22459 | T601 | EPSD|PSP | KCNA4 KCNA4L | QNAVSCPYLPSNLLKKFRSStSSSLGDKSEYLEMEEGVKES |
| P22626 | S231 | Sugiyama | HNRNPA2B1 HNRPA2B1 | DsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyNGyGGGP |
| P23142 | S246 | Sugiyama | FBLN1 PP213 | SCRLGESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDEC |
| P23142 | S247 | Sugiyama | FBLN1 PP213 | CRLGESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDECE |
| P23193 | S57 | Sugiyama | TCEA1 GTF2S TFIIS | TLELLQSTRIGMSVNAIRKQstDEEVTSLAKSLIKSWKKLL |
| P23381 | S353 | Sugiyama | WARS1 IFI53 WARS WRS | ALLHSTFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVN |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P23588 | S359 | Sugiyama | EIF4B | RstPKEDDSsASTSQSTRAAsIFGGAKPVDtAAREREVEER |
| P23677 | T311 | iPTMNet|EPSD | ITPKA | KMLAVDPEAPTEEEHAQRAVtKPRYMQWREGISSSTTLGFR |
| P23771 | S308 | EPSD|PSP | GATA3 | GLYHKMNGQNRPLIKPKRRLsAARRAGTSCANCQTTTTTLW |
| P24046 | S444 | iPTMNet|EPSD | GABRR1 | MVQLTLAsERssPQRKsQRssYVsMRIDTHAIDKYSRIIFP |
| P24385 | S197 | ELM|iPTMNet|EPSD|PSP | CCND1 BCL1 PRAD1 | IIRKHAQTFVALCATDVKFIsNPPSMVAAGSVVAAVQGLNL |
| P24385 | S234 | ELM|iPTMNet|EPSD|PSP | CCND1 BCL1 PRAD1 | GLNLRsPNNFLSYYRLTRFLsRVIKCDPDCLRACQEQIEAL |
| P24385 | S90 | ELM|iPTMNet|EPSD|PSP | CCND1 BCL1 PRAD1 | EQKCEEEVFPLAMNYLDRFLsLEPVKKSRLQLLGATCMFVA |
| P24390 | S209 | EPSD|PSP | KDELR1 ERD2.1 | VLYCDFFYLYITKVLKGKKLsLPA_________________ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P24752 | S69 | Sugiyama | ACAT1 ACAT MAT | RTPIGSFLGSLSLLPATKLGsIAIQGAIEKAGIPKEEVKEA |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S2054 | ELM|iPTMNet|EPSD | APC DP2.5 | sEDDLLQECISSAMPKKKKPsRLKGDNEKHsPRNMGGILGE |
| P25098 | S685 | ELM|iPTMNet|EPSD | GRK2 ADRBK1 BARK BARK1 | KNKPRsPVVELsKVPLVQRGsANGL________________ |
| P25205 | S374 | Sugiyama | MCM3 | LLRYVLCTAPRAIPttGRGSsGVGLTAAVtTDQETGERRLE |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25685 | S252 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | PADIVFVLKDKPHNIFKRDGsDVIYPARISLREALCGCTVN |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25786 | S211 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | GLRALRETLPAEQDLttKNVsIGIVGKDLEFTIyDDDDVsP |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P26038 | T558 | ELM|EPSD|PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26374 | S321 | Sugiyama | CHML REP2 | LTFCLEYEQHPDEYQAFRQCsFSEYLKTKKLTPNLQHFVLH |
| P26599 | S16 | ELM|iPTMNet|EPSD|PSP | PTBP1 PTB | _____MDGIVPDIAVGTKRGsDELFSTCVTNGPFIMSSNSA |
| P26678 | S16 | ELM|iPTMNet|EPSD|PSP | PLN PLB | _____MEKVQYLTRSAIRRAstIEMPQQARQKLQNLFINFC |
| P27105 | S10 | ELM | STOM BND7 EPB72 | ___________MAEKRHTRDsEAQRLPDsFKDsPSKGLGPC |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P27448 | T507 | EPSD|PSP | MARK3 CTAK1 EMK2 | KKsstVPSSNTAsGGMTRRNtYVCSERTTADRHSVIQNGKE |
| P27708 | S1406 | ELM|iPTMNet|EPSD|PSP | CAD | EKNFELVINLSMRGAGGRRLssFVTKGYRTRRLAADFSVPL |
| P27708 | S1859 | iPTMNet|EPSD|PSP|Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27815 | S145 | EPSD|PSP | PDE4A DPDE2 | sQAsPGLVLHAGAATSQRREsFLYRSDsDYDMsPKTMSRNs |
| P27816 | S636 | Sugiyama | MAP4 | sAAPtFMIsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNs |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P27986 | S83 | EPSD|PSP | PIK3R1 GRB1 | TGERGDFPGTYVEYIGRKKIsPPTPKPRPPRPLPVAPGSSK |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28340 | S1064 | Sugiyama | POLD1 POLD | LNALEERFSRLWTQCQRCQGsLHEDVICTSRDCPIFyMRKK |
| P29350 | S591 | GPS6 | PTPN6 HCP PTP1C | NKREEKVKKQRSADKEKSKGsLKRK________________ |
| P29401 | S104 | Sugiyama | TKT | AVWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGs |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P29474 | S1177 | EPSD|PSP | NOS3 | EDIFGLTLRTQEVTSRIRtQsFsLQERQLRGAVPWAFDPPG |
| P29474 | S615 | EPSD|PSP | NOS3 | GPYNSsPRPEQHKSYKIRFNsISCSDPLVssWRRKRKEssN |
| P29474 | S633 | ELM|EPSD|PSP | NOS3 | FNsISCSDPLVssWRRKRKEssNtDSAGALGTLRFCVFGLG |
| P29474 | T495 | EPSD|PSP | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29475 | S852 | iPTMNet|EPSD | NOS1 | EMRHPNSVQEERKSYKVRFNsVSSYSDsQKSSGDGPDLRDN |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30153 | S146 | Sugiyama | PPP2R1A | AHFVPLVKRLAGGDWFTSRTsACGLFSVCYPRVSSAVKAEL |
| P30154 | S158 | Sugiyama | PPP2R1B | AYFVPLVKRLASGDWFTSRTsACGLFSVCYPRASNAVKAEI |
| P30273 | S69 | EPSD|PSP | FCER1G | QVRKAAITSyEKsDGVytGLsTRNQEtyEtLKHEKPPQ___ |
| P30301 | S229 | ELM|iPTMNet|EPSD | MIP AQP0 | IIGGGLGSLLYDFLLFPRLKsIsERLsVLKGAKPDVSNGQP |
| P30301 | S231 | ELM|iPTMNet|EPSD | MIP AQP0 | GGGLGSLLYDFLLFPRLKsIsERLsVLKGAKPDVSNGQPEV |
| P30518 | S255 | EPSD|PSP | AVPR2 ADHR DIR DIR3 V2R | SLVPGPSERPGGRRRGRRTGsPGEGAHVSAAVAKTVRMTLV |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31323 | S114 | ELM|EPSD|PSP | PRKAR2B | APADAGAFNAPVINRFTRRAsVCAEAyNPDEEEDDAESRII |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31939 | S554 | Sugiyama | ATIC PURH OK/SW-cl.86 | VSISSDAFFPFRDNVDRAKRsGVAyIAAPSGsAADKVVIEA |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32245 | S329 | ELM|iPTMNet|EPSD | MC4R | LRKtFKEIICCYPLGGLCDLssRY_________________ |
| P32245 | S330 | ELM|iPTMNet|EPSD | MC4R | RKtFKEIICCYPLGGLCDLssRY__________________ |
| P32245 | T312 | ELM|iPTMNet|EPSD|PSP | MC4R | MCNSIIDPLIYALRSQELRKtFKEIICCYPLGGLCDLssRY |
| P32927 | S601 | ELM | CSF2RB IL3RB IL5RB | EKQASSFDFNGPyLGPPHSRsLPDILGQPEPPQEGGSQKSP |
| P33076 | S1050 | GPS6|ELM|iPTMNet|EPSD|PSP | CIITA MHC2TA | LGAYKLAEALPSLAASLLRLsLYNNCICDVGAESLARVLPD |
| P33076 | S1128 | GPS6 | CIITA MHC2TA | WTPTIPFSVQEHLQQQDSRIsLR__________________ |
| P33076 | S834 | GPS6|ELM|iPTMNet|EPSD|PSP | CIITA MHC2TA | HEAEEAGIWQHVVQELPGRLsFLGTRLTPPDAHVLGKALEA |
| P33240 | S310 | Sugiyama | CSTF2 | VSMERGQVPMQDPRAAMQRGsLPANVPtPRGLLGDAPNDPR |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P33992 | S605 | Sugiyama | MCM5 CDC46 | RYIIMRSGARQHERDSDRRSsIPITVRQLEAIVRIAEALSK |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P34998 | S301 | PSP | CRHR1 CRFR CRFR1 CRHR | LINFIFLFNIVRILMTKLRAsTTSETIQYRKAVKATLVLLP |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35222 | S179 | PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | LLNDEDQVVVNKAAVMVHQLsKKEAsRHAIMRsPQMVSAIV |
| P35222 | S45 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | WQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQVLyE |
| P35222 | S552 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AIPRLVQLLVRAHQDtQRRtsMGGtQQQFVEGVRMEEIVEG |
| P35222 | S675 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AAAVLFRMSEDKPQDyKKRLsVELtssLFRTEPMAWNETAD |
| P35222 | T41 | PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDVDTsQ |
| P35236 | S44 | ELM|EPSD|PSP | PTPN7 | QPPPEKTPAKKHVRLQERRGsNVALMLDVRSLGAVEPICsV |
| P35240 | S10 | EPSD|PSP | NF2 SCH | ___________MAGAIASRMsFssLKRKQPKTFTVRIVTMD |
| P35240 | S518 | ELM|EPSD|PSP | NF2 SCH | FNLIGDSLSFDFKDTDMKRLsMEIEKEKVEYMEKSKHLQEQ |
| P35367 | S398 | ELM|EPSD|PSP | HRH1 | sGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQLG |
| P35408 | S222 | ELM | PTGER4 PTGER2 | CNVLVCGALLRMHRQFMRRtsLGtEQHHAAAAASVASRGHP |
| P35408 | S259 | ELM | PTGER4 PTGER2 | RGHPAAsPALPRLSDFRRRRsFRRIAGAEIQMVILLIATSL |
| P35573 | S1282 | Sugiyama | AGL GDE | KMGESDRARNRGIPATPRDGsAVEIVGLSKSAVRWLLELSK |
| P35579 | S1808 | Sugiyama | MYH9 | KELKVKLQEMEGtVKsKYKAsITALEAKIAQLEEQLDNEtK |
| P35611 | S408 | ELM|iPTMNet|EPSD | ADD1 ADDA | GYRTGYPYRYPALREKSKKysDVEVPASVtGysFAsDGDsG |
| P35611 | S436 | ELM|iPTMNet|EPSD | ADD1 ADDA | VtGysFAsDGDsGtCsPLRHsFQKQQREKtRWLNSGRGDEA |
| P35611 | S481 | ELM | ADD1 ADDA | QNGssPKsKTKWTKEDGHRtstsAVPNLFVPLNTNPKEVQE |
| P35611 | S59 | ELM | ADD1 ADDA | RNMAPDLRQDFNMMEQKKRVsMILQsPAFCEELESMIQEQF |
| P35611 | S726 | PSP | ADD1 ADDA | GsDGSPGKSPsKKKKKFRtPsFLKKSKKKSDS_________ |
| P35612 | S713 | iPTMNet|EPSD | ADD2 ADDB | sPEGsPsKsPsKKKKKFRTPsFLKKSKKKEKVEs_______ |
| P35612 | S726 | iPTMNet|EPSD | ADD2 ADDB | KKKFRTPsFLKKSKKKEKVEs____________________ |
| P35612 | T55 | ELM | ADD2 ADDB | RNRAADLRQDFNLMEQKKRVtMILQsPSFREELEGLIQEQM |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36382 | S120 | iPTMNet|EPSD | GJA5 | VRMQEKRKLREAERAKEVRGsGsYEYPVAEKAELSCWEEGN |
| P36382 | S345 | iPTMNet|EPSD | GJA5 | NGVSPGHRLPHGYHSDKRRLsKASSKARSDDLSV_______ |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36955 | S227 | EPSD|PSP | SERPINF1 PEDF PIG35 | LLGVAHFKGQWVTKFDSRKTsLEDFYLDEERTVRVPMMSDP |
| P36956 | S338 | EPSD|PSP | SREBF1 BHLHD1 SREBP1 | AQSRGEKRTAHNAIEKRYRSsINDKIIELKDLVVGTEAKLN |
| P37802 | S163 | EPSD|PSP|Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38606 | S384 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | RLAEMPADSGYPAyLGARLAsFYERAGRVKCLGNPEREGSV |
| P38646 | S148 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | YDDPEVQKDIKNVPFKIVRAsNGDAWVEAHGKLYSPSQIGA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39019 | S59 | EPSD|PSP | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P39880 | S1215 | ELM|EPSD|PSP | CUX1 CUTL1 | VEKLMDMKRMEKKAYMKRRHssVsDsQPCEPPsVGtEysQG |
| P39880 | S1237 | EPSD|PSP | CUX1 CUTL1 | VsDsQPCEPPsVGtEysQGAsPQPQHQLKKPRVVLAPEEKE |
| P39880 | S1270 | EPSD|PSP | CUX1 CUTL1 | VLAPEEKEALKRAYQQKPYPsPKTIEDLATQLNLKTSTVIN |
| P40189 | S838 | Sugiyama | IL6ST | NCsQHEssPDISHFERSKQVssVNEEDFVRLKQQISDHISQ |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P41161 | S367 | ELM|EPSD|PSP | ETV5 ERM | GKVKQEPTMYREGPPYQRRGsLQLWQFLVTLLDDPANAHFI |
| P41181 | S256 | ELM|EPSD|PSP | AQP2 | VLKGLEPDTDWEEREVRRRQsVELHsPQsLPRGtKA_____ |
| P41208 | S170 | ELM|PSP | CETN2 CALT CEN2 | DRDGDGEVsEQEFLRIMKKTsLY__________________ |
| P41240 | S364 | iPTMNet|EPSD|PSP | CSK | DTGKLPVKWTAPEALREKKFsTKSDVWSFGILLWEIYSFGR |
| P42261 | S863 | GPS6|ELM|iPTMNet|EPSD|PSP | GRIA1 GLUA1 GLUH1 GLUR1 | CLIPQQsINEAIRTStLPRNsGAGASSGGSGENGRVVSHDF |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42858 | S2548 | PSP | HTT HD IT15 | EQQPRNKPLKALDTRFGRKLsIIRGIVEQEIQAMVSKRENI |
| P43121 | S93 | Sugiyama | MCAM MUC18 | IFRVRQGQGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P43694 | S262 | EPSD|PSP | GATA4 | GLYHKMNGINRPLIKPQRRLsASRRVGLSCANCQTTTTTLW |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46020 | S1018 | EPSD | PHKA1 PHKA | ERTGIMQLKSEIKQVEFRRLsISAESQsPGtsMtPSSGSFP |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46459 | S207 | Sugiyama | NSF | KAENSSLNLIGKAKTKENRQsIINPDWNFEKMGIGGLDKEF |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46778 | S104 | Sugiyama | RPL21 | ILAKRINVRIEHIKHSKSRDsFLKRVKENDQKKKEAKEKGt |
| P46779 | T89 | Sugiyama | RPL28 | GQRKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMA |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47736 | S490 | ELM|iPTMNet|EPSD|PSP | RAP1GAP KIAA0474 RAP1GA1 | LAKAAGIsLIVPGKsPtRKKsGPFGsRRssAIGIENIQEVQ |
| P47736 | S499 | ELM|iPTMNet|EPSD|PSP | RAP1GAP KIAA0474 RAP1GA1 | IVPGKsPtRKKsGPFGsRRssAIGIENIQEVQEKREsPPAG |
| P48058 | S862 | ELM|iPTMNet|EPSD | GRIA4 GluA4 GLUR4 | AEAKRMKLtFSEAIRNKARLsITGSVGENGRVLTPDCPKAV |
| P48436 | S181 | ELM|EPSD|PSP | SOX9 | LRVQHKKDHPDYKYQPRRRKsVKNGQAEAEEATEQtHIsPN |
| P48436 | S64 | ELM|EPSD|PSP | SOX9 | ENTRPQENTFPKGEPDLKKEsEEDKFPVCIREAVSQVLKGY |
| P48544 | S412 | EPSD|PSP | KCNJ5 GIRK4 | AGLDAEAEQNEEDEPKGLGGsREARGSV_____________ |
| P48544 | T199 | EPSD|PSP | KCNJ5 GIRK4 | NAFMVGCMFVKISQPKKRAEtLMFSNNAVISMRDEKLCLMF |
| P48549 | S385 | EPSD|PSP | KCNJ3 GIRK1 | LLMSSPLIAPAITNSKERHNsVECLDGLDDITTKLPsKLQK |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48729 | S218 | EPSD|PSP | CSNK1A1 | QSRRDDMESLGYVLMYFNRTsLPWQGLKAATKKQKYEKISE |
| P48729 | S242 | EPSD|PSP | CSNK1A1 | QGLKAATKKQKYEKISEKKMsTPVEVLCKGFPAEFAMYLNY |
| P48736 | T1024 | PSP | PIK3CG | PHFQKFQDICVKAYLALRHHtNLLIILFSMMLMTGMPQLTS |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49588 | S237 | Sugiyama | AARS1 AARS | LVFIQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSN |
| P49588 | S627 | Sugiyama | AARS1 AARS | ATHILNFALRSVLGEADQKGsLVAPDRLRFDFTAKGAMSTQ |
| P49588 | T240 | Sugiyama | AARS1 AARS | IQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSNYDT |
| P49675 | S195 | PSP | STAR STARD1 | AGNLVGPRDFVSVRCAKRRGsTCVLAGMATDFGNMPEQKGV |
| P49675 | S57 | PSP | STAR STARD1 | RRALGGPTPSTWINQVRRRSsLLGSRLEETLYSDQELAYLQ |
| P49685 | S357 | EPSD|PSP | GPR15 | LTKALstFIHAEDFARRRKRsVsL_________________ |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49748 | S586 | PSP | ACADVL VLCAD | QRLADGAIDLYAMVVVLSRAsRsLsEGHPTAQHEKMLCDTW |
| P49768 | S310 | ELM|iPTMNet|EPSD | PSEN1 AD3 PS1 PSNL1 | STMVWLVNMAEGDPEAQRRVsKNsKyNAEstEREsQDtVAE |
| P49792 | T3217 | Sugiyama | RANBP2 NUP358 | DTVKKIESFGsPKGSVCRRItITECGQI_____________ |
| P49840 | S21 | ELM|iPTMNet|EPSD|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | ELM|iPTMNet|EPSD|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50402 | S49 | EPSD|PSP | EMD EDMD STA | stRRLyEKKIFEyEtQRRRLsPPsssAAssysFsDLNstRG |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50549 | S191 | iPTMNet|EPSD|PSP | ETV1 ER81 | PSQSIPDSSYPMDHRFRRQLsEPCNSFPPLPTMPREGRPMY |
| P50549 | S216 | iPTMNet|EPSD|PSP | ETV1 ER81 | SFPPLPTMPREGRPMYQRQMsEPNIPFPPQGFKQEYHDPVY |
| P50549 | S334 | iPTMNet|EPSD|PSP | ETV1 ER81 | GDIKQEPGMYREGPTYQRRGsLQLWQFLVALLDDPSNSHFI |
| P50552 | S157 | ELM|iPTMNet|EPSD|PSP | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50552 | S239 | ELM|iPTMNet|EPSD|PSP | VASP | GGAGAPGLAAAIAGAKLRKVsKQEEAsGGPTAPKAESGRSG |
| P50552 | T278 | ELM|iPTMNet|EPSD|PSP | VASP | SGGGGLMEEMNAMLARRRKAtQVGEKtPKDEsANQEEPEAR |
| P50750 | S347 | PSP | CDK9 CDC2L4 TAK | MLSTHLTSMFEyLAPPRRKGsQItQQstNQsRNPAttNQtE |
| P50895 | S621 | EPSD|PSP | BCAM LU MSK19 | EQPEQtGLLMGGAsGGARGGsGGFGDEC_____________ |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51398 | S185 | EPSD|PSP | DAP3 MRPS29 | CRDLLQSSYNKQRFDQPLEAstWLKNFKTTNERFLNQIKVQ |
| P51398 | S220 | EPSD|PSP | DAP3 MRPS29 | NQIKVQEKYVWNKREstEKGsPLGEVVEQGITRVRNAtDAV |
| P51398 | S31 | EPSD|PSP | DAP3 MRPS29 | SRIHKLDPGRFLHMGTQARQsIAAHLDNQVPVEsPRAISRT |
| P51398 | T186 | EPSD|PSP | DAP3 MRPS29 | RDLLQSSYNKQRFDQPLEAstWLKNFKTTNERFLNQIKVQE |
| P51787 | S27 | EPSD|PSP | KCNQ1 KCNA8 KCNA9 KVLQT1 | PPRAERKRWGWGRLPGARRGsAGLAKKCPFSLELAEGGPAG |
| P51858 | S107 | Sugiyama | HDGF HMG1L2 | WEIENNPtVKASGYQSsQKKsCVEEPEPEPEAAEGDGDKKG |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52565 | S174 | EPSD|PSP | ARHGDIA GDIA1 | EEyEFLtPVEEAPKGMLARGsYsIKSRFTDDDKTDHLSWEW |
| P52597 | S265 | Sugiyama | HNRNPF HNRPF | EySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQs |
| P52888 | S643 | ELM|iPTMNet|EPSD | THOP1 | FHTRFKQEGVLNSKVGMDYRsCILRPGGSEDASAMLRRFLG |
| P53041 | S403 | Sugiyama | PPP5C PPP5 | DLLWSDPQPQNGRSISKRGVsCQFGPDVTKAFLEENNLDyI |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53365 | S74 | Sugiyama | ARFIP2 POR1 | GYGGSGDGLIPTGSGRHPSHsTtPSGPGDEVARGIAGEKFD |
| P53396 | S455 | ELM|iPTMNet|EPSD|Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P54253 | S775 | EPSD|PSP | ATXN1 ATX1 SCA1 | APFLTKIEPSKPAATRKRRWsAPESRKLEKSEDEPPLTLPK |
| P54296 | S76 | EPSD|PSP | MYOM2 | RAssQTsLGGTICRVCAKRVstQEDEEQENRSRYQsLVAAY |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55036 | S358 | Sugiyama | PSMD4 MCB1 | VLENLPGVDPNNEAIRNAMGsLAsQATKDGKKDKKEEDKK_ |
| P55042 | S257 | iPTMNet|EPSD | RRAD RAD | HHNVQALFEGVVRQIRLRRDsKEANARRQAGTRRREsLGKK |
| P55042 | S273 | iPTMNet|EPSD|PSP | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55060 | T341 | Sugiyama | CSE1L CAS XPO2 | LASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEA |
| P55064 | S156 | EPSD|PSP | AQP5 | LILTFQLALCIFASTDSRRTsPVGSPALSIGLSVTLGHLVG |
| P55087 | S276 | EPSD|PSP | AQP4 | VEFKRRFKEAFSKAAQQTKGsYMEVEDNRsQVETDDLILKP |
| P55211 | S183 | EPSD|PSP | CASP9 MCH6 | CLIINNVNFCRESGLRTRTGsNIDCEKLRRRFssLHFMVEV |
| P55211 | S195 | EPSD|PSP | CASP9 MCH6 | SGLRTRTGsNIDCEKLRRRFssLHFMVEVKGDLTAKKMVLA |
| P55211 | S99 | EPSD|PSP | CASP9 MCH6 | DTGQDMLASFLRTNRQAAKLsKPTLENLtPVVLRPEIRKPE |
| P55273 | T141 | EPSD|PSP | CDKN2D | AVVSFLAAESDLHRRDARGLtPLELALQRGAQDLVDILQGH |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55884 | S119 | Sugiyama | EIF3B EIF3S9 | PPVPAQGEAPGEQARDERsDsRAQAVsEDAGGNEGRAAEAE |
| P56211 | S104 | PSP | ARPP19 | KTEVTGDHIPTPQDLPQRKPsLVAsKLAG____________ |
| P56524 | S265 | PSP | HDAC4 KIAA0288 | AsEPNLKLRSRLKQKVAERRssPLLRRKDGPVVTALKKRPL |
| P56524 | S266 | PSP | HDAC4 KIAA0288 | sEPNLKLRSRLKQKVAERRssPLLRRKDGPVVTALKKRPLD |
| P56524 | S584 | PSP | HDAC4 KIAA0288 | EsDEEEAEPPREVEPGQRQPsEQELLFRQQALLLEQQRIHQ |
| P56537 | S6 | Sugiyama | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | _______________MAVRAsFENNCEIGCFAKLTNTYCLV |
| P56545 | S164 | PSP | CTBP2 | NLYRRNTWLYQALREGTRVQsVEQIREVASGAARIRGETLG |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60880 | S187 | PSP | SNAP25 SNAP | MGNEIDTQNRQIDRIMEKADsNKTRIDEANQRATKMLGSG_ |
| P60880 | S28 | PSP | SNAP25 SNAP | RNELEEMQRRADQLADESLEstRRMLQLVEESKDAGIRTLV |
| P60880 | T138 | iPTMNet|EPSD|PSP | SNAP25 SNAP | ARVVDEREQMAISGGFIRRVtNDARENEMDENLEQVsGIIG |
| P60880 | T29 | PSP | SNAP25 SNAP | NELEEMQRRADQLADESLEstRRMLQLVEESKDAGIRTLVM |
| P60983 | S83 | ELM|iPTMNet|EPSD|PSP | GMFB | ERQPRFIVYsYKYQHDDGRVsYPLCFIFSSPVGCKPEQQMM |
| P60983 | T27 | ELM|iPTMNet|EPSD|PSP | GMFB | VCDVAEDLVEKLRKFRFRKEtNNAAIIMKIDKDKRLVVLDE |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61224 | S179 | ELM|iPTMNet|EPSD|PSP | RAP1B OK/SW-cl.11 | yDLVRQINRKTPVPGKARKKssCQLL_______________ |
| P61224 | S180 | PSP | RAP1B OK/SW-cl.11 | DLVRQINRKTPVPGKARKKssCQLL________________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61586 | S188 | ELM|iPTMNet|EPSD|PSP | RHOA ARH12 ARHA RHO12 | REVFEMAtRAALQARRGKKKsGCLVL_______________ |
| P61964 | S184 | Sugiyama | WDR5 BIG3 | LKTLPAHSDPVSAVHFNRDGsLIVSSSYDGLCRIWDTASGQ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62195 | S120 | EPSD|PSP | PSMC5 SUG1 | DKNIDINDVtPNCRVALRNDsytLHKILPNKVDPLVSLMMV |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S69 | Sugiyama | RPS14 PRO2640 | GKETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELG |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | S74 | Sugiyama | RPS11 | tyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIVIRRDYLH |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62805 | S48 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | QGItKPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIR |
| P62807 | S15 | ELM | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | ______MPEPAKsAPAPKKGsKKAVTKAQKKDGKKRKRsRK |
| P62807 | S33 | ELM | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KGsKKAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDT |
| P62807 | S37 | ELM|Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62834 | S180 | ELM|iPTMNet|EPSD|PSP | RAP1A KREV1 | DLVRQINRKTPVEKKKPKKKsCLLL________________ |
| P62857 | S23 | Sugiyama | RPS28 | TSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRsII |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | S58 | ELM|EPSD|PSP | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63252 | S425 | EPSD|PSP | KCNJ2 IRK1 | DIDLHNQASVPLEPRPLRREsEI__________________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78348 | S479 | ELM|iPTMNet|EPSD | ASIC1 ACCN2 BNAC2 | EVIKHKLCRRGKCQKEAKRSsADKGVALsLDDVKRHNPCEs |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84243 | S11 | EPSD | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| P84243 | S29 | EPSD | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | RKstGGKAPRKQLATKAARKsAPsTGGVKKPHRyRPGtVAL |
| P98082 | S723 | Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| P98161 | S4252 | EPSD|PSP | PKD1 | ATEDVyQLEQQLHSLQGRRSsRAPAGSSRGPSPGLRPALPS |
| Q00059 | S160 | EPSD|PSP | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00059 | S55 | EPSD|PSP | TFAM TCF6 TCF6L2 | FVYLPRWFSSVLASCPKKPVssYLRFsKEQLPIFKAQNPDA |
| Q00059 | S56 | EPSD|PSP | TFAM TCF6 TCF6L2 | VYLPRWFSSVLASCPKKPVssYLRFsKEQLPIFKAQNPDAK |
| Q00059 | S61 | EPSD|PSP | TFAM TCF6 TCF6L2 | WFSSVLASCPKKPVssYLRFsKEQLPIFKAQNPDAKTTELI |
| Q00341 | S904 | Sugiyama | HDLBP HBP VGL | FHRSVMGPKGSRIQQITRDFsVQIKFPDREENAVHSTEPVV |
| Q00536 | S110 | ELM|EPSD|PSP | CDK16 PCTAIRE1 PCTK1 | sDEVQsPVRVRMRNHPPRKIstEDINKRLsLPADIRLPEGY |
| Q00536 | S119 | ELM|EPSD|PSP | CDK16 PCTAIRE1 PCTK1 | VRMRNHPPRKIstEDINKRLsLPADIRLPEGYLEKLTLNsP |
| Q00536 | S12 | ELM|EPSD|PSP | CDK16 PCTAIRE1 PCTK1 | _________MDRMKKIKRQLsMTLRGGRGIDKTNGAPEQIG |
| Q00536 | S153 | ELM|EPSD|PSP | CDK16 PCTAIRE1 PCTK1 | KLTLNsPIFDKPLsRRLRRVsLsEIGFGKLETYIKLDKLGE |
| Q00587 | S350 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | HyPEMDARQERVEVLPQARAsWEsLDEEWRAPQAGsRtPVP |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00610 | S1483 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VNEsLNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHE |
| Q00613 | S320 | GPS6|EPSD|PSP | HSF1 HSTF1 | EPPsPPQsPRVEEAsPGRPssVDtLLsPtALIDsILREsEP |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01082 | S1966 | Sugiyama | SPTBN1 SPTB2 | VELLMNNHQGIKAEIDARNDsFTTCIELGKSLLARKHYASE |
| Q01082 | T2159 | iPTMNet|EPSD|PSP | SPTBN1 SPTB2 | PRMAETVDTsEMVNGAtEQRtssKEssPIPsPtsDRKAKTA |
| Q01094 | S235 | PSP | E2F1 RBBP3 | ESEQQLDHLMNICTTQLRLLsEDTDSQRLAYVTCQDLRSIA |
| Q01094 | S364 | PSP | E2F1 RBBP3 | tDPSQSLLSLEQEPLLSRMGsLRAPVDEDRLsPLVAADSLL |
| Q01094 | T130 | PSP | E2F1 RBBP3 | GRGRHPGKGVKSPGEKSRYEtSLNLTTKRFLELLSHSADGV |
| Q01130 | S121 | EPSD|PSP | SRSF2 SFRS2 | sRRGPPPRRYGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSR |
| Q01130 | S128 | EPSD|PSP | SRSF2 SFRS2 | RRYGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSRSRYSRSK |
| Q01130 | S130 | EPSD|PSP | SRSF2 SFRS2 | YGGGGYGRRSRsPRRRRRsRsRSRSRSRSRSRSRYSRSKSR |
| Q01130 | S171 | EPSD|PSP | SRSF2 SFRS2 | SRTRSRSRSTSKSRSARRSKsKSSSVSRSRSRSRSRsRsRs |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01860 | S288 | EPSD|PSP | POU5F1 OCT3 OCT4 OTF3 | GLEKDVVRVWFCNRRQKGKRssSDYAQREDFEAAGSPFSGG |
| Q01860 | S289 | EPSD|PSP | POU5F1 OCT3 OCT4 OTF3 | LEKDVVRVWFCNRRQKGKRssSDYAQREDFEAAGSPFSGGP |
| Q01970 | S1105 | ELM|EPSD|PSP | PLCB3 | EMNEREKKELQKILDRKRHNsIsEAKMRDKHKKEAELTEIN |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02952 | S627 | EPSD|PSP | AKAP12 AKAP250 | VtPWAsFKKMVtPKKRVRRPsEsDKEDELDKVKsAtLsstE |
| Q02952 | S696 | EPSD|PSP | AKAP12 AKAP250 | SVSWEALICVGSSKKRARRGsssDEEGGPKAMGGDHQKADE |
| Q02952 | S698 | EPSD|PSP | AKAP12 AKAP250 | SWEALICVGSSKKRARRGsssDEEGGPKAMGGDHQKADEAG |
| Q02952 | S772 | EPSD|PSP | AKAP12 AKAP250 | EGEGVstWEsFKRLVtPRKKsKSKLEEKsEDsIAGsGVEHs |
| Q04206 | S276 | iPTMNet|EPSD|PSP | RELA NFKB3 | PYADPsLQAPVRVsMQLRRPsDRELsEPMEFQYLPDTDDRH |
| Q04206 | S42 | EPSD|PSP | RELA NFKB3 | EIIEQPKQRGMRFRYKCEGRsAGsIPGERSTDTTKTHPTIK |
| Q04206 | S45 | EPSD|PSP | RELA NFKB3 | EQPKQRGMRFRYKCEGRsAGsIPGERSTDTTKTHPTIKING |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05209 | S39 | ELM|iPTMNet|EPSD|PSP | PTPN12 | sPDHNGEDNFARDFMRLRRLsTKYRTEKIyPTATGEKEENV |
| Q05209 | S435 | ELM|iPTMNet|EPSD|PSP | PTPN12 | LPGKNESTIEQIDKKLERNLsFEIKKVPLQEGPKsFDGNtL |
| Q05469 | S853 | ELM|iPTMNet|EPSD|PSP | LIPE | ELSGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKN |
| Q05469 | S855 | ELM|iPTMNet|EPSD | LIPE | SGRKSQKMSEPIAEPMRRsVsEAALAQPQGPLGTDSLKNLT |
| Q05469 | S950 | ELM|iPTMNet|EPSD | LIPE | PMDRGLGVRAAFPEGFHPRRssQGATQMPLYSSPIVKNPFM |
| Q05469 | S951 | ELM|iPTMNet|EPSD|PSP | LIPE | MDRGLGVRAAFPEGFHPRRssQGATQMPLYSSPIVKNPFMS |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06124 | S189 | PSP | PTPN11 PTP2C SHPTP2 | HVMIRCQELKYDVGGGERFDsLTDLVEHYKKNPMVETLGTV |
| Q06124 | T73 | PSP | PTPN11 PTP2C SHPTP2 | HIKIQNTGDyYDLYGGEKFAtLAELVQYYMEHHGQLKEKNG |
| Q06210 | S205 | ELM|EPSD|PSP | GFPT1 GFAT GFPT | FALVFKSVHFPGQAVGTRRGsPLLIGVRSEHKLSTDHIPIL |
| Q06210 | S235 | ELM|EPSD|PSP | GFPT1 GFAT GFPT | HKLSTDHIPILYRTARTQIGsKFTRWGsQGERGKDKKGSCN |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1680 | Sugiyama | TJP1 ZO1 | QGAIPEGVEQEIYFKVCRDNsILPPLDKEKGETLLSPLVMC |
| Q07343 | S133 | ELM|EPSD|PSP | PDE4B DPDE4 | SSSAGLVLHATFPGHSQRREsFLYRsDsDYDLsPKAMSRNS |
| Q07352 | S334 | EPSD|PSP | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | SGSDSPTLDNSRRLPIFsRLsIsDD________________ |
| Q07352 | S54 | EPSD|PSP | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | CLLDRKAVGtPAGGGFPRRHsVTLPSSKFHQNQLLSsLKGE |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07866 | S445 | Sugiyama | KLC1 KLC KNS2 | PIWMHAEEREECKGKQKDGTsFGEyGGWyKACKVDsPtVTT |
| Q07954 | S4517 | ELM | LRP1 A2MR APR | DKPTNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPED |
| Q07954 | S4520 | ELM|iPTMNet|EPSD|PSP | LRP1 A2MR APR | TNFTNPVyATLYMGGHGsRHsLAsTDEKRELLGRGPEDEIG |
| Q07955 | S119 | EPSD|PSP | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | GGGGGGGGAPRGRYGPPSRRsENRVVVSGLPPSGsWQDLKD |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q08289 | S483 | EPSD | CACNB2 CACNLB2 MYSB | ATHPPSSSLPNPLLSRTLATsSLPLSPTLASNsQGSQGDQR |
| Q08289 | S495 | EPSD | CACNB2 CACNLB2 MYSB | LLSRTLATsSLPLSPTLASNsQGSQGDQRTDRSAPIRsAsQ |
| Q08289 | S514 | ELM|EPSD | CACNB2 CACNLB2 MYSB | NsQGSQGDQRTDRSAPIRsAsQAEEEPSVEPVKKSQHRSss |
| Q08289 | S533 | ELM|EPSD | CACNB2 CACNLB2 MYSB | AsQAEEEPSVEPVKKSQHRSssSAPHHNHRSGTSRGLSRQE |
| Q08289 | S534 | ELM|EPSD | CACNB2 CACNLB2 MYSB | sQAEEEPSVEPVKKSQHRSssSAPHHNHRSGTSRGLSRQEt |
| Q08289 | T219 | ELM|EPSD | CACNB2 CACNLB2 MYSB | KSGGNSSSSLGDIVPSSRKstPPssAIDIDATGLDAEENDI |
| Q08378 | S465 | Sugiyama | GOLGA3 | LSTKLQAQVECSHSSQQRQDsLsSEVDTLKQsCWDLERAMT |
| Q08495 | S403 | ELM|iPTMNet|EPSD|PSP | DMTN DMT EPB49 | sPEEFGKLALWKRNELKKKAsLF__________________ |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09470 | S446 | EPSD|PSP | KCNA1 | QLLHVSSPNLASDSDLSRRSsSTMSKSEYMEIEEDMNNSIA |
| Q0VGL1 | S67 | PSP | LAMTOR4 C7orf59 | VSTACGFRLHRGMNVPFKRLsVVFGEHTLLVTVSGQRVFVV |
| Q12778 | S153 | PSP | FOXO1 FKHR FOXO1A | QHPPVPPAAAGPLAGQPRKSsSSRRNAWGNLSYADLITKAI |
| Q12778 | S276 | PSP | FOXO1 FKHR FOXO1A | sMDNNSKFAKSRSRAAKKKAsLQSGQEGAGDsPGSQFSKWP |
| Q12798 | S170 | ELM|iPTMNet|EPSD | CETN1 CEN1 CETN | DRDGDGEVNEEEFLRIMKKTsLY__________________ |
| Q12802 | S1565 | ELM|EPSD|PSP | AKAP13 BRX HT31 LBC | PANCSVLRSSMRSLsPFRRHsWGPGKNAASDAEMNHRSSMR |
| Q12802 | S2733 | ELM|EPSD|PSP | AKAP13 BRX HT31 LBC | PSIAKsGsLDsELsVsPKRNsISRTHKDKGPFHILSSTSQT |
| Q12805 | S196 | Sugiyama | EFEMP1 FBLN3 FBNL | ECTAGTHNCRADQVCINLRGsFACQCPPGYQKRGEQCVDID |
| Q12809 | S1137 | ELM|EPSD | KCNH2 ERG ERG1 HERG | CEELPPGAPELPQEGPTRRLsLPGQLGALTSQPLHRHGSDP |
| Q12809 | S283 | ELM|EPSD | KCNH2 ERG ERG1 HERG | SSCSLARTRSRESCASVRRAssADDIEAMRAGVLPPPPRHA |
| Q12809 | S890 | EPSD | KCNH2 ERG ERG1 HERG | GSPGSTELEGGFSRQRKRKLsFRRRtDKDTEQPGEVSALGP |
| Q12809 | T895 | EPSD | KCNH2 ERG ERG1 HERG | TELEGGFSRQRKRKLsFRRRtDKDTEQPGEVSALGPGRAGA |
| Q12906 | S20 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | _MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtER |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q12972 | S178 | ELM|EPSD | PPP1R8 ARD1 NIPP1 | EEEtELDNLTEFNTAHNKRIsTLTIEEGNLDIQRPKRKRKN |
| Q12972 | S199 | ELM|EPSD | PPP1R8 ARD1 NIPP1 | TLTIEEGNLDIQRPKRKRKNsRVtFsEDDEIINPEDVDPSV |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q12983 | T188 | PSP | BNIP3 NIP3 | SLLLSHLLAIGLGIYIGRRLttststF______________ |
| Q13002 | S697 | ELM | GRIK2 GLUR6 | QTKIEYGAVEDGATMTFFKKsKISTYDKMWAFMSSRRQsVL |
| Q13002 | S715 | ELM | GRIK2 GLUR6 | KKsKISTYDKMWAFMSSRRQsVLVKSNEEGIQRVLTSDYAF |
| Q13085 | S1201 | GPS6|ELM|EPSD | ACACA ACAC ACC1 ACCA | QFMLPTSHPNRGNIPTLNRMsFssNLNHyGMtHVAsVsDVL |
| Q13085 | S78 | GPS6|ELM|EPSD | ACACA ACAC ACC1 ACCA | tLsDLGISSLQDGLALHIRssMsGLHLVKQGRDRKKIDSQR |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13136 | S239 | Sugiyama | PPFIA1 LIP1 | GVLDINHEQENtPstsGKRssDGsLsHEEDLAKVIELQEII |
| Q13136 | S242 | Sugiyama | PPFIA1 LIP1 | DINHEQENtPstsGKRssDGsLsHEEDLAKVIELQEIISKQ |
| Q13185 | S93 | EPSD|PSP | CBX3 | IEAFLNSQKAGKEKDGtKRKsLsDsEsDDsKSKKKRDAADK |
| Q13200 | S361 | PSP | PSMD2 TRAP2 | EPKVPDDIyKtHLENNRFGGsGsQVDSARMNLASSFVNGFV |
| Q13224 | S1166 | PSP | GRIN2B NMDAR2B | WEHVDLTDIYKERsDDFKRDsVSGGGPCTNRSHIKHGTGDK |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13310 | S51 | Sugiyama | PABPC4 APP1 PABP4 | FSPAGPVLsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| Q13351 | T23 | iPTMNet|EPSD | KLF1 EKLF | TAETALPSISTLTALGPFPDtQDDFLKWWRSEEAQDMGPGP |
| Q13363 | T144 | PSP | CTBP1 CTBP | SVEETADSTLCHILNLYRRAtWLHQALREGTRVQsVEQIRE |
| Q13370 | S296 | EPSD|PSP | PDE3B | PRLssAAEEKVPVIRPRRRssCVsLGETAASYYGSCKIFRR |
| Q13370 | S318 | ELM|iPTMNet|EPSD|PSP | PDE3B | VsLGETAASYYGSCKIFRRPsLPCISREQMILWDWDLKQWY |
| Q13370 | S73 | EPSD|PSP | PDE3B | RFCNVELRPPPAsPQQPRRCsPFCRARLSLGALAAFVLALL |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q13522 | S67 | EPSD|PSP | PPP1R1A IPP1 | sPEIDEDRIPNPHLKSTLAMsPRQRKKMtRITPTMKELQMM |
| Q13522 | T35 | EPSD|PSP | PPP1R1A IPP1 | PLLEPHLDPEAAEQIRRRRPtPAtLVLTSDQSsPEIDEDRI |
| Q13522 | T75 | EPSD|PSP | PPP1R1A IPP1 | IPNPHLKSTLAMsPRQRKKMtRITPTMKELQMMVEHHLGQQ |
| Q13526 | S16 | ELM|EPSD|PSP | PIN1 | _____MADEEKLPPGWEKRMsRSSGRVyYFNHItNAsQWER |
| Q13526 | S71 | PSP | PIN1 | EPARVRCSHLLVKHsQSRRPsSWRQEKITRTKEEALELING |
| Q13535 | S435 | EPSD|PSP | ATR FRP1 | TQQENLSSNSDGIsPKRRRLsSSLNPSKRAPKQTEEIKHVD |
| Q13563 | S829 | EPSD|PSP | PKD2 TRPP1 TRPP2 | LDDsEEDDDEDSGHSSRRRGsIssGVsYEEFQVLVRRVDRM |
| Q13576 | T716 | EPSD|PSP | IQGAP2 | KIQAFWKGYKQRKEYMHRRQtFIDNTDSIVKIQSWFRMATA |
| Q13586 | T389 | PSP | STIM1 GOK | AEKQLLVAKEGAEKIKKKRNtLFGTFHVAHSssLDDVDHKI |
| Q13610 | S485 | Sugiyama | PWP1 | SVNEAFGRRERLVLGSARNssISGPFGsRssDTPMES____ |
| Q13868 | S124 | Sugiyama | EXOSC2 RRP4 | LDSVLLLSSMNLPGGELRRRsAEDELAMRGFLQEGDLISAE |
| Q13936 | S1535 | EPSD|PSP | CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 | IINLFVAVIMDNFDYLTRDWsILGPHHLDEFKRIWAEYDPE |
| Q13936 | S1981 | PSP | CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 | DIRQSPKRGFLRSASLGRRAsFHLECLKRQKDRGGDISQKT |
| Q13972 | S927 | iPTMNet|EPSD|PSP | RASGRF1 CDC25 GNRP GRF1 | AIATAGANEGTPNKEKYRRMsLASAGFPPDQRNGDKEFVIR |
| Q14008 | S1471 | Sugiyama | CKAP5 KIAA0097 | MLRKGPAEDMSSKLNQARsMsGHPEAAQMVRREFQLDLDEI |
| Q14103 | S87 | ELM|iPTMNet|EPSD|PSP | HNRNPD AUF1 HNRPD | KIDAsKNEEDEGHsNssPRHsEAAtAQREEWKMFIGGLSWD |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14185 | S1250 | PSP | DOCK1 | CDNYTEAAYTLLLHAKLLKWsEDVCVAHLTQRDGYQATTQG |
| Q14203 | S31 | Sugiyama | DCTN1 | RTPSGSRMsAEASARPLRVGsRVEVIGKGHRGTVAYVGATL |
| Q14204 | S2384 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FSEDVLSTDMIFNNFLARLRsIPLDEGEDEAQRRRKGKEDE |
| Q14204 | S4162 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GRIFVFEPPPGVKANMLRTFssIPVSRICKSPNERARLYFL |
| Q14204 | S4368 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | MLEDEDDLAyAETEKKTRtDstsDGRPAWMRTLHTTASNWL |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14289 | S778 | PSP | PTK2B FAK2 PYK2 RAFTK | sPVNsLHtPPLHRHNVFKRHsMREEDFIQPSSREEAQQLWE |
| Q14344 | T203 | ELM|iPTMNet|EPSD|PSP | GNA13 | KLGEPDYIPSQQDILLARRPtKGIHEYDFEIKNVPFKMVDV |
| Q14432 | S312 | EPSD|PSP | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | S428 | EPSD|PSP | PDE3A | sDsEESSEKDKLAIPKRLRRsLPPGLLRRVsstWttttsAT |
| Q14432 | S438 | PSP | PDE3A | KLAIPKRLRRsLPPGLLRRVsstWttttsATGLPTLEPAPV |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14494 | S599 | ELM | NFE2L1 HBZ17 NRF1 TCF11 | MAPSALDSADLPPPSALKKGsKEKQADFLDKQMSRDEHRAR |
| Q14500 | S431 | iPTMNet|EPSD | KCNJ12 IRK2 KCNJN1 | DFDRLQAGGGVLEQRPYRREsEI__________________ |
| Q14524 | S516 | PSP | SCN5A | KsDsEDGPRAMNHLsLTRGLsRTSMKPRssRGsIFTFRRRD |
| Q14524 | S524 | PSP | SCN5A | RAMNHLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFA |
| Q14524 | S525 | PSP | SCN5A | AMNHLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFAD |
| Q14524 | S528 | PSP | SCN5A | HLsLTRGLsRTSMKPRssRGsIFTFRRRDLGsEADFADDEN |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14643 | S1598 | EPSD | ITPR1 INSP3R1 | IVQKTAMNWRLSARNAARRDsVLAASRDYRNIIERLQDIVS |
| Q14643 | S1764 | EPSD | ITPR1 INSP3R1 | LRQVLVNRYYGNVRPSGRREsLtsFGNGPLSAGGPGKPGGG |
| Q14669 | S1054 | Sugiyama | TRIP12 KIAA0045 ULF | TQsPKSSFLASLNPKTWGRLstQsNSNNIEPARTAGGSGLA |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14674 | S1501 | EPSD|PSP | ESPL1 ESP1 KIAA0165 | GPEIMRTIPEEELTDNWRKMsFEILRGsDGEDsASGGKTPA |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14697 | S190 | Sugiyama | GANAB G2AN KIAA0088 | VNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRDGDK |
| Q14738 | S573 | EPSD|PSP | PPP2R5D | TEAVQMLKDIKKEKVLLRRKsELPQDVyTIKALEAHKRAEE |
| Q14738 | S60 | EPSD|PSP | PPP2R5D | PQPQPQPQAQSQPPSSNKRPsNstPPPTQLSKIKYsGGPQI |
| Q14738 | S75 | EPSD|PSP | PPP2R5D | SNKRPsNstPPPTQLSKIKYsGGPQIVKKERRQsssRFNLs |
| Q14749 | S10 | iPTMNet|EPSD | GNMT | ___________MVDSVYRtRsLGVAAEGLPDQYADGEAARV |
| Q14847 | S146 | ELM|EPSD|PSP|Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | S61 | Sugiyama | LASP1 MLN50 | MKNYKGYEKKPYCNAHyPKQsFtMVADtPENLRLKQQSELQ |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14896 | S275 | ELM|EPSD|PSP | MYBPC3 | TVHEAMGTGDLDLLSAFRRTsLAGGGRRIsDSHEDTGILDF |
| Q14896 | S284 | ELM|EPSD|PSP | MYBPC3 | DLDLLSAFRRTsLAGGGRRIsDSHEDTGILDFSSLLKKRDs |
| Q14896 | S304 | ELM|EPSD|PSP | MYBPC3 | sDSHEDTGILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEI |
| Q14896 | S311 | ELM|EPSD|PSP | MYBPC3 | GILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEILRQAPPS |
| Q14978 | S622 | iPTMNet|EPSD | NOLC1 KIAA0035 NS5ATP13 | KIKLQtPNtFPKRKKGEKRAssPFRRVREEEIEVDsRVADN |
| Q14978 | S623 | ELM|iPTMNet|EPSD | NOLC1 KIAA0035 NS5ATP13 | IKLQtPNtFPKRKKGEKRAssPFRRVREEEIEVDsRVADNs |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15029 | S944 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | QPAPHLAREFMIKTRRRKGLsEDVsIsKFFDDPMLLELAKQ |
| Q15042 | S340 | Sugiyama | RAB3GAP1 KIAA0066 RAB3GAP | PQCLLGDFVTEFFKICRRKEsTDEILGRSAFEEEGKETADI |
| Q15052 | S684 | EPSD|PSP | ARHGEF6 COOL2 KIAA0006 PIXA | EAYCTSANFQQGHGsstRKDsIPQVLLPEEEKLIIEETRsN |
| Q15054 | S458 | EPSD|PSP | POLD3 KIAA0039 | EERKGPKKGTAALGKANRQVsITGFFQRK____________ |
| Q15084 | S156 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | KDRLGGRSGGYSSGKQGRSDsSSKKDVIELtDDsFDKNVLD |
| Q15084 | S375 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GYPAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGst |
| Q15139 | S421 | PSP | PRKD1 PKD PKD1 PRKCM | sNNIPLMRVVQsVKHTKRKSsTVMKEGWMVHyTSKDTLRKR |
| Q15149 | S4642 | EPSD|PSP | PLEC PLEC1 | stAGsRtGsRtGsRAGsRRGsFDAtGsGFsMtFSsssYSSS |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15208 | S10 | EPSD|PSP | STK38 NDR1 | ___________MAMTGstPCssMSNHTKERVTMTKVTLENF |
| Q15208 | S11 | EPSD|PSP | STK38 NDR1 | __________MAMTGstPCssMSNHTKERVTMTKVTLENFy |
| Q15256 | S339 | EPSD | PTPRR ECPTP PTPRQ | TSVCPsPFKMKPIGLQERRGsNVSLTLDMSSLGNIEPFVSI |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15642 | T225 | PSP | TRIP10 CIP4 STOT STP | YFSQMPQIFDKLQDMDERRAtRLGAGYGLLSEAELEVVPII |
| Q15746 | S13 | ELM | MYLK MLCK MLCK1 MYLK1 | ________MGDVKLVASSHIsKTsLsVDPSRVDSMPLTEAP |
| Q15746 | S1773 | EPSD|PSP | MYLK MLCK MLCK1 MYLK1 | RAIGRLssMAMISGLSGRKsstGsPtsPLNAEKLEsEEDVs |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15814 | S23 | Sugiyama | TBCC | SVSCSAAAVRTGDMESQRDLsLVPERLQRREQERQLEVERR |
| Q15831 | S428 | iPTMNet|EPSD|PSP | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q15835 | S21 | ELM|EPSD|PSP | GRK1 RHOK | MDFGsLETVVANSAFIAARGsFDGSSSQPSRDKKYLAKLKL |
| Q15942 | S505 | Sugiyama | ZYX | DQANRPHCVPDYHKQYAPRCsVCSEPIMPEPGRDETVRVVA |
| Q16181 | T198 | GPS6|PSP | SEPTIN7 CDC10 SEPT7 | EFMKRLHEKVNIIPLIAKADtLTPEECQQFKKQIMKEIQEH |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16531 | S645 | EPSD|PSP | DDB1 XAP1 | DRKKVTLGTQPTVLRTFRSLstTNVFACSDRPtVIyssNHK |
| Q16543 | S97 | PSP | CDC37 CDC37A | GKAELERLQAEAQQLRKEERsWEQKLEEMRKKEKSMPWNVD |
| Q16613 | S205 | ELM|iPTMNet|EPSD | AANAT SNAT | SLTFMELHCSLRGHPFLRRNsGC__________________ |
| Q16613 | T31 | ELM|iPTMNet|EPSD | AANAT SNAT | PEAPRLPPGIPESPSCQRRHtLPASEFRCLTPEDAVSAFEI |
| Q16629 | S183 | Sugiyama | SRSF7 SFRS7 | sRSISLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSI |
| Q16629 | S187 | Sugiyama | SRSF7 SFRS7 | SLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSISRPR |
| Q16629 | Y189 | Sugiyama | SRSF7 SFRS7 | RRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSISRPRSS |
| Q16637 | S187 | PSP | SMN1 SMN SMNT; SMN2 SMNC | TDESENSRSPGNKsDNIKPKsAPWNSFLPPPPPMPGPRLGP |
| Q16637 | S4 | PSP | SMN1 SMN SMNT; SMN2 SMNC | _________________MAMssGGsGGGVPEQEDsVLFRRG |
| Q16637 | S5 | PSP | SMN1 SMN SMNT; SMN2 SMNC | ________________MAMssGGsGGGVPEQEDsVLFRRGt |
| Q16637 | S8 | PSP | SMN1 SMN SMNT; SMN2 SMNC | _____________MAMssGGsGGGVPEQEDsVLFRRGtGQs |
| Q16637 | T25 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | sGGsGGGVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDK |
| Q16637 | T85 | PSP | SMN1 SMN SMNT; SMN2 SMNC | KPKttPKRKPAKKNKSQKKNtAAsLQQWKVGDKCSAIWSED |
| Q16665 | S465 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | NINLAMsPLPtAETPKPLRSsADPALNQEVALKLEPNPESL |
| Q16665 | S692 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | AGKGVIEQTEKSHPRsPNVLsVALsQRTtVPEEELNPKILA |
| Q16665 | S727 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | NPKILALQNAQRKRKMEHDGsLFQAVGIGTLLQQPDDHAAT |
| Q16665 | S760 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | QPDDHAATTSLSWKRVKGCKssEQNGMEQKTIILIPSDLAC |
| Q16665 | S761 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | PDDHAATTSLSWKRVKGCKssEQNGMEQKTIILIPSDLACR |
| Q16665 | S809 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | ESGLPQLtSYDCEVNAPIQGsRNLLQGEELLRALDQVN___ |
| Q16665 | T455 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | MLPSPNEKLQNINLAMsPLPtAETPKPLRSsADPALNQEVA |
| Q16665 | T63 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | QLPLPHNVSSHLDKASVMRLtISYLRVRKLLDAGDLDIEDD |
| Q16665 | T700 | EPSD|PSP | HIF1A BHLHE78 MOP1 PASD8 | TEKSHPRsPNVLsVALsQRTtVPEEELNPKILALQNAQRKR |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q16790 | T443 | EPSD|PSP | CA9 G250 MN | LFAVTSVAFLVQMRRQHRRGtKGGVsyRPAEVAETGA____ |
| Q16821 | S48 | ELM | PPP1R3A PP1G | DEEVTFQPGFSPQPSRRGsDsSEDIYLDTPSSGTRRVsFAD |
| Q16821 | S65 | ELM | PPP1R3A PP1G | GsDsSEDIYLDTPSSGTRRVsFADSFGFNLVSVKEFDCWEL |
| Q16875 | S461 | EPSD|PSP | PFKFB3 | THRERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEE |
| Q16891 | S528 | EPSD|PSP | IMMT HMP MIC60 MINOS2 PIG4 PIG52 | EFEQNLsEKLsEQELQFRRLsQEQVDNFTLDINTAYARLRG |
| Q2Q1W2 | S3 | PSP | TRIM71 LIN41 | __________________MAsFPETDFQICLLCKEMCGSPA |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q58FF7 | S185 | Sugiyama | HSP90AB3P HSP90BC | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEQDKEIs |
| Q58FF7 | S488 | Sugiyama | HSP90AB3P HSP90BC | TYGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIM |
| Q5JTH9 | S1049 | Sugiyama | RRP12 KIAA0690 | HRVLVNIRKAEARAKRHRALsQAAVEEEEEEEEEEEPAQGK |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5S007 | S1443 | PSP | LRRK2 PARK8 | KGQAEVDAMKPWLFNIKARAsssPVILVGtHLDVsDEKQRK |
| Q5S007 | S1444 | EPSD|PSP | LRRK2 PARK8 | GQAEVDAMKPWLFNIKARAsssPVILVGtHLDVsDEKQRKA |
| Q5S007 | S910 | EPSD|PSP | LRRK2 PARK8 | SDDLDSEGSEGSFLVKKKsNsISVGEFYRDAVLQRCsPNLQ |
| Q5S007 | S935 | PSP | LRRK2 PARK8 | EFYRDAVLQRCsPNLQRHsNsLGPIFDHEDLLKRKRKILSs |
| Q5SW79 | S881 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sstPssLALtsAsRIRERsEsLDPDssMDTtLILKDTEAVM |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T2W1 | S505 | PSP | PDZK1 CAP70 NHERF3 PDZD1 | KEGIVVESNHDSHMAKERAHsTASHSSSNSEDTEM______ |
| Q5T4S7 | S3846 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | KELLEYDLQQREAATKSSRTsVQPTFTASQyRALsVLGCGH |
| Q5T4S7 | T904 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | LLSPPFGWASGSQDSNSRRAttPLYHGFKEVEENWSKHFSS |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5T6F2 | S856 | Sugiyama | UBAP2 KIAA1491 | PVDyyGIPFAAPTALASRDGsLANNPYPGDVTKFGRGDSAS |
| Q5VT52 | S1068 | Sugiyama | RPRD2 KIAA0460 HSPC099 | SLTATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETL |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q63ZY3 | S356 | Sugiyama | KANK2 ANKRD25 KIAA1518 MXRA3 SIP | PREVEVVASTAAGAPAQRAQsLEPYGtGLRALAMPGRPEsP |
| Q676U5 | S269 | PSP | ATG16L1 APG16L UNQ9393/PRO34307 | DHtEEtsPVRAISRAATKRLsQPAGGLLDsITNIFGRRsVs |
| Q684P5 | S7 | PSP | RAP1GAP2 GARNL4 KIAA1039 RAP1GA2 | ______________MFGRKRsVsFGGFGWIDKTMLASLKVK |
| Q68EM7 | S702 | EPSD|PSP | ARHGAP17 RICH1 MSTP066 MSTP110 | tGQPPGQPSAPSQLSAPRRysssLsPIQAPNHPPPQPPTQA |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6GYQ0 | S860 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | DEFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQ |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6J4K2 | S258 | EPSD|PSP | SLC8B1 NCKX6 NCLX SLC24A6 | VFYVVTVILCTWIYQRQRRGsLFCPMPVTPEILsDsEEDRV |
| Q6NUQ4 | S456 | Sugiyama | TMEM214 PP446 | LQETIQSLKLTNQELLRKGssNNQDVVTCDMACKGLLQQVQ |
| Q6P1J9 | S174 | Sugiyama | CDC73 C1orf28 HRPT2 | AARLEGHKEGIVQTEQIRSLsEAMsVEKIAAIKAKIMAKKR |
| Q6P2Q9 | T1404 | Sugiyama | PRPF8 PRPC8 | RVWAEYALKRQEAIAQNRRLtLEDLEDSWDRGIPRINTLFQ |
| Q6P6C2 | S96 | Sugiyama | ALKBH5 ABH5 OFOXD1 | LQKEEEARKVKSGIRQMRLFsQDECAKIEARIDEVVSRAEK |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PIY7 | S116 | PSP | TENT2 GLD2 PAPD4 | PHQEPtVVNQIVPLsGERRYsMPPLFHTHYVPDIVRCVPPF |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UVK1 | S1609 | Sugiyama | CSPG4 MCSP | TLTVCPGSVQPLSSQTLRASsSAGtDPQLLLYRVVRGPQLG |
| Q6UVK1 | S321 | Sugiyama | CSPG4 MCSP | DQYPTHTSNRGVLSYLEPRGsLLLGGLDAEASRHLQEHRLG |
| Q6UVK1 | T1613 | Sugiyama | CSPG4 MCSP | CPGSVQPLSSQTLRASsSAGtDPQLLLYRVVRGPQLGRLFH |
| Q6UXD5 | S719 | Sugiyama | SEZ6L2 PSK UNQ1903/PRO4349 | CQKIMTCADPGEIANGHRTAsDAGFPVGSHVQYRCLPGYSL |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | S473 | Sugiyama | SND1 TDRD11 | ALVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGL |
| Q7KZI7 | S40 | Sugiyama | MARK2 EMK1 | TLGHLDSKPssKSNMIRGRNsAtsADEQPHIGNyRLLKTIG |
| Q7KZI7 | S409 | PSP | MARK2 EMK1 | PsPsHKVQRsVsANPKQRRFsDQAAGPAIPTSNsYsKKTQS |
| Q7LDG7 | S587 | EPSD|PSP | RASGRP2 CDC25L MCG7 | MHSHHHRAFsFsLPRPGRRGsRPPEIREEEVQTVEDGVFDI |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z2W7 | S9 | EPSD|PSP | TRPM8 LTRPC6 TRPP8 | ____________MSFRAARLsMRNRRNDtLDSTRTLYSSAS |
| Q7Z2W7 | T17 | EPSD|PSP | TRPM8 LTRPC6 TRPP8 | ____MSFRAARLsMRNRRNDtLDSTRTLYSSASRSTDLSYS |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z589 | T207 | PSP | EMSY C11orf30 GL002 | VYVKSVSCsDEDEKPRKRRRtNsssssPVVLKEVPKAVVPV |
| Q7Z5L9 | S15 | Sugiyama | IRF2BP2 | ______MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEP |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q7Z5P4 | S33 | PSP | HSD17B13 SCDR9 SDR16C3 HMFN0376 UNQ497/PRO1014 | TIIYSYLESLVKFFIPQRRKsVAGEIVLITGAGHGIGRQTT |
| Q7Z6Z7 | S1368 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | ATEYLLTHPPPIMGGVVRDLsMsEEDQMMRAIAMsLGQDIP |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86SQ0 | S384 | Sugiyama | PHLDB2 LL5B | PSHSLLAGESDRVFATRRNFsCGsVEFDEADLESLRQAsGt |
| Q86SQ0 | S387 | Sugiyama | PHLDB2 LL5B | SLLAGESDRVFATRRNFsCGsVEFDEADLESLRQAsGtPQP |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86UR1 | S172 | EPSD|PSP | NOXA1 P51NOX | WPEGSLNGLDSALDQVQRRGsLPPRQVPRGEVFRPHRWHLK |
| Q86UR1 | S461 | EPSD|PSP | NOXA1 P51NOX | CDGRIGIFPKCFVVPAGPRMsGAPGRLPRSQQGDQP_____ |
| Q86V48 | S703 | Sugiyama | LUZP1 | EPKPQPNsREKAKTRGAPRTsLFENDKDAGMENESVKSVRA |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V87 | S325 | EPSD|PSP | FHIP2B FAM160B2 RAI16 FP13191 | PVFLDPADIATLEGISWRLPsAPSDEASFPGKEALAAFLGW |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86W92 | S794 | Sugiyama | PPFIBP1 KIAA1230 | RAIQVLRINNFEPNCLRRRPsDENtIAPSEVQKWTNHRVME |
| Q86X29 | S432 | Sugiyama | LSR ILDR3 LISCH | LANFDPsRPGPPsGRVERAMsEVtsLHEDDWRSRPSRGPAL |
| Q86X55 | S447 | PSP | CARM1 PRMT4 | FAKAGDTLSGTCLLIANKRQsYDISIVAQVDQTGSKSSNLL |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IVT5 | S888 | EPSD|PSP | KSR1 KSR | PSFSLLMDMLEKLPKLNRRLsHPGHFWKSADINSSKVVPRF |
| Q8IW41 | S115 | EPSD|PSP | MAPKAPK5 PRAK | RARLLIVMEMMEGGELFHRIsQHRHFTEKQASQVTKQIALA |
| Q8IWQ3 | T260 | EPSD|PSP | BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 | PPDCQSLLRGMIEVDAARRLtLEHIQKHIWYIGGKNEPEPE |
| Q8IWU9 | S19 | EPSD|PSP | TPH2 NTPH | __MQPAMMMFSSKYWARRGFsLDSAVPEEHQLLGSSTLNKP |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IYM1 | S198 | PSP | SEPTIN12 SEPT12 | EFLQRLCRTVNVVPVIARADsLTMEEREAFRRRIQQNLRTH |
| Q8IYT8 | S1027 | EPSD|PSP | ULK2 KIAA0623 | QDPADIENVHKYKCSIERRLsALCHSTATV___________ |
| Q8N122 | S791 | PSP | RPTOR KIAA1303 RAPTOR | sPENEEHILSFETIDKMRRAssYSSLNSLIGVSFNSVYTQI |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N5S9 | S475 | EPSD|PSP | CAMKK1 CAMKKA | RKRsFGNPFEPQARREERSMsAPGNLLVKEGFGEGGKsPEL |
| Q8N5S9 | S74 | EPSD|PSP | CAMKK1 CAMKKA | IPGstSRLLPARPsLsARKLsLQERPAGsyLEAQAGPyAtG |
| Q8N5S9 | T108 | ELM | CAMKK1 CAMKKA | AGPyAtGPAsHIsPRAWRRPtIEsHHVAIsDAEDCVQLNQY |
| Q8N6T3 | S361 | Sugiyama | ARFGAP1 ARF1GAP | RKsPssDsWtCADtstERRssDsWEVWGSASTNRNSNsDGG |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8N983 | S30 | Sugiyama | MRPL43 | FLASVLHNGLGRYVQQLQRLsFSVSRDGASSRGAREFVERE |
| Q8NAF0 | S455 | Sugiyama | ZNF579 | AGGPAPHPCPRCPRRFSRAYsLLRHQRCHRAELERAAALQA |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NCN5 | S127 | Sugiyama | PDPR KIAA1990 | KLYYQLEQETGIQTGYTRTGsIFLAQTQDRLISLKRINAGL |
| Q8NE71 | S105 | Sugiyama | ABCF1 ABC50 | KKDVDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKK |
| Q8NE71 | T108 | Sugiyama | ABCF1 ABC50 | VDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKG |
| Q8NER1 | S502 | EPSD|PSP | TRPV1 VR1 | VLGGVYFFFRGIQYFLQRRPsMKTLFVDSYSEMLFFLQSLF |
| Q8TAE6 | T73 | EPSD|PSP | PPP1R14C KEPI | AAAAGQVQQQQQRRHQQGKVtVKYDRKELRKRLVLEEWIVE |
| Q8TAP6 | S571 | Sugiyama | CEP76 C18orf9 | DQLSYLLSPALASYEFERTTsISAGNEEFQDAIRRAVPDGH |
| Q8TCU6 | S436 | EPSD|PSP | PREX1 KIAA1415 | LYHMMMNKKVNLIKDRRRKLsTVPKCFLGNEFVAWLLEIGE |
| Q8TD19 | S331 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RRREMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYV |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TEB1 | S147 | Sugiyama | DCAF11 WDR23 GL014 PRO2389 | QKHSFPRMLHQRERGLCHRGsFSLGEQSRVISHFLPNDLGF |
| Q8WTQ7 | S23 | ELM|EPSD|PSP | GRK7 GPRK7 | DMGALDNLIANTAYLQARKPsDCDSKELQRRRRsLALPGLQ |
| Q8WTQ7 | S36 | ELM|EPSD|PSP | GRK7 GPRK7 | YLQARKPsDCDSKELQRRRRsLALPGLQGCAELRQKLSLNF |
| Q8WUI4 | S573 | Sugiyama | HDAC7 HDAC7A | SRLQERGLRSQCECLRGRKAsLEELQSVHSERHVLLYGtNP |
| Q8WVI7 | T34 | EPSD|PSP | PPP1R1C | PVFQSQIAPEAAEQIRKRRPtPASLVILNEHNPPEIDDKRG |
| Q8WWM7 | S500 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | VTSSVSDPGVGsIsPAsPKIsLAPTDVKELSTKEPGRTLEP |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q8WZ42 | S4010 | PSP | TTN | SANPLENAGQDSAVRIEEGKsLRFPLALEEKQVLLKEEHSD |
| Q8WZ42 | S4065 | PSP | TTN | EPVAIKKVQEVQGRDLLSKEsLLSGIPEEQRLNLKIQICRA |
| Q8WZ42 | S4185 | EPSD|PSP | TTN | YEEIDILTAEGPRIQQGAKTsLQEEMDSFSGSQKVEPITEP |
| Q92547 | S998 | Sugiyama | TOPBP1 KIAA0259 | AQECKHLPESLYPHTYNPKMsLDIsAVQDGRLCNSRLLSAV |
| Q92597 | S330 | iPTMNet|EPSD|PSP|Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92597 | T366 | iPTMNet|EPSD|PSP | NDRG1 CAP43 DRG1 RTP | tSEGTRsRsHtsEGtRsRsHtsEGAHLDItPNsGAAGNsAG |
| Q92625 | S663 | Sugiyama | ANKS1A ANKS1 KIAA0229 ODIN | sRsEsLsNCsIGKKRLEKsPsFAsEWDEIEKIMssIGEGID |
| Q92736 | S2031 | ELM|EPSD|PSP | RYR2 | LDEDGSLDGNSDLTIRGRLLsLVEKVTYLKKKQAEKPVESD |
| Q92736 | S2808 | ELM|iPTMNet|EPSD|PSP | RYR2 | RIERTREGDSMALYNRTRRIsQTSQVsVDAAHGYSPRAIDM |
| Q92747 | S292 | Sugiyama | ARPC1A SOP2L | FNYDDRGCLTFVSKLDIPKQsIQRNMSAMERFRNMDKRATT |
| Q92777 | S10 | ELM|iPTMNet|EPSD | SYN2 | ___________MMNFLRRRLsDSSFIANLPNGYMTDLQRPE |
| Q92837 | S188 | EPSD|PSP | FRAT1 | CRRGWLRGAAASRRLQQRRGsQPETRTGDDDPHRLLQQLVL |
| Q92890 | S229 | PSP | UFD1 UFD1L | stEGEADHsGyAGELGFRAFsGsGNRLDGKKKGVEPsPsPI |
| Q92917 | S27 | EPSD|PSP | GPKOW GPATC5 GPATCH5 T54 | GVLPLTAAsTAPIsFGFtRtsARRRLADsGDGAGPsPEEKD |
| Q92917 | T316 | EPSD|PSP | GPKOW GPATC5 GPATCH5 T54 | EFDKNTLDLRQQNGTASSRKtLWNQELYIQQDNsERKRKHL |
| Q92934 | S118 | iPTMNet|EPSD|PSP | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S153 | iPTMNet|EPSD | BAD BBC6 BCL2L8 | KsAGtATQMRQSSSWTRVFQsWWDRNLGRGSSAPSQ_____ |
| Q92934 | S75 | ELM|EPSD|PSP | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | EPSD|PSP | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q92945 | S193 | Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q93034 | S730 | ELM|iPTMNet|EPSD|PSP | CUL5 VACM1 | LRILRTQEAIIQIMKMRKKIsNAQLQTELVEILKNMFLPQK |
| Q93045 | S50 | iPTMNet|EPSD | STMN2 SCG10 SCGN10 | RNINIYTYDDMEVKQINKRAsGQAFELILKPPsPISEAPRT |
| Q93045 | S97 | iPTMNet|EPSD | STMN2 SCG10 SCGN10 | KDLsLEEIQKKLEAAEERRKsQEAQVLKQLAEKREHEREVL |
| Q93052 | S537 | Sugiyama | LPP | DAGGLIHCIEDFHKKFAPRCsVCKEPIMPAPGQEETVRIVA |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q969F2 | S223 | PSP | NKD2 | ELAEEPRVADRRLSAHVRRPstDPQPCSERGPYCVDENTER |
| Q96A00 | T38 | ELM|EPSD|PSP | PPP1R14A CPI17 PPP1INL | SRARGPGGsPGGLQKRHARVtVKYDRRELQRRLDVEKWIDG |
| Q96BY7 | S497 | Sugiyama | ATG2B C14orf103 | PSNLVHPTPLQKtsLPsRsVsVDESRPELIFRLAVGTFSIS |
| Q96D21 | S239 | PSP | RASD2 TEM2 | MRRVKEMDAYGMVSPFARRPsVNSDLKYIKAKVLREGQARE |
| Q96D31 | S34 | PSP | ORAI1 CRACM1 TMEM142A | PELPPSGGSTTSGsRRsRRRsGDGEPPGAPPPPPSAVTYPD |
| Q96EN8 | S528 | Sugiyama | MOCOS | TGAPSADSQADVIPAVMGRRsLsPQEDALTGSRVWNNSSTV |
| Q96G46 | S236 | Sugiyama | DUS3L | QQLRKREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPR |
| Q96IZ0 | S162 | Sugiyama | PAWR PAR4 | PSARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEA |
| Q96IZ0 | T163 | Sugiyama | PAWR PAR4 | SARKGKGQIEKRKLREKRRstGVVNIPAAECLDEyEDDEAG |
| Q96JJ3 | S503 | Sugiyama | ELMO2 CED12A KIAA1834 | RALPSKPNSLDQFKSKLRsLsYsEILRLRQSERMSQDDFQS |
| Q96JP5 | S177 | Sugiyama | ZFP91 ZNF757 FKSG11 | TSVSRHRDTENTRSSRSKTGsLQLICKSEPNTDQLDYDVGE |
| Q96MH2 | S194 | Sugiyama | HEXIM2 L3 | EAGDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELV |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q96P20 | S295 | EPSD|PSP | NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 | LIMSCCPDPNPPIHKIVRKPsRILFLMDGFDELQGAFDEHI |
| Q96PU5 | S342 | ELM|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | NGEQFsSLIQREPssRLRsCsVtDAVAEQGHLPPPSAPAGR |
| Q96PU5 | S448 | ELM|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | sATNSNNHLIEPQIRRPRsLssPtVTLSAPLEGAKDsPVRR |
| Q96PU5 | T367 | ELM|EPSD|PSP | NEDD4L KIAA0439 NEDL3 | VAEQGHLPPPSAPAGRARsstVtGGEEPTPsVAYVHttPGL |
| Q96PZ0 | S569 | Sugiyama | PUS7 KIAA1897 | EMLTADNLDIDNMRHKIRDysLsGAyRKIIIRPQNVSWEVV |
| Q96RL1 | S124 | Sugiyama | UIMC1 RAP80 RXRIP110 | EEEEELLRKAIAESLNSCRPsDASATRSRPLATGPssQsHQ |
| Q96RR4 | S100 | PSP | CAMKK2 CAMKKB KIAA0787 | EVPLDtsGSQARPHLSGRKLsLQERsQGGLAAGGsLDMNGR |
| Q96RR4 | S495 | PSP | CAMKK2 CAMKKB KIAA0787 | VKHIPSLAtVILVKTMIRKRsFGNPFEGsRREERSLsAPGN |
| Q96RR4 | S511 | PSP | CAMKK2 CAMKKB KIAA0787 | IRKRsFGNPFEGsRREERSLsAPGNLLTKKPTRECESLSEL |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q96SB3 | S100 | ELM|iPTMNet|EPSD | PPP1R9B PPP1R6 | LAEAPRASERGVRLsLPRASsLNENVDHSALLKLGTSVSER |
| Q96SB3 | S94 | ELM|iPTMNet|EPSD | PPP1R9B PPP1R6 | AGGGAGLAEAPRASERGVRLsLPRASsLNENVDHSALLKLG |
| Q96T49 | S333 | GPS6 | PPP1R16B ANKRD4 KIAA0823 | ELKHKHDVIMKSQLRHKSsLsRRTsSAGSRGKVVRRAsLSD |
| Q96T49 | S337 | GPS6 | PPP1R16B ANKRD4 KIAA0823 | KHDVIMKSQLRHKSsLsRRTsSAGSRGKVVRRAsLSDRTNL |
| Q96T58 | S1268 | Sugiyama | SPEN KIAA0929 MINT SHARP | SRQISEDsERtGGsPsVRHGsFHEDEDPIGsPRLLSVKGsP |
| Q96T88 | S298 | EPSD|PSP | UHRF1 ICBP90 NP95 RNF106 | FKIERPGEGsPMVDNPMRRKsGPSCKHCKDDVNRLCRVCAC |
| Q99259 | T91 | EPSD|PSP | GAD1 GAD GAD67 | QSSKNLLSCENSDRDARFRRtETDFSNLFARDLLPAKNGEE |
| Q99497 | T154 | GPS6|PSP | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99759 | S166 | EPSD | MAP3K3 MAPKKK3 MEKK3 | QsAGDINtIyQPPEPRsRHLsVssQNPGRssPPPGYVPERQ |
| Q99759 | S197 | iPTMNet|EPSD | MAP3K3 MAPKKK3 MEKK3 | PPPGYVPERQQHIARQGSYTsINSEGEFIPETSEQCMLDPL |
| Q99759 | S337 | EPSD | MAP3K3 MAPKKK3 MEKK3 | tNGENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPs |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99996 | S43 | PSP | AKAP9 AKAP350 AKAP450 KIAA0803 | RKAQSDGQSPSKKQKKKRKTsSSKHDVSAHHDLNIDQSQCN |
| Q9BQ04 | S338 | Sugiyama | RBM4B RBM30 | EGYGYGPESELSQASAATRNsLyDMARYEREQYVDRARYSA |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BTC0 | S1456 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | EAKVTVDDLPNRMCADVRRNsVERPAEPVAGAAtPsLVEQQ |
| Q9BVJ6 | S437 | Sugiyama | UTP14A SDCCAG16 | EEILLREFEERRSLRKRsELsQDAEPAGsQEtKDsGsQEVL |
| Q9BWD1 | S226 | Sugiyama | ACAT2 ACTL | LVstRKGLIEVKtDEFPRHGsNIEAMSKLKPYFLTDGTGTV |
| Q9BWF3 | S343 | Sugiyama | RBM4 RBM4A | EGYGYGHEsELsQAsAAARNsLyDMARYEREQYADRARYSA |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9BXS5 | S305 | Sugiyama | AP1M1 CLTNM | KHSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKF |
| Q9BXS5 | T306 | Sugiyama | AP1M1 CLTNM | HSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKFK |
| Q9BY41 | S39 | ELM|iPTMNet|EPSD|PSP | HDAC8 HDACL1 CDA07 | IYSPEYVSMCDSLAKIPKRAsMVHSLIEAYALHKQMRIVKP |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S198 | Sugiyama | PRKD2 PKD2 HSPC187 | KRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCT |
| Q9BZL6 | S200 | Sugiyama | PRKD2 PKD2 HSPC187 | CAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCTAE |
| Q9C0C2 | S1158 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | sPssKMEGGHFVPPGKttAGsVDWTDQLGLRNLEVssCVGs |
| Q9C0C2 | S872 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QGtyssRDAELQDQEFGKRDsLGtyssRDVsLGDWEFGKRD |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9C0C2 | S936 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GRyssQDADEQDWEFQKRDVsLGTyGSRAAEPQEQEFGKSA |
| Q9GZU1 | S557 | EPSD|PSP | MCOLN1 ML4 TRPML1 MSTP080 | LQAYIAQCQDsPtSGKFRRGsGsACSLLCCCGRDPSEEHSL |
| Q9GZU1 | S559 | EPSD|PSP | MCOLN1 ML4 TRPML1 MSTP080 | AYIAQCQDsPtSGKFRRGsGsACSLLCCCGRDPSEEHSLLV |
| Q9GZX7 | S38 | EPSD|PSP | AICDA AID | VRWAKGRREtYLCYVVKRRDsATsFsLDFGYLRNKNGCHVE |
| Q9GZX7 | T27 | EPSD|PSP | AICDA AID | NRRKFLYQFKNVRWAKGRREtYLCYVVKRRDsATsFsLDFG |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H0D6 | S678 | Sugiyama | XRN2 | LRAALEEVyPDLTPEEtRRNsLGGDVLFVGKHHPLHDFILE |
| Q9H0K1 | S358 | EPSD|PSP | SIK2 KIAA0781 QIK SNF1LK2 | KSHRssFPVEQRLDGRQRRPstIAEQtVAKAQtVGLPVTMH |
| Q9H2G2 | S189 | PSP | SLK KIAA0204 STK2 | IKLADFGVsAKNTRtIQRRDsFIGtPYWMAPEVVMCETSKD |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H2G2 | S341 | Sugiyama | SLK KIAA0204 STK2 | EDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILE |
| Q9H2S1 | S135 | EPSD|PSP | KCNN2 | QNIGYKLGHRRALFEKRKRLsDYALIFGMFGIVVMVIETEL |
| Q9H2S1 | S464 | EPSD|PSP | KCNN2 | DHAKVRKHQRKFLQAIHQLRsVKMEQRKLNDQANTLVDLAK |
| Q9H2S1 | S567 | EPSD|PSP | KCNN2 | YDKHVTYNAERSRSSSRRRRsssTAPPTSSESS________ |
| Q9H2S1 | S568 | EPSD|PSP | KCNN2 | DKHVTYNAERSRSSSRRRRsssTAPPTSSESS_________ |
| Q9H2S1 | S569 | EPSD|PSP | KCNN2 | KHVTYNAERSRSSSRRRRsssTAPPTSSESS__________ |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H3Q1 | S309 | Sugiyama | CDC42EP4 BORG4 CEP4 | AAPsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPD |
| Q9H3Z4 | S10 | iPTMNet|EPSD|PSP | DNAJC5 CLN4 | ___________MADQRQRsLstsGEsLyHVLGLDKNATSDD |
| Q9H492 | S12 | EPSD|PSP | MAP1LC3A | _________MPSDRPFKQRRsFADRCKEVQQIRDQHPSKIP |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H6T3 | S480 | Sugiyama | RPAP3 | NNPINLANVIAATGTTSKKNssQDDLFPTsDtPRAKVLKIE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H814 | T151 | Sugiyama | PHAX RNUXA | ATELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDL |
| Q9HBA0 | S824 | EPSD|PSP | TRPV4 VRL2 VROAC | TyQYYGFSHtVGRLRRDRWssVVPRVVELNKNSNPDEVVVP |
| Q9HC16 | T32 | EPSD|PSP | APOBEC3G MDS019 | MYRDTFSYNFYNRPILSRRNtVWLCYEVKTKGPSRPPLDAK |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9HCR9 | S117 | EPSD|PSP | PDE11A | PLSPSWAGGSRGDGNLQRRAsQKELRKSFARSKAIHVNRtY |
| Q9HCR9 | S162 | EPSD|PSP | PDE11A | TSRAQEPLSSVRRRALLRKAsSLPPTTAHILSALLESRVNL |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NP62 | S269 | PSP | GCM1 GCMA | DLTDQTSTVDPMKLYEKRKLsSSRTYsSGDLLPPSASGVYS |
| Q9NP62 | S275 | PSP | GCM1 GCMA | STVDPMKLYEKRKLsSSRTYsSGDLLPPSASGVYSDHGDLQ |
| Q9NP71 | S196 | EPSD|PSP | MLXIPL BHLHD14 MIO WBSCR14 | VVMREYHKWRIYYKKRLRKPsREDDLLAPKQAEGRWPPPEQ |
| Q9NP97 | S73 | EPSD|PSP | DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162 | ARStVRDIDPQNDLtFLRIRsKKNEIMVAPDKDYFLIVIQN |
| Q9NPC2 | S373 | EPSD|PSP | KCNK9 TASK3 | SISPGLHSFTDHQRLMKRRKsV___________________ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ55 | S47 | Sugiyama | PPAN BXDC3 SSF1 | ANPHSFVFTRGCTGRNIRQLsLDVRRVMEPLTASRLQVRKK |
| Q9NQA5 | T708 | EPSD|PSP | TRPV5 ECAC1 | LSRTASQSSSHRGWEILRQNtLGHLNLGLNLSEGDGEEVYH |
| Q9NQU5 | S113 | PSP | PAK6 PAK5 | SVISSNtLRGRSPTSRRRAQsLGLLGDEHWATDPDMYLQsP |
| Q9NR82 | S88 | PSP | KCNQ5 | LGGGGGGLREsRRGKQGARMsLLGKPLSYTSSQSCRRNVKY |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NRD9 | S1217 | EPSD|PSP | DUOX1 DUOX LNOX1 THOX1 | VLLLILAIMYVFASHHFRRRsFRGFWLTHHLYILLYVLLII |
| Q9NRD9 | S955 | EPSD|PSP | DUOX1 DUOX LNOX1 THOX1 | QLCVKGVEVPEVIKDLCRRAsYISQDMICPSPRVSARCSRS |
| Q9NRI5 | S58 | PSP | DISC1 KIAA0457 | RLARRPGYMRSStGPGIGFLsPAVGTLFRFPGGVSGEESHH |
| Q9NRI5 | S713 | PSP | DISC1 KIAA0457 | ADLEACRLLIQSLQLQEARGsLSVEDERQMDDLEGAAPPIP |
| Q9NS28 | S216 | EPSD|PSP | RGS18 RGS13 | DIYLDLMEGRPQRPTNLRRRsRsFTCNEFQDVQSDVAIWL_ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NX63 | T11 | EPSD|PSP | CHCHD3 MIC19 MINOS3 | __________MGGTTSTRRVtFEADENENITVVKGIRLsEN |
| Q9NXH3 | T58 | ELM | PPP1R14D GBPI | ESKSHPDSSKIPRSRRPSRLtVKYDRGQLQRWLEMEQWVDA |
| Q9NXR1 | S306 | EPSD|PSP | NDE1 NUDE | TGGPASGRSSKNRDGGERRPsstsVPLGDKGLDTSCRWLSK |
| Q9NXR1 | T131 | EPSD|PSP | NDE1 NUDE | QKYIRELEQANDDLERAKRAtIMSLEDFEQRLNQAIERNAF |
| Q9NYF0 | S237 | EPSD|PSP | DACT1 DPR1 HNG3 | LEYKEGHCEDQASGAVCRSLsTPQFNSLDVIADVNPKYQCD |
| Q9NYF0 | S827 | EPSD|PSP | DACT1 DPR1 HNG3 | KTFVKIKASHNLKKKILRFRsGSLKLMTTV___________ |
| Q9NYK5 | S57 | Sugiyama | MRPL39 C21orf92 MRPL5 RPML5 MSTP003 PRED22 | PTELTEMRNDLFNKEKARQLsLTPRTEKIEVKHVGKTDPGT |
| Q9NYV4 | S1053 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | LPHWQDCHELWSKKRRRQRQsGVVVEEPPPSKTSRKETtsG |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9NZV8 | S552 | EPSD|PSP | KCND2 KIAA1044 | RRHKKTFRIPNANVSGSHQGsIQELSTIQIRCVERTPLSNS |
| Q9P0L9 | S682 | EPSD|PSP | PKD2L1 PKD2L PKDL TRPP3 | RQDLEEERVALNTEIEKLGRsIVssPQGKSGPEAARAGGWV |
| Q9P0L9 | S685 | EPSD|PSP | PKD2L1 PKD2L PKDL TRPP3 | LEEERVALNTEIEKLGRsIVssPQGKSGPEAARAGGWVSGE |
| Q9P0L9 | S686 | EPSD|PSP | PKD2L1 PKD2L PKDL TRPP3 | EEERVALNTEIEKLGRsIVssPQGKSGPEAARAGGWVSGEE |
| Q9P258 | S45 | Sugiyama | RCC2 KIAA1470 TD60 | PRKRGGPAGRKRERPERCssssGGGssGDEDGLELDGAPGG |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9P289 | T178 | EPSD|PSP | STK26 MASK MST4 | VKLADFGVAGQLtDtQIKRNtFVGtPFWMAPEVIQQSAYDS |
| Q9P2N2 | S69 | Sugiyama | ARHGAP28 KIAA1314 | RINRMLsNESLHPPAFsRSNsEASVDSASMEDFWREIESIK |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UD71 | T34 | GPS6|ELM|EPSD|PSP | PPP1R1B DARPP32 | PAPPSQLDPRQVEMIRRRRPtPAMLFRLsEHssPEEEAsPH |
| Q9UGP4 | S233 | Sugiyama | LIMD1 | GsDPPLPKPCGDHPLNHRQLsLsSSRssEGsLGGQNSGIGG |
| Q9UGP4 | S235 | Sugiyama | LIMD1 | DPPLPKPCGDHPLNHRQLsLsSSRssEGsLGGQNSGIGGRs |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UH17 | T214 | GPS6|PSP | APOBEC3B | DPDTFTFNFNNDPLVLRRRQtYLCYEVERLDNGTWVLMDQH |
| Q9UH77 | S433 | EPSD|PSP | KLHL3 KIAA1129 | AYSYKTNEWFFVAPMNTRRSsVGVGVVEGKLYAVGGYDGAS |
| Q9UH99 | S116 | ELM|EPSD|PSP | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | GEDLRVRRRRGtGGsEssRAsGLVGRKATEDFLGsSSGYss |
| Q9UH99 | S12 | ELM|EPSD|PSP | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | _________MSRRSQRLtRysQGDDDGssssGGSSVAGsQs |
| Q9UH99 | S54 | ELM|EPSD|PSP | SUN2 FRIGG KIAA0668 RAB5IP UNC84B | LFKDsPLRTLKRKSSNMKRLsPAPQLGPssDAHTSYYSESL |
| Q9UHD1 | S200 | Sugiyama | CHORDC1 CHP1 | SGVPIFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTK |
| Q9UHD1 | T204 | Sugiyama | CHORDC1 CHP1 | IFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTKKDAG |
| Q9UHL0 | T239 | PSP | DDX25 GRTH | IIGTPGTVLDWCFKLKLIDLtKIRVFVLDEADVMIDTQGFS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S39 | EPSD|PSP | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJY1 | S57 | EPSD|PSP | HSPB8 CRYAC E2IG1 HSP22 PP1629 | MDPFPDDLTASWPDWALPRLsSAWPGtLRSGMVPRGPTATA |
| Q9UJY4 | S183 | Sugiyama | GGA2 KIAA1080 | QDPKLPVDKILPPPSPWPKSsIFDADEEKSKLLTRLLKSNH |
| Q9UKG1 | S410 | EPSD|PSP | APPL1 APPL DIP13A KIAA1428 | VNQsALEAVtPsPsFQQRHEsLRPAAGQSRPPTARTSSSGs |
| Q9UL62 | S794 | PSP | TRPC5 TRP5 | STELSQRDDNNDGSGGARAKsKsVSFNLGCKKKTCHGPPLI |
| Q9UL62 | S796 | PSP | TRPC5 TRP5 | ELSQRDDNNDGSGGARAKsKsVSFNLGCKKKTCHGPPLIRT |
| Q9ULJ8 | S460 | EPSD|PSP | PPP1R9A KIAA1222 | SEIVGLPEEEEIPANRKIKFsSAPIKVFNTYSNEDYDRRND |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UMX1 | S346 | EPSD|PSP | SUFU UNQ650/PRO1280 | PINPQRQNGLAHDRAPsRKDsLEsDsstAIIPHELIRTRQL |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UNZ2 | S176 | PSP | NSFL1C UBXN2C | RLGAAPEEEsAyVAGEKRQHssQDVHVVLKLWKsGFsLDNG |
| Q9UPQ0 | S190 | Sugiyama | LIMCH1 KIAA1102 | PKRSIRDsGyIDCWDsERsDsLsPPRHGRDDsFDsLDsFGs |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQL6 | S279 | EPSD|PSP | HDAC5 KIAA0600 | sEPNLKVRSRLKQKVAERRssPLLRRKDGTVIStFKKRAVE |
| Q9Y210 | T70 | PSP | TRPC6 TRP6 | CYGYYPCFRGSDNRLAHRRQtVLREKGRRLANRGPAYMFSD |
| Q9Y230 | S43 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | GAHSHIRGLGLDDALEPRQAsQGMVGQLAARRAAGVVLEMI |
| Q9Y230 | T419 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | LRYAIQLITAASLVCRKRKGtEVQVDDIKRVysLFLDEsRS |
| Q9Y259 | S39 | EPSD|PSP | CHKB CHETK CHKL | AKDGLQQSKCPDTTPKRRRAssLSRDAERRAYQWCREYLGG |
| Q9Y259 | S40 | EPSD|PSP | CHKB CHETK CHKL | KDGLQQSKCPDTTPKRRRAssLSRDAERRAYQWCREYLGGA |
| Q9Y283 | T795 | PSP | INVS INV NPHP2 | KPSRRHDTEPKAKCAPQKRRtQELRGGRCSPAGSSRPGSAR |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2H0 | S977 | Sugiyama | DLGAP4 DAP4 KIAA0964 SAPAP4 | RKRLLAAKRAAsVRQNsAtEsADsIEIYVPEAQTRL_____ |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2K2 | S551 | PSP | SIK3 KIAA0999 QSK L19 | LLQPPTLQLLNGMGPLGRRAsDGGANIQLHAQQLLKRPRGP |
| Q9Y2K2 | S626 | PSP | SIK3 KIAA0999 QSK L19 | YKDSNTLHLPTERFSPVRRFsDGAASIQAFKAHLEKMGNNS |
| Q9Y2K2 | T469 | PSP | SIK3 KIAA0999 QSK L19 | DEGEEPSPEALVRYLSMRRHtVGVADPRTEVMEDLQKLLPG |
| Q9Y2K6 | S333 | EPSD|PSP | USP20 KIAA1003 LSFR3A VDU2 | IPDEAGRAISEKERMKDRKFsWGQQRtNsEQVDEDADVDtA |
| Q9Y3P9 | S931 | Sugiyama | RABGAP1 HSPC094 | QLKEMCRRELDKAESEIKKNssIIGDYKQICSQLSERLEKQ |
| Q9Y3P9 | S932 | Sugiyama | RABGAP1 HSPC094 | LKEMCRRELDKAESEIKKNssIIGDYKQICSQLSERLEKQQ |
| Q9Y478 | S24 | PSP | PRKAB1 AMPK | TSSERAALERHGGHKTPRRDssGGTKDGDRPKILMDsPEDA |
| Q9Y4C1 | S265 | EPSD|PSP | KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA | HDNLVTCGNSARIGAVKRKssENNGTLVSKQAKsCsEAsPS |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y698 | T321 | iPTMNet|EPSD | CACNG2 | NCIQKENKDSLHSNTANRRTtPV__________________ |
| Q9Y6A5 | S558 | PSP | TACC3 ERIC1 | VDyLEQFGTSSFKEsALRKQsLYLKFDPLLRDsPGRPVPVA |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
| Q9Y6D6 | S883 | EPSD|PSP | ARFGEF1 ARFGEP1 BIG1 | KDLPEEYLSAIYNEIAGKKIsMKETKELTIPTKSSKQNVAS |
| Q9Y6E0 | S434 | Sugiyama | STK24 MST3 STK3 | ACPGISDTMVAQLVQRLQRYsLSGGGtSsH___________ |
| Q9Y6E0 | T18 | ELM|EPSD|PSP | STK24 MST3 STK3 | ___MDSRAQLWGLALNKRRAtLPHPGGSTNLKADPEELFTK |
| Q9Y6Q9 | S857 | EPSD|PSP | NCOA3 AIB1 BHLHE42 RAC3 TRAM1 | LGLKSSQSVQSIRPPYNRAVsLDsPVsVGssPPVKNISAFP |
| Q9Y6R1 | S1026 | ELM|EPSD|PSP | SLC4A4 NBC NBC1 NBCE1 | IPEKDKKKKEDEKKKKKKKGsLDsDNDDsDCPYSEKVPSIK |
| Q9Y6X9 | T582 | PSP | MORC2 KIAA0852 ZCWCC1 | KQLTEKIRQQQEKLEALQKTtPIRSQADLKKLPLEVTTRPS |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 2.966696e-09 | 8.528 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.186938e-08 | 7.926 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.039645e-08 | 7.298 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.791943e-08 | 7.319 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.321795e-07 | 6.879 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.492809e-07 | 6.347 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.277765e-06 | 5.894 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.504980e-06 | 5.822 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.488451e-06 | 5.604 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.268943e-06 | 5.486 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.708219e-06 | 5.173 | 1 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.300088e-06 | 5.032 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 8.540559e-06 | 5.069 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.148560e-05 | 4.940 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.400245e-05 | 4.854 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.362083e-05 | 4.473 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.732125e-05 | 4.428 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.828316e-05 | 4.417 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.121080e-05 | 4.291 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.967783e-05 | 4.224 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.986308e-05 | 4.156 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.168933e-04 | 3.932 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.194843e-04 | 3.923 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.222390e-04 | 3.913 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.333192e-04 | 3.875 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.500607e-04 | 3.824 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.807594e-04 | 3.743 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.820194e-04 | 3.740 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.969419e-04 | 3.706 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.151833e-04 | 3.667 | 1 | 1 |
| Axon guidance | R-HSA-422475 | 2.243178e-04 | 3.649 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.584553e-04 | 3.588 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.551748e-04 | 3.593 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.839935e-04 | 3.547 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.051644e-04 | 3.515 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.432105e-04 | 3.464 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.838606e-04 | 3.416 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.224246e-04 | 3.374 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 5.581496e-04 | 3.253 | 1 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.786476e-04 | 3.238 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.264645e-04 | 3.203 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.846919e-04 | 3.165 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.101553e-04 | 3.041 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.738085e-04 | 3.012 | 1 | 1 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.738085e-04 | 3.012 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.978711e-04 | 3.098 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.978711e-04 | 3.098 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.668662e-04 | 3.015 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.668662e-04 | 3.015 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.976158e-04 | 3.047 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.992418e-04 | 3.097 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.720526e-04 | 3.059 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.434726e-04 | 3.025 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.333362e-04 | 3.135 | 1 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.389469e-04 | 3.027 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.505376e-04 | 3.070 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.517670e-04 | 3.124 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.395380e-04 | 3.027 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.032605e-03 | 2.986 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.204960e-03 | 2.919 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.181685e-03 | 2.927 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.168432e-03 | 2.932 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.303881e-03 | 2.885 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.422864e-03 | 2.847 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.414508e-03 | 2.849 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.587271e-03 | 2.799 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.864543e-03 | 2.729 | 1 | 1 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.784985e-03 | 2.748 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.823290e-03 | 2.739 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.884862e-03 | 2.725 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.044768e-03 | 2.689 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.996524e-03 | 2.700 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.979225e-03 | 2.704 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.464408e-03 | 2.608 | 1 | 1 |
| Calmodulin induced events | R-HSA-111933 | 2.728627e-03 | 2.564 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 2.728627e-03 | 2.564 | 1 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.638202e-03 | 2.579 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.723587e-03 | 2.565 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.765166e-03 | 2.558 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.907738e-03 | 2.536 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.982599e-03 | 2.525 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.302969e-03 | 2.481 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.749052e-03 | 2.426 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.965567e-03 | 2.402 | 1 | 0 |
| Depurination | R-HSA-73927 | 3.971881e-03 | 2.401 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.110144e-03 | 2.386 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.204760e-03 | 2.376 | 1 | 1 |
| Reproduction | R-HSA-1474165 | 4.313377e-03 | 2.365 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.360433e-03 | 2.360 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.746226e-03 | 2.324 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.990772e-03 | 2.302 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.057633e-03 | 2.296 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.154211e-03 | 2.288 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.247710e-03 | 2.280 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.187897e-03 | 2.285 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.494876e-03 | 2.260 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.150312e-03 | 2.211 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.474491e-03 | 2.189 | 1 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.965733e-03 | 2.157 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.779757e-03 | 2.169 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.069689e-03 | 2.151 | 1 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.173094e-03 | 2.144 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.173094e-03 | 2.144 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.173094e-03 | 2.144 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.173094e-03 | 2.144 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.553540e-03 | 2.122 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.818755e-03 | 2.107 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.117241e-03 | 2.040 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.117241e-03 | 2.040 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.134110e-03 | 2.039 | 1 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.134110e-03 | 2.039 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.134110e-03 | 2.039 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.188826e-03 | 2.037 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.188826e-03 | 2.037 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.777347e-03 | 2.010 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.362425e-03 | 2.029 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.622499e-03 | 2.017 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.821555e-03 | 2.008 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.014469e-02 | 1.994 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.014901e-02 | 1.994 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.061669e-02 | 1.974 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.223128e-02 | 1.913 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.236446e-02 | 1.908 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.236446e-02 | 1.908 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.189121e-02 | 1.925 | 1 | 1 |
| PLC beta mediated events | R-HSA-112043 | 1.149765e-02 | 1.939 | 1 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.156477e-02 | 1.937 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.201152e-02 | 1.920 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.201152e-02 | 1.920 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.262114e-02 | 1.899 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.311023e-02 | 1.882 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.369293e-02 | 1.864 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.438320e-02 | 1.842 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.445673e-02 | 1.840 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.454629e-02 | 1.837 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.489175e-02 | 1.827 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.501316e-02 | 1.824 | 1 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.645478e-02 | 1.784 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.645478e-02 | 1.784 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.614589e-02 | 1.792 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.570339e-02 | 1.804 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.591296e-02 | 1.798 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.513175e-02 | 1.820 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.672387e-02 | 1.777 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.693267e-02 | 1.771 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.693267e-02 | 1.771 | 1 | 1 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.693267e-02 | 1.771 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.745504e-02 | 1.758 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.809058e-02 | 1.743 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.846489e-02 | 1.734 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.846489e-02 | 1.734 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.863377e-02 | 1.730 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.897933e-02 | 1.722 | 1 | 1 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.866272e-02 | 1.729 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.846489e-02 | 1.734 | 1 | 1 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.012950e-02 | 1.696 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.893922e-02 | 1.723 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.059217e-02 | 1.686 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.076612e-02 | 1.683 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.127454e-02 | 1.672 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.262361e-02 | 1.645 | 1 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.282953e-02 | 1.642 | 1 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.320705e-02 | 1.634 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.330479e-02 | 1.633 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.338074e-02 | 1.631 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.484607e-02 | 1.605 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.484607e-02 | 1.605 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.484607e-02 | 1.605 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.484607e-02 | 1.605 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.484607e-02 | 1.605 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.638401e-02 | 1.579 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.471839e-02 | 1.607 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.665446e-02 | 1.574 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.778931e-02 | 1.556 | 1 | 1 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.896168e-02 | 1.538 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.011866e-02 | 1.521 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.041231e-02 | 1.517 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.057437e-02 | 1.515 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.083263e-02 | 1.511 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.083263e-02 | 1.511 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.090160e-02 | 1.510 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.158354e-02 | 1.501 | 1 | 1 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.713901e-02 | 1.430 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.435057e-02 | 1.464 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.435057e-02 | 1.464 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.435057e-02 | 1.464 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.430890e-02 | 1.465 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.430890e-02 | 1.465 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.710149e-02 | 1.431 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.710149e-02 | 1.431 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.713901e-02 | 1.430 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.713901e-02 | 1.430 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.713901e-02 | 1.430 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.473166e-02 | 1.459 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.645138e-02 | 1.438 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.448665e-02 | 1.462 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.746756e-02 | 1.426 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.167366e-02 | 1.380 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.179780e-02 | 1.379 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.315867e-02 | 1.365 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.387124e-02 | 1.358 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.436359e-02 | 1.353 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.490202e-02 | 1.348 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.587663e-02 | 1.338 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.587663e-02 | 1.338 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.169092e-02 | 1.287 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.408000e-02 | 1.267 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.408000e-02 | 1.267 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.408000e-02 | 1.267 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.818458e-02 | 1.317 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.999618e-02 | 1.301 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.999618e-02 | 1.301 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.063027e-02 | 1.296 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.115888e-02 | 1.291 | 1 | 1 |
| Signaling by Hippo | R-HSA-2028269 | 5.313056e-02 | 1.275 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.048163e-02 | 1.297 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.048163e-02 | 1.297 | 1 | 1 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.408000e-02 | 1.267 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.388134e-02 | 1.269 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.818458e-02 | 1.317 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.257772e-02 | 1.279 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.487389e-02 | 1.261 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.551078e-02 | 1.256 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.556349e-02 | 1.255 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.612416e-02 | 1.251 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.632202e-02 | 1.249 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.633956e-02 | 1.249 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.740910e-02 | 1.241 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.740910e-02 | 1.241 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.900559e-02 | 1.229 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.929790e-02 | 1.227 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.929790e-02 | 1.227 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.937133e-02 | 1.226 | 1 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.211974e-02 | 1.207 | 1 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.295442e-02 | 1.201 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.295442e-02 | 1.201 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.295442e-02 | 1.201 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.302444e-02 | 1.200 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.302444e-02 | 1.200 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.302444e-02 | 1.200 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 7.407076e-02 | 1.130 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.407076e-02 | 1.130 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 7.407076e-02 | 1.130 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.407076e-02 | 1.130 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 7.407076e-02 | 1.130 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.950166e-02 | 1.158 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.950166e-02 | 1.158 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.009210e-02 | 1.154 | 1 | 1 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.192926e-02 | 1.143 | 1 | 1 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.457478e-02 | 1.127 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.950166e-02 | 1.158 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.800708e-02 | 1.167 | 1 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.788491e-02 | 1.168 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.435092e-02 | 1.191 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.457478e-02 | 1.127 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.430046e-02 | 1.192 | 1 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.475610e-02 | 1.189 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.779541e-02 | 1.109 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.791486e-02 | 1.108 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.082049e-02 | 1.092 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.088729e-02 | 1.092 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.101099e-02 | 1.091 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.243378e-02 | 1.084 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.290270e-02 | 1.081 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.290270e-02 | 1.081 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.290270e-02 | 1.081 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.290270e-02 | 1.081 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.290270e-02 | 1.081 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.396431e-02 | 1.076 | 1 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.504157e-02 | 1.070 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.504157e-02 | 1.070 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.504157e-02 | 1.070 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.504157e-02 | 1.070 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.539795e-02 | 1.069 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.539795e-02 | 1.069 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.623150e-02 | 1.064 | 1 | 1 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.683034e-02 | 1.014 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.756556e-02 | 1.011 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.756556e-02 | 1.011 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.756556e-02 | 1.011 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.669988e-02 | 1.015 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.481853e-02 | 1.023 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.481853e-02 | 1.023 | 1 | 1 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.626352e-02 | 1.017 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.044640e-01 | 0.981 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.015752e-01 | 0.993 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.012517e-02 | 1.045 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.012517e-02 | 1.045 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.012517e-02 | 1.045 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.838721e-02 | 1.007 | 1 | 1 |
| Mitotic Prometaphase | R-HSA-68877 | 8.844444e-02 | 1.053 | 1 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.163249e-02 | 1.038 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.371911e-02 | 1.028 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.970937e-02 | 1.001 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.481078e-02 | 1.023 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.044640e-01 | 0.981 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.974646e-02 | 1.047 | 1 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.826924e-02 | 1.008 | 1 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.940657e-02 | 1.049 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.076262e-02 | 1.042 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.010602e-01 | 0.995 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.044640e-01 | 0.981 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.032231e-01 | 0.986 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.070604e-01 | 0.970 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.087846e-01 | 0.963 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.094579e-01 | 0.961 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.099131e-01 | 0.959 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.099131e-01 | 0.959 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.103671e-01 | 0.957 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.103671e-01 | 0.957 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.103671e-01 | 0.957 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.108984e-01 | 0.955 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.113422e-01 | 0.953 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.134410e-01 | 0.945 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.134410e-01 | 0.945 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.137238e-01 | 0.944 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.162891e-01 | 0.934 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.165367e-01 | 0.934 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.168709e-01 | 0.932 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.177588e-01 | 0.929 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.185115e-01 | 0.926 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.193787e-01 | 0.923 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.220306e-01 | 0.914 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.220306e-01 | 0.914 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.220306e-01 | 0.914 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.220306e-01 | 0.914 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.230726e-01 | 0.910 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.230726e-01 | 0.910 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.145203e-01 | 0.669 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.145203e-01 | 0.669 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.145203e-01 | 0.669 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.145203e-01 | 0.669 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.145203e-01 | 0.669 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.642893e-01 | 0.784 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.642893e-01 | 0.784 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.642893e-01 | 0.784 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.038585e-01 | 0.517 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.038585e-01 | 0.517 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.038585e-01 | 0.517 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.038585e-01 | 0.517 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.038585e-01 | 0.517 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.038585e-01 | 0.517 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.038585e-01 | 0.517 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.038585e-01 | 0.517 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.038585e-01 | 0.517 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.038585e-01 | 0.517 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.038585e-01 | 0.517 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.038585e-01 | 0.517 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.038585e-01 | 0.517 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.038585e-01 | 0.517 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.038585e-01 | 0.517 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.038585e-01 | 0.517 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.038585e-01 | 0.517 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.074762e-01 | 0.683 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.074762e-01 | 0.683 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.074762e-01 | 0.683 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.074762e-01 | 0.683 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.493184e-01 | 0.826 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.493184e-01 | 0.826 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.493184e-01 | 0.826 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.306513e-01 | 0.884 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.306513e-01 | 0.884 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.306513e-01 | 0.884 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.306513e-01 | 0.884 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.306513e-01 | 0.884 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.306513e-01 | 0.884 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.783332e-01 | 0.749 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.783332e-01 | 0.749 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.516527e-01 | 0.599 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.516527e-01 | 0.599 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.830402e-01 | 0.417 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.830402e-01 | 0.417 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.830402e-01 | 0.417 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.830402e-01 | 0.417 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.830402e-01 | 0.417 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.830402e-01 | 0.417 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.830402e-01 | 0.417 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.830402e-01 | 0.417 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.830402e-01 | 0.417 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.830402e-01 | 0.417 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.830402e-01 | 0.417 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.830402e-01 | 0.417 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.830402e-01 | 0.417 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.087194e-01 | 0.680 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.087194e-01 | 0.680 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.087194e-01 | 0.680 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.960356e-01 | 0.529 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 2.960356e-01 | 0.529 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.960356e-01 | 0.529 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.485671e-01 | 0.828 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.401354e-01 | 0.620 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.401354e-01 | 0.620 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.401354e-01 | 0.620 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.401354e-01 | 0.620 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.401354e-01 | 0.620 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.401354e-01 | 0.620 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.992956e-01 | 0.701 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.992956e-01 | 0.701 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.676599e-01 | 0.776 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.676599e-01 | 0.776 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.352207e-01 | 0.869 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.876533e-01 | 0.727 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.876533e-01 | 0.727 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.876533e-01 | 0.727 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.876533e-01 | 0.727 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.722605e-01 | 0.565 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.722605e-01 | 0.565 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.400070e-01 | 0.469 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.400070e-01 | 0.469 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.400070e-01 | 0.469 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.400070e-01 | 0.469 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.400070e-01 | 0.469 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.400070e-01 | 0.469 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.400070e-01 | 0.469 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.532196e-01 | 0.344 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5688399 | 4.532196e-01 | 0.344 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.532196e-01 | 0.344 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.532196e-01 | 0.344 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.532196e-01 | 0.344 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.532196e-01 | 0.344 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.532196e-01 | 0.344 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.532196e-01 | 0.344 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5683678 | 4.532196e-01 | 0.344 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.532196e-01 | 0.344 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.278972e-01 | 0.893 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.278972e-01 | 0.893 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.495175e-01 | 0.825 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.758395e-01 | 0.755 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.084507e-01 | 0.681 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.499045e-01 | 0.602 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.499045e-01 | 0.602 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.644890e-01 | 0.784 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.047985e-01 | 0.516 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.047985e-01 | 0.516 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.047985e-01 | 0.516 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.299515e-01 | 0.638 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.438343e-01 | 0.842 | 1 | 1 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.121888e-01 | 0.673 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.761592e-01 | 0.559 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.830866e-01 | 0.417 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.830866e-01 | 0.417 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.830866e-01 | 0.417 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.520529e-01 | 0.599 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.312687e-01 | 0.636 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.312687e-01 | 0.636 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.312687e-01 | 0.636 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.374808e-01 | 0.472 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.374808e-01 | 0.472 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.130468e-01 | 0.672 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.746518e-01 | 0.561 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.122335e-01 | 0.673 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.708929e-01 | 0.567 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.976455e-01 | 0.526 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.976455e-01 | 0.526 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.297664e-01 | 0.482 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.154197e-01 | 0.288 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.154197e-01 | 0.288 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.154197e-01 | 0.288 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.154197e-01 | 0.288 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.154197e-01 | 0.288 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 5.154197e-01 | 0.288 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.442354e-01 | 0.612 | 1 | 1 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.442354e-01 | 0.612 | 1 | 1 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.050078e-01 | 0.688 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.209335e-01 | 0.494 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.138511e-01 | 0.670 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.023449e-01 | 0.395 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.023449e-01 | 0.395 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.023449e-01 | 0.395 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.023449e-01 | 0.395 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.652020e-01 | 0.332 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.652020e-01 | 0.332 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.222491e-01 | 0.492 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.680054e-01 | 0.434 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.680054e-01 | 0.434 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.680054e-01 | 0.434 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.029552e-01 | 0.519 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.540117e-01 | 0.451 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.341309e-01 | 0.362 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.341309e-01 | 0.362 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.107510e-01 | 0.386 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.916062e-01 | 0.407 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.878654e-01 | 0.541 | 1 | 1 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.293835e-01 | 0.482 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.151363e-01 | 0.382 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.373905e-01 | 0.359 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.652677e-01 | 0.332 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 4.652677e-01 | 0.332 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.037734e-01 | 0.298 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.705473e-01 | 0.244 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.705473e-01 | 0.244 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.705473e-01 | 0.244 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.705473e-01 | 0.244 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.705473e-01 | 0.244 | 1 | 1 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.705473e-01 | 0.244 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.705473e-01 | 0.244 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.705473e-01 | 0.244 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.385169e-01 | 0.358 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.325806e-01 | 0.478 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.325806e-01 | 0.478 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.956233e-01 | 0.305 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.198199e-01 | 0.377 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.198199e-01 | 0.377 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.404933e-01 | 0.267 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.404933e-01 | 0.267 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.575073e-01 | 0.340 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.575073e-01 | 0.340 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.845444e-01 | 0.315 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.554726e-01 | 0.342 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.250891e-01 | 0.280 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.250891e-01 | 0.280 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.070636e-01 | 0.295 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.008076e-01 | 0.300 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.766642e-01 | 0.322 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.636598e-01 | 0.334 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.535780e-01 | 0.257 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.752838e-01 | 0.240 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.752838e-01 | 0.240 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.752838e-01 | 0.240 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.752838e-01 | 0.240 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.752838e-01 | 0.240 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 5.752838e-01 | 0.240 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 5.752838e-01 | 0.240 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.194063e-01 | 0.208 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.194063e-01 | 0.208 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.194063e-01 | 0.208 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.194063e-01 | 0.208 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.194063e-01 | 0.208 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.194063e-01 | 0.208 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.194063e-01 | 0.208 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.194063e-01 | 0.208 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.194063e-01 | 0.208 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.194063e-01 | 0.208 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.194063e-01 | 0.208 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.810225e-01 | 0.236 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.607117e-01 | 0.251 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.869112e-01 | 0.231 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.081086e-01 | 0.216 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.866914e-01 | 0.232 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.926400e-01 | 0.227 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.095093e-01 | 0.215 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.095093e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.926400e-01 | 0.227 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.070636e-01 | 0.295 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.395171e-01 | 0.268 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.485671e-01 | 0.828 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.876533e-01 | 0.727 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.385169e-01 | 0.358 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.138793e-01 | 0.212 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.845365e-01 | 0.546 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.387463e-01 | 0.622 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.616752e-01 | 0.336 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.497419e-01 | 0.603 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.195879e-01 | 0.377 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.810225e-01 | 0.236 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.178384e-01 | 0.379 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.800965e-01 | 0.744 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.961829e-01 | 0.707 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.230423e-01 | 0.652 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.752838e-01 | 0.240 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.700669e-01 | 0.432 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.560695e-01 | 0.807 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.874256e-01 | 0.727 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.008076e-01 | 0.300 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.405524e-01 | 0.852 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.032277e-01 | 0.518 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.810225e-01 | 0.236 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.366829e-01 | 0.360 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.523403e-01 | 0.817 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.992956e-01 | 0.701 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.797692e-01 | 0.420 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.497419e-01 | 0.603 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.783332e-01 | 0.749 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.087194e-01 | 0.680 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.595868e-01 | 0.338 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.131959e-01 | 0.212 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.131959e-01 | 0.212 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.250891e-01 | 0.280 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.783332e-01 | 0.749 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.516527e-01 | 0.599 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.087194e-01 | 0.680 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.400070e-01 | 0.469 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.761592e-01 | 0.559 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.329241e-01 | 0.478 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.652020e-01 | 0.332 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.674604e-01 | 0.776 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.540117e-01 | 0.451 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.751916e-01 | 0.426 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.373905e-01 | 0.359 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.892075e-01 | 0.410 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.845444e-01 | 0.315 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.210034e-01 | 0.283 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.787544e-01 | 0.422 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.646818e-01 | 0.577 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.278972e-01 | 0.893 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.250891e-01 | 0.280 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.395171e-01 | 0.268 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.047985e-01 | 0.516 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.560882e-01 | 0.807 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.845444e-01 | 0.315 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.642971e-01 | 0.578 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.141558e-01 | 0.669 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.493184e-01 | 0.826 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.783332e-01 | 0.749 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.485671e-01 | 0.828 | 1 | 1 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.722605e-01 | 0.565 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.047985e-01 | 0.516 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.830866e-01 | 0.417 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.374808e-01 | 0.472 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.249087e-01 | 0.372 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.154197e-01 | 0.288 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.023449e-01 | 0.395 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.199212e-01 | 0.658 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.705473e-01 | 0.244 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.441940e-01 | 0.463 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.081086e-01 | 0.216 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.926400e-01 | 0.227 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.924428e-01 | 0.227 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.037734e-01 | 0.298 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.630139e-01 | 0.249 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.936900e-01 | 0.713 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.835594e-01 | 0.416 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.087194e-01 | 0.680 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.087194e-01 | 0.680 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.758395e-01 | 0.755 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 2.508603e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.442354e-01 | 0.612 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.752838e-01 | 0.240 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.995112e-01 | 0.398 | 1 | 1 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.197508e-01 | 0.377 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.008076e-01 | 0.300 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.199394e-01 | 0.495 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.160910e-01 | 0.500 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.119955e-01 | 0.506 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.242278e-01 | 0.649 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.566003e-01 | 0.591 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.783332e-01 | 0.749 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.516527e-01 | 0.599 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.752768e-01 | 0.756 | 1 | 1 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.752768e-01 | 0.756 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.960356e-01 | 0.529 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.400070e-01 | 0.469 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.830866e-01 | 0.417 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.830866e-01 | 0.417 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.830866e-01 | 0.417 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.708929e-01 | 0.567 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.297664e-01 | 0.482 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.249087e-01 | 0.372 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.329241e-01 | 0.478 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.037734e-01 | 0.298 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.385169e-01 | 0.358 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.404933e-01 | 0.267 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.039838e-01 | 0.394 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.148103e-01 | 0.288 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.767733e-01 | 0.322 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.603653e-01 | 0.252 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.742385e-01 | 0.241 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.337700e-01 | 0.273 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.446215e-01 | 0.840 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.455202e-01 | 0.263 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.275731e-01 | 0.485 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.039838e-01 | 0.394 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.862197e-01 | 0.232 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.175727e-01 | 0.379 | 1 | 1 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.981321e-01 | 0.223 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.981321e-01 | 0.223 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.291784e-01 | 0.276 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.296967e-01 | 0.276 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.122335e-01 | 0.673 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.311542e-01 | 0.365 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.892075e-01 | 0.410 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.267958e-01 | 0.897 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.404933e-01 | 0.267 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.761806e-01 | 0.239 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.761806e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.761806e-01 | 0.239 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.761806e-01 | 0.239 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.065555e-01 | 0.217 | 1 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.291784e-01 | 0.276 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.595728e-01 | 0.444 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.642893e-01 | 0.784 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.329241e-01 | 0.478 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.652020e-01 | 0.332 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.194063e-01 | 0.208 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.939118e-01 | 0.306 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.591172e-01 | 0.445 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.479953e-01 | 0.606 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.823949e-01 | 0.739 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.868258e-01 | 0.729 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.444661e-01 | 0.352 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.333932e-01 | 0.632 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.070636e-01 | 0.295 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.810225e-01 | 0.236 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.774228e-01 | 0.423 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.444661e-01 | 0.352 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.444661e-01 | 0.352 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.646818e-01 | 0.577 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.638456e-01 | 0.439 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.466877e-01 | 0.834 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.570176e-01 | 0.804 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.396745e-01 | 0.620 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.858736e-01 | 0.544 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.722605e-01 | 0.565 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.499045e-01 | 0.602 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.607108e-01 | 0.443 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.078614e-01 | 0.216 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.248710e-01 | 0.488 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.780441e-01 | 0.556 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.065591e-01 | 0.295 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.400070e-01 | 0.469 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.579685e-01 | 0.588 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.291784e-01 | 0.276 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.578968e-01 | 0.802 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.895057e-01 | 0.310 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.588637e-01 | 0.445 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.596264e-01 | 0.252 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.908202e-01 | 0.408 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.783450e-01 | 0.320 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.812012e-01 | 0.318 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.535780e-01 | 0.257 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.440061e-01 | 0.264 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.496962e-01 | 0.456 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.963992e-01 | 0.402 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.705105e-01 | 0.568 | 1 | 1 |
| Interleukin-17 signaling | R-HSA-448424 | 4.674126e-01 | 0.330 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.599150e-01 | 0.252 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.862742e-01 | 0.730 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.637965e-01 | 0.786 | 1 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.145203e-01 | 0.669 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.642893e-01 | 0.784 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.783332e-01 | 0.749 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.783332e-01 | 0.749 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.516527e-01 | 0.599 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.830402e-01 | 0.417 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.485671e-01 | 0.828 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.485671e-01 | 0.828 | 1 | 1 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.676599e-01 | 0.776 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.242278e-01 | 0.649 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.722605e-01 | 0.565 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.722605e-01 | 0.565 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.532196e-01 | 0.344 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.047985e-01 | 0.516 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.299515e-01 | 0.638 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.374808e-01 | 0.472 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.122335e-01 | 0.673 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.154197e-01 | 0.288 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.154197e-01 | 0.288 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.154197e-01 | 0.288 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.652020e-01 | 0.332 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.680054e-01 | 0.434 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.151363e-01 | 0.382 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.652677e-01 | 0.332 | 1 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.705473e-01 | 0.244 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.705473e-01 | 0.244 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.705473e-01 | 0.244 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.386536e-01 | 0.358 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.874675e-01 | 0.312 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.535780e-01 | 0.257 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.194063e-01 | 0.208 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.194063e-01 | 0.208 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.194063e-01 | 0.208 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.194063e-01 | 0.208 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.194063e-01 | 0.208 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.073727e-01 | 0.217 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.095093e-01 | 0.215 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.163480e-01 | 0.210 | 1 | 1 |
| Neuronal System | R-HSA-112316 | 4.153866e-01 | 0.382 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.414124e-01 | 0.467 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.395171e-01 | 0.268 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.547652e-01 | 0.810 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.982585e-01 | 0.703 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.175727e-01 | 0.379 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.832662e-01 | 0.737 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.981980e-01 | 0.703 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.155828e-01 | 0.381 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.962976e-01 | 0.707 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.428120e-01 | 0.354 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.360014e-01 | 0.866 | 1 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.912950e-01 | 0.536 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.098551e-01 | 0.678 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.520529e-01 | 0.599 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.652677e-01 | 0.332 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 5.752838e-01 | 0.240 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.869112e-01 | 0.231 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.095093e-01 | 0.215 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.655844e-01 | 0.437 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.824699e-01 | 0.317 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.474818e-01 | 0.831 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.074762e-01 | 0.683 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.783332e-01 | 0.749 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.783332e-01 | 0.749 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.400070e-01 | 0.469 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.520529e-01 | 0.599 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.374808e-01 | 0.472 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.560695e-01 | 0.807 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.568198e-01 | 0.448 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.636724e-01 | 0.334 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.702277e-01 | 0.328 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.752838e-01 | 0.240 | 1 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.752838e-01 | 0.240 | 1 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.752838e-01 | 0.240 | 1 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.194063e-01 | 0.208 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.194063e-01 | 0.208 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.194063e-01 | 0.208 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.673549e-01 | 0.246 | 1 | 1 |
| Processing of SMDT1 | R-HSA-8949664 | 6.081086e-01 | 0.216 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.427516e-01 | 0.465 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.408768e-01 | 0.467 | 1 | 1 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.745339e-01 | 0.758 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.249087e-01 | 0.372 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.444180e-01 | 0.463 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.148103e-01 | 0.288 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.485671e-01 | 0.828 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.326785e-01 | 0.274 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.326785e-01 | 0.274 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.058545e-01 | 0.392 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.962976e-01 | 0.707 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.029357e-01 | 0.395 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.956233e-01 | 0.305 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.710196e-01 | 0.327 | 1 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.033469e-01 | 0.298 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.197508e-01 | 0.377 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.038585e-01 | 0.517 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.306513e-01 | 0.884 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.830402e-01 | 0.417 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.087194e-01 | 0.680 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.401354e-01 | 0.620 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.830866e-01 | 0.417 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.249087e-01 | 0.372 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.154197e-01 | 0.288 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.838563e-01 | 0.416 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.341309e-01 | 0.362 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.341309e-01 | 0.362 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.650949e-01 | 0.577 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.705473e-01 | 0.244 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.705473e-01 | 0.244 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.895057e-01 | 0.310 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.194063e-01 | 0.208 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.810225e-01 | 0.236 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.761806e-01 | 0.239 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.981321e-01 | 0.223 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.163480e-01 | 0.210 | 1 | 1 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.131959e-01 | 0.212 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.916062e-01 | 0.407 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.895057e-01 | 0.310 | 1 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.329241e-01 | 0.478 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.085063e-01 | 0.681 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.614561e-01 | 0.442 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.210034e-01 | 0.283 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.910389e-01 | 0.228 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.493184e-01 | 0.826 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.660929e-01 | 0.575 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.081086e-01 | 0.216 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.155508e-01 | 0.211 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.340047e-01 | 0.631 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.635671e-01 | 0.249 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.960356e-01 | 0.529 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.147094e-01 | 0.502 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.151025e-01 | 0.288 | 1 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.003288e-01 | 0.698 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.023449e-01 | 0.395 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.375662e-01 | 0.359 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.299091e-01 | 0.482 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.258103e-01 | 0.487 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.913448e-01 | 0.718 | 1 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.516527e-01 | 0.599 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.400070e-01 | 0.469 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.400070e-01 | 0.469 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.830866e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.154197e-01 | 0.288 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.705473e-01 | 0.244 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.705473e-01 | 0.244 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.995112e-01 | 0.398 | 1 | 1 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.084303e-01 | 0.294 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.752838e-01 | 0.240 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.194063e-01 | 0.208 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.950531e-01 | 0.710 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.803207e-01 | 0.318 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.440061e-01 | 0.264 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.209335e-01 | 0.494 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.810225e-01 | 0.236 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.535780e-01 | 0.257 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.516527e-01 | 0.599 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.700669e-01 | 0.432 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.249087e-01 | 0.372 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.023449e-01 | 0.395 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.194063e-01 | 0.208 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.194063e-01 | 0.208 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.862197e-01 | 0.232 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.670246e-01 | 0.435 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.028311e-01 | 0.519 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.752838e-01 | 0.240 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.073727e-01 | 0.217 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.670246e-01 | 0.435 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.291784e-01 | 0.276 | 1 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.107510e-01 | 0.386 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.196827e-01 | 0.284 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.752838e-01 | 0.240 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.130205e-01 | 0.504 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.081086e-01 | 0.216 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.652020e-01 | 0.332 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.743094e-01 | 0.241 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.240185e-01 | 0.205 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.240185e-01 | 0.205 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.240185e-01 | 0.205 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.240185e-01 | 0.205 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.313302e-01 | 0.200 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.313302e-01 | 0.200 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.313302e-01 | 0.200 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.313302e-01 | 0.200 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.313302e-01 | 0.200 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.321904e-01 | 0.199 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.325942e-01 | 0.199 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.325942e-01 | 0.199 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.325942e-01 | 0.199 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.325942e-01 | 0.199 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.325942e-01 | 0.199 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.340895e-01 | 0.198 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.340895e-01 | 0.198 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.340895e-01 | 0.198 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.340895e-01 | 0.198 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.340895e-01 | 0.198 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.384642e-01 | 0.195 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.384642e-01 | 0.195 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.389647e-01 | 0.195 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.389647e-01 | 0.195 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.389647e-01 | 0.195 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.389647e-01 | 0.195 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.389647e-01 | 0.195 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.389647e-01 | 0.195 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.389647e-01 | 0.195 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.389647e-01 | 0.195 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.393001e-01 | 0.194 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.525113e-01 | 0.185 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.525113e-01 | 0.185 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.542263e-01 | 0.184 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.544406e-01 | 0.184 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.566665e-01 | 0.183 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.566665e-01 | 0.183 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.566665e-01 | 0.183 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.566665e-01 | 0.183 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.627090e-01 | 0.179 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.627090e-01 | 0.179 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.627090e-01 | 0.179 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.627090e-01 | 0.179 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.627090e-01 | 0.179 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.627090e-01 | 0.179 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.627090e-01 | 0.179 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.627090e-01 | 0.179 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.627090e-01 | 0.179 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.627090e-01 | 0.179 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.678751e-01 | 0.175 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.678751e-01 | 0.175 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.678751e-01 | 0.175 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.678751e-01 | 0.175 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.678751e-01 | 0.175 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.678751e-01 | 0.175 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.678751e-01 | 0.175 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.678751e-01 | 0.175 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.678751e-01 | 0.175 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.680554e-01 | 0.175 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.680801e-01 | 0.175 | 1 | 1 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.680801e-01 | 0.175 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.688430e-01 | 0.175 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.700129e-01 | 0.174 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.712253e-01 | 0.173 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.712253e-01 | 0.173 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.738911e-01 | 0.171 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.759979e-01 | 0.170 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.773521e-01 | 0.169 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.774091e-01 | 0.169 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.795809e-01 | 0.168 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.817721e-01 | 0.166 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.822993e-01 | 0.166 | 1 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.834127e-01 | 0.165 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.834127e-01 | 0.165 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.885588e-01 | 0.162 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.908339e-01 | 0.161 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.919286e-01 | 0.160 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.919286e-01 | 0.160 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.919286e-01 | 0.160 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.940233e-01 | 0.159 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.948831e-01 | 0.158 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.948831e-01 | 0.158 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.948831e-01 | 0.158 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.948831e-01 | 0.158 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.948831e-01 | 0.158 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.948831e-01 | 0.158 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.948831e-01 | 0.158 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.948831e-01 | 0.158 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.948831e-01 | 0.158 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.948831e-01 | 0.158 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.978267e-01 | 0.156 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.978267e-01 | 0.156 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.983143e-01 | 0.156 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.999986e-01 | 0.155 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.008132e-01 | 0.154 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.008132e-01 | 0.154 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.010872e-01 | 0.154 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.010872e-01 | 0.154 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.010872e-01 | 0.154 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.010872e-01 | 0.154 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.010872e-01 | 0.154 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.010872e-01 | 0.154 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.010872e-01 | 0.154 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.010872e-01 | 0.154 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.010872e-01 | 0.154 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.010872e-01 | 0.154 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.010872e-01 | 0.154 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.013394e-01 | 0.154 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.013394e-01 | 0.154 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.013394e-01 | 0.154 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.013394e-01 | 0.154 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.038643e-01 | 0.153 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.038643e-01 | 0.153 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.038643e-01 | 0.153 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.060577e-01 | 0.151 | 1 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.104735e-01 | 0.148 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.104735e-01 | 0.148 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.200472e-01 | 0.143 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.200472e-01 | 0.143 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.200472e-01 | 0.143 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.200472e-01 | 0.143 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.200472e-01 | 0.143 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.200472e-01 | 0.143 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.200472e-01 | 0.143 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.200472e-01 | 0.143 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.200472e-01 | 0.143 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.200472e-01 | 0.143 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.200472e-01 | 0.143 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.208849e-01 | 0.142 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.215619e-01 | 0.142 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.219525e-01 | 0.141 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.219525e-01 | 0.141 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.257965e-01 | 0.139 | 1 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.281889e-01 | 0.138 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.281889e-01 | 0.138 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.281889e-01 | 0.138 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.281889e-01 | 0.138 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.308712e-01 | 0.136 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.312752e-01 | 0.136 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.321328e-01 | 0.135 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.351006e-01 | 0.134 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.351006e-01 | 0.134 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.351006e-01 | 0.134 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.351006e-01 | 0.134 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.351006e-01 | 0.134 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.351006e-01 | 0.134 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.351006e-01 | 0.134 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.351006e-01 | 0.134 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.351006e-01 | 0.134 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.351006e-01 | 0.134 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.351006e-01 | 0.134 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.351006e-01 | 0.134 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.351006e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.358257e-01 | 0.133 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.358257e-01 | 0.133 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.390959e-01 | 0.131 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.390959e-01 | 0.131 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.414386e-01 | 0.130 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 7.414386e-01 | 0.130 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.420038e-01 | 0.130 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.434373e-01 | 0.129 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.434373e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.434373e-01 | 0.129 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.434373e-01 | 0.129 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.434373e-01 | 0.129 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.434373e-01 | 0.129 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.434373e-01 | 0.129 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.434373e-01 | 0.129 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.434373e-01 | 0.129 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.438742e-01 | 0.129 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.438742e-01 | 0.129 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.480233e-01 | 0.126 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.500506e-01 | 0.125 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.508314e-01 | 0.124 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.574255e-01 | 0.121 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.574255e-01 | 0.121 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.590869e-01 | 0.120 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.598081e-01 | 0.119 | 1 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.598218e-01 | 0.119 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.598218e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.598218e-01 | 0.119 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.598218e-01 | 0.119 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.611595e-01 | 0.119 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.611595e-01 | 0.119 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.611595e-01 | 0.119 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.611595e-01 | 0.119 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.643197e-01 | 0.117 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.646868e-01 | 0.117 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.651312e-01 | 0.116 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.651312e-01 | 0.116 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.651312e-01 | 0.116 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.651312e-01 | 0.116 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.651312e-01 | 0.116 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.651312e-01 | 0.116 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.651931e-01 | 0.116 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.651931e-01 | 0.116 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.652453e-01 | 0.116 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.652453e-01 | 0.116 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.652453e-01 | 0.116 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.652453e-01 | 0.116 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.652453e-01 | 0.116 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.652453e-01 | 0.116 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.652453e-01 | 0.116 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.652453e-01 | 0.116 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.652453e-01 | 0.116 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.652453e-01 | 0.116 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.652453e-01 | 0.116 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.652453e-01 | 0.116 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.652453e-01 | 0.116 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.652453e-01 | 0.116 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.652453e-01 | 0.116 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.652453e-01 | 0.116 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.764385e-01 | 0.110 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.771318e-01 | 0.110 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.771318e-01 | 0.110 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.781016e-01 | 0.109 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.789183e-01 | 0.109 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.829325e-01 | 0.106 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.829325e-01 | 0.106 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.843395e-01 | 0.105 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.852121e-01 | 0.105 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.852121e-01 | 0.105 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.852121e-01 | 0.105 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.852121e-01 | 0.105 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.852121e-01 | 0.105 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.852121e-01 | 0.105 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.919612e-01 | 0.101 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.919612e-01 | 0.101 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.919612e-01 | 0.101 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.919612e-01 | 0.101 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.919612e-01 | 0.101 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.919612e-01 | 0.101 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.919612e-01 | 0.101 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.919612e-01 | 0.101 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.919612e-01 | 0.101 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.919612e-01 | 0.101 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.919612e-01 | 0.101 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.919612e-01 | 0.101 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.919612e-01 | 0.101 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.919612e-01 | 0.101 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.919612e-01 | 0.101 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.920169e-01 | 0.101 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.920169e-01 | 0.101 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.934019e-01 | 0.101 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.934019e-01 | 0.101 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.934019e-01 | 0.101 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.934019e-01 | 0.101 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.934019e-01 | 0.101 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.939708e-01 | 0.100 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.943659e-01 | 0.100 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.954174e-01 | 0.099 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.037659e-01 | 0.095 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.043251e-01 | 0.095 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.046664e-01 | 0.094 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.063527e-01 | 0.093 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.063527e-01 | 0.093 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.063653e-01 | 0.093 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.086689e-01 | 0.092 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.086689e-01 | 0.092 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.086689e-01 | 0.092 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.116610e-01 | 0.091 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.125725e-01 | 0.090 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.156382e-01 | 0.089 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.156382e-01 | 0.089 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.156382e-01 | 0.089 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.156382e-01 | 0.089 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.156382e-01 | 0.089 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.156382e-01 | 0.089 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.156382e-01 | 0.089 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.156382e-01 | 0.089 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.156382e-01 | 0.089 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.156382e-01 | 0.089 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.156382e-01 | 0.089 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.156382e-01 | 0.089 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.156382e-01 | 0.089 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.156382e-01 | 0.089 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.156471e-01 | 0.088 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.163823e-01 | 0.088 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.169891e-01 | 0.088 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.170419e-01 | 0.088 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.176559e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.176559e-01 | 0.087 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.176559e-01 | 0.087 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.176559e-01 | 0.087 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.208802e-01 | 0.086 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.208802e-01 | 0.086 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.208802e-01 | 0.086 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.208802e-01 | 0.086 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.208802e-01 | 0.086 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.208802e-01 | 0.086 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.208802e-01 | 0.086 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.208802e-01 | 0.086 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.208802e-01 | 0.086 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.208802e-01 | 0.086 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.208802e-01 | 0.086 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.212103e-01 | 0.086 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.229717e-01 | 0.085 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.229717e-01 | 0.085 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.229717e-01 | 0.085 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.229717e-01 | 0.085 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.229717e-01 | 0.085 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.276774e-01 | 0.082 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.276774e-01 | 0.082 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.299259e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.315294e-01 | 0.080 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.338278e-01 | 0.079 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.363511e-01 | 0.078 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.366217e-01 | 0.077 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.366217e-01 | 0.077 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.366217e-01 | 0.077 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.366217e-01 | 0.077 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.366217e-01 | 0.077 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.366217e-01 | 0.077 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.366217e-01 | 0.077 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.366217e-01 | 0.077 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.366217e-01 | 0.077 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.366422e-01 | 0.077 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.366422e-01 | 0.077 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.366422e-01 | 0.077 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.385222e-01 | 0.076 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.409754e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.415007e-01 | 0.075 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.415007e-01 | 0.075 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.415007e-01 | 0.075 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.415007e-01 | 0.075 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.425833e-01 | 0.074 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.472248e-01 | 0.072 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.482910e-01 | 0.071 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.485714e-01 | 0.071 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.488486e-01 | 0.071 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.488486e-01 | 0.071 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.511379e-01 | 0.070 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.511379e-01 | 0.070 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.511379e-01 | 0.070 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.511379e-01 | 0.070 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.511379e-01 | 0.070 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.511379e-01 | 0.070 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.524057e-01 | 0.069 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.552180e-01 | 0.068 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.552180e-01 | 0.068 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.552180e-01 | 0.068 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.552180e-01 | 0.068 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.552180e-01 | 0.068 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.552180e-01 | 0.068 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.552180e-01 | 0.068 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.552180e-01 | 0.068 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.552180e-01 | 0.068 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.552180e-01 | 0.068 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.552180e-01 | 0.068 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.552180e-01 | 0.068 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.553416e-01 | 0.068 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.566202e-01 | 0.067 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.581257e-01 | 0.066 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.582049e-01 | 0.066 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.586412e-01 | 0.066 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.595774e-01 | 0.066 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.605067e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.605067e-01 | 0.065 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.605067e-01 | 0.065 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.605067e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.626671e-01 | 0.064 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.644514e-01 | 0.063 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.644514e-01 | 0.063 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.644514e-01 | 0.063 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.644514e-01 | 0.063 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.644514e-01 | 0.063 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.644514e-01 | 0.063 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.648624e-01 | 0.063 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.667917e-01 | 0.062 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.713677e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.713677e-01 | 0.060 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.713677e-01 | 0.060 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.716985e-01 | 0.060 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.716985e-01 | 0.060 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.716985e-01 | 0.060 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.716985e-01 | 0.060 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.716985e-01 | 0.060 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.716985e-01 | 0.060 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.716985e-01 | 0.060 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.716985e-01 | 0.060 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.716985e-01 | 0.060 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.716985e-01 | 0.060 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.716985e-01 | 0.060 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.716985e-01 | 0.060 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.716985e-01 | 0.060 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.716985e-01 | 0.060 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.716985e-01 | 0.060 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.716985e-01 | 0.060 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.717634e-01 | 0.060 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.723113e-01 | 0.059 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.723113e-01 | 0.059 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.726387e-01 | 0.059 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.766639e-01 | 0.057 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.786119e-01 | 0.056 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.797354e-01 | 0.056 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.813652e-01 | 0.055 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.813652e-01 | 0.055 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.814737e-01 | 0.055 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.814737e-01 | 0.055 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.814737e-01 | 0.055 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.814737e-01 | 0.055 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.814737e-01 | 0.055 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.814737e-01 | 0.055 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.840715e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.840715e-01 | 0.054 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.852604e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.863040e-01 | 0.052 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.863040e-01 | 0.052 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.863040e-01 | 0.052 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.863040e-01 | 0.052 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.863040e-01 | 0.052 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.863040e-01 | 0.052 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.863040e-01 | 0.052 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.863040e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.863040e-01 | 0.052 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.863040e-01 | 0.052 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.863040e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.878535e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.878535e-01 | 0.052 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.878535e-01 | 0.052 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.898556e-01 | 0.051 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.898556e-01 | 0.051 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.898556e-01 | 0.051 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.908661e-01 | 0.050 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.908661e-01 | 0.050 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.913527e-01 | 0.050 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.917455e-01 | 0.050 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.928052e-01 | 0.049 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.929955e-01 | 0.049 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.934485e-01 | 0.049 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.950808e-01 | 0.048 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.951042e-01 | 0.048 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.978092e-01 | 0.047 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.978092e-01 | 0.047 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.978092e-01 | 0.047 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.980947e-01 | 0.047 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.980947e-01 | 0.047 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.980947e-01 | 0.047 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.980947e-01 | 0.047 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.980947e-01 | 0.047 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.980947e-01 | 0.047 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.980947e-01 | 0.047 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.992475e-01 | 0.046 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.992475e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.992475e-01 | 0.046 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.992475e-01 | 0.046 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.992475e-01 | 0.046 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.992475e-01 | 0.046 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.992475e-01 | 0.046 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.992475e-01 | 0.046 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.992475e-01 | 0.046 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.992475e-01 | 0.046 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.995856e-01 | 0.046 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.995856e-01 | 0.046 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.995856e-01 | 0.046 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.995856e-01 | 0.046 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.051515e-01 | 0.043 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.052523e-01 | 0.043 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.052523e-01 | 0.043 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.067530e-01 | 0.043 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.074585e-01 | 0.042 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.074585e-01 | 0.042 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.074585e-01 | 0.042 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.074585e-01 | 0.042 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.076719e-01 | 0.042 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.107182e-01 | 0.041 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.107182e-01 | 0.041 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.107182e-01 | 0.041 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.107182e-01 | 0.041 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.107182e-01 | 0.041 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.107182e-01 | 0.041 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.107182e-01 | 0.041 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.107182e-01 | 0.041 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.107182e-01 | 0.041 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.122109e-01 | 0.040 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.151632e-01 | 0.039 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.151632e-01 | 0.039 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.151632e-01 | 0.039 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.160118e-01 | 0.038 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.160118e-01 | 0.038 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.160118e-01 | 0.038 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.162230e-01 | 0.038 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.182090e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.208835e-01 | 0.036 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.208835e-01 | 0.036 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.208835e-01 | 0.036 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.208835e-01 | 0.036 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.208835e-01 | 0.036 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.208835e-01 | 0.036 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.208835e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.220966e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.220966e-01 | 0.035 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.220966e-01 | 0.035 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.220966e-01 | 0.035 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.220966e-01 | 0.035 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.238177e-01 | 0.034 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.238606e-01 | 0.034 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.247753e-01 | 0.034 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.247753e-01 | 0.034 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.262060e-01 | 0.033 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.268693e-01 | 0.033 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.277314e-01 | 0.033 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.285077e-01 | 0.032 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.285077e-01 | 0.032 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.298920e-01 | 0.032 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.298920e-01 | 0.032 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.298920e-01 | 0.032 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.298920e-01 | 0.032 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.298920e-01 | 0.032 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.298920e-01 | 0.032 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.298920e-01 | 0.032 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.298920e-01 | 0.032 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.298920e-01 | 0.032 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.304299e-01 | 0.031 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.329693e-01 | 0.030 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.341515e-01 | 0.030 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.344304e-01 | 0.029 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.344304e-01 | 0.029 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.349699e-01 | 0.029 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.354295e-01 | 0.029 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.354295e-01 | 0.029 | 1 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.356974e-01 | 0.029 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.361488e-01 | 0.029 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.374207e-01 | 0.028 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.374207e-01 | 0.028 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.374207e-01 | 0.028 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.378752e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.378752e-01 | 0.028 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.378752e-01 | 0.028 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.378752e-01 | 0.028 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.378752e-01 | 0.028 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.378752e-01 | 0.028 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.378752e-01 | 0.028 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.378752e-01 | 0.028 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.378752e-01 | 0.028 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.378752e-01 | 0.028 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.378752e-01 | 0.028 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.379506e-01 | 0.028 | 1 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.387192e-01 | 0.027 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.387895e-01 | 0.027 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.390614e-01 | 0.027 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.406002e-01 | 0.027 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.432351e-01 | 0.025 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.433251e-01 | 0.025 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.433251e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.442343e-01 | 0.025 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.449395e-01 | 0.025 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.449498e-01 | 0.025 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.449498e-01 | 0.025 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.449498e-01 | 0.025 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.449498e-01 | 0.025 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.451599e-01 | 0.024 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.451599e-01 | 0.024 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.465077e-01 | 0.024 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.465077e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.472233e-01 | 0.024 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.493973e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.508245e-01 | 0.022 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.510326e-01 | 0.022 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.512191e-01 | 0.022 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.512191e-01 | 0.022 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.512191e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.512191e-01 | 0.022 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.512191e-01 | 0.022 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.512191e-01 | 0.022 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.512191e-01 | 0.022 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.515472e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.534058e-01 | 0.021 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.535461e-01 | 0.021 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.535802e-01 | 0.021 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.535802e-01 | 0.021 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.538648e-01 | 0.021 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.538648e-01 | 0.021 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.538648e-01 | 0.021 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.538648e-01 | 0.021 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.543898e-01 | 0.020 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.552629e-01 | 0.020 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.567418e-01 | 0.019 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.567748e-01 | 0.019 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.567748e-01 | 0.019 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.567748e-01 | 0.019 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.567748e-01 | 0.019 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.567748e-01 | 0.019 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.567748e-01 | 0.019 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.567748e-01 | 0.019 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.578020e-01 | 0.019 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.580173e-01 | 0.019 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.580173e-01 | 0.019 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.580173e-01 | 0.019 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.580173e-01 | 0.019 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.580173e-01 | 0.019 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.580173e-01 | 0.019 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.587449e-01 | 0.018 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.597546e-01 | 0.018 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.603690e-01 | 0.018 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.603690e-01 | 0.018 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.603690e-01 | 0.018 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.610075e-01 | 0.017 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.616980e-01 | 0.017 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.616980e-01 | 0.017 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.616980e-01 | 0.017 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.620060e-01 | 0.017 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.620461e-01 | 0.017 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.620461e-01 | 0.017 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.620461e-01 | 0.017 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.624876e-01 | 0.017 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.625420e-01 | 0.017 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.635063e-01 | 0.016 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.635063e-01 | 0.016 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.638443e-01 | 0.016 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.638937e-01 | 0.016 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.647491e-01 | 0.016 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.657022e-01 | 0.015 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.657022e-01 | 0.015 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.660607e-01 | 0.015 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.660607e-01 | 0.015 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.660607e-01 | 0.015 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.660607e-01 | 0.015 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.664115e-01 | 0.015 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.664115e-01 | 0.015 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.669122e-01 | 0.015 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.671487e-01 | 0.015 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.690181e-01 | 0.014 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.690181e-01 | 0.014 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.690181e-01 | 0.014 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.690181e-01 | 0.014 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.690848e-01 | 0.014 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.691000e-01 | 0.014 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.691000e-01 | 0.014 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.694822e-01 | 0.013 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.699267e-01 | 0.013 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.699267e-01 | 0.013 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.699267e-01 | 0.013 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.699267e-01 | 0.013 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.699267e-01 | 0.013 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.699267e-01 | 0.013 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.699267e-01 | 0.013 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.699267e-01 | 0.013 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.699267e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.720238e-01 | 0.012 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.720667e-01 | 0.012 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.731652e-01 | 0.012 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.733526e-01 | 0.012 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.733526e-01 | 0.012 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.733526e-01 | 0.012 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.733526e-01 | 0.012 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.733526e-01 | 0.012 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.739530e-01 | 0.011 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.747470e-01 | 0.011 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.747470e-01 | 0.011 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.763884e-01 | 0.010 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.763884e-01 | 0.010 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.763884e-01 | 0.010 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.763884e-01 | 0.010 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.763884e-01 | 0.010 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.763884e-01 | 0.010 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.772131e-01 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.776949e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.783440e-01 | 0.010 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.790784e-01 | 0.009 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.790784e-01 | 0.009 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.790784e-01 | 0.009 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.790784e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.794452e-01 | 0.009 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.794452e-01 | 0.009 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.794452e-01 | 0.009 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.798493e-01 | 0.009 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.798740e-01 | 0.009 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.814429e-01 | 0.008 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.814622e-01 | 0.008 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.814622e-01 | 0.008 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.814622e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.814622e-01 | 0.008 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.814622e-01 | 0.008 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.814647e-01 | 0.008 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.814806e-01 | 0.008 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.816539e-01 | 0.008 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.816539e-01 | 0.008 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.816539e-01 | 0.008 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.822402e-01 | 0.008 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.823076e-01 | 0.008 | 1 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.828294e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.831351e-01 | 0.007 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.832909e-01 | 0.007 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.835744e-01 | 0.007 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.835744e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.839514e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.843956e-01 | 0.007 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.849418e-01 | 0.007 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.849418e-01 | 0.007 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.854461e-01 | 0.006 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.854461e-01 | 0.006 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.854461e-01 | 0.006 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.854461e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.856991e-01 | 0.006 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.860294e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.863322e-01 | 0.006 | 1 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.864336e-01 | 0.006 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.869104e-01 | 0.006 | 1 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.871046e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.871046e-01 | 0.006 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.871046e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.873718e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.877810e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.878390e-01 | 0.005 | 1 | 1 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.885742e-01 | 0.005 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.885742e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.885742e-01 | 0.005 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.885742e-01 | 0.005 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.888660e-01 | 0.005 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.899488e-01 | 0.004 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.900957e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.900957e-01 | 0.004 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.910303e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.910303e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.910303e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.915914e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.919801e-01 | 0.003 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.920527e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.920527e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.923130e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.923130e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.928073e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.929586e-01 | 0.003 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.929586e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.929586e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.929586e-01 | 0.003 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.929586e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.929750e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.935123e-01 | 0.003 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.935123e-01 | 0.003 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.935820e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.937424e-01 | 0.003 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.937613e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.937613e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.937613e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.938474e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.940145e-01 | 0.003 | 1 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.940145e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.941116e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.941116e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.941384e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.944725e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.947566e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.951027e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.951027e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.951027e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.951350e-01 | 0.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.955520e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.956611e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.956611e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.956611e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.960203e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.961558e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.961558e-01 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.964575e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.965837e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.965837e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.965942e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.965942e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.966197e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.967385e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.969191e-01 | 0.001 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.969826e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.969826e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.971776e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.972457e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.972457e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.973216e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.973267e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.974427e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.975276e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.975276e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.975276e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.976316e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.976316e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.976316e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.976880e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977810e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.979017e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.979709e-01 | 0.001 | 1 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.981411e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.981411e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.981411e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.981882e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.982136e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.982437e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.983020e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.983740e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.984706e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.985367e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.985410e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.985466e-01 | 0.001 | 1 | 1 |
| Interferon Signaling | R-HSA-913531 | 9.985943e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.986693e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.987112e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.987779e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.988444e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.988549e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.988989e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.989641e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.989856e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.989856e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.991511e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.992140e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992543e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.992543e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.993182e-01 | 0.000 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.993182e-01 | 0.000 | 1 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.993319e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.993557e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.994015e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994639e-01 | 0.000 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.995097e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.995097e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.995421e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.995656e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996306e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996554e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.996554e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.997325e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.997325e-01 | 0.000 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.997432e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997631e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997631e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997684e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997697e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998120e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998141e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998306e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998353e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.998428e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998541e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998731e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.998731e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998867e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998887e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.999205e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999295e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999469e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999486e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999497e-01 | 0.000 | 1 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999522e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999566e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999594e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999671e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999733e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999791e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999793e-01 | 0.000 | 1 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999855e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999921e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999926e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999962e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999985e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999985e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999986e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999997e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| NRAGE signals death through JNK | R-HSA-193648 | 9.279296e-09 | 8.032 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.061873e-08 | 7.296 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.450213e-07 | 6.611 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.098481e-07 | 6.293 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.579867e-07 | 6.120 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.129913e-06 | 5.947 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.561965e-06 | 5.255 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.779518e-05 | 4.750 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.005474e-05 | 4.698 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.307342e-05 | 4.637 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.317363e-05 | 4.635 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.505565e-05 | 4.601 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.682561e-05 | 4.434 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.877475e-05 | 4.411 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.139895e-05 | 4.289 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.007280e-05 | 4.221 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.553958e-05 | 4.183 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.438044e-05 | 4.191 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.697916e-05 | 4.061 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.056827e-04 | 3.976 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.387751e-04 | 3.858 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.405841e-04 | 3.852 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.524841e-04 | 3.817 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.572019e-04 | 3.804 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.704486e-04 | 3.768 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.951194e-04 | 3.710 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.057189e-04 | 3.687 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.988198e-04 | 3.702 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.122066e-04 | 3.673 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.849141e-04 | 3.545 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.124173e-04 | 3.505 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.251764e-04 | 3.488 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.552579e-04 | 3.449 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.841612e-04 | 3.415 | 1 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.353935e-04 | 3.361 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.564530e-04 | 3.341 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.844876e-04 | 3.315 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.761213e-04 | 3.322 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.412600e-04 | 3.267 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.867699e-04 | 3.232 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.867699e-04 | 3.232 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.875152e-04 | 3.231 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.944788e-04 | 3.158 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.346645e-04 | 3.134 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.009228e-04 | 3.096 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.482804e-04 | 3.071 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.293617e-04 | 3.032 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.716962e-04 | 3.012 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.716962e-04 | 3.012 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.020073e-03 | 2.991 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.970093e-04 | 3.001 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.163891e-03 | 2.934 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.138457e-03 | 2.944 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.158053e-03 | 2.936 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.118006e-03 | 2.952 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.167606e-03 | 2.933 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.347929e-03 | 2.870 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.676189e-03 | 2.776 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.856212e-03 | 2.731 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.929286e-03 | 2.715 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.963799e-03 | 2.707 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.020012e-03 | 2.695 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.240451e-03 | 2.650 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.280467e-03 | 2.642 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.538183e-03 | 2.595 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.650308e-03 | 2.577 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.670455e-03 | 2.573 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.077329e-03 | 2.512 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.072763e-03 | 2.512 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.072763e-03 | 2.512 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.367235e-03 | 2.473 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.576215e-03 | 2.447 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.134467e-03 | 2.384 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.285142e-03 | 2.368 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.285142e-03 | 2.368 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.658599e-03 | 2.332 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.827057e-03 | 2.316 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.935308e-03 | 2.307 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.974702e-03 | 2.303 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.249509e-03 | 2.280 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.214826e-03 | 2.283 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.249509e-03 | 2.280 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.460063e-03 | 2.263 | 1 | 1 |
| Cell junction organization | R-HSA-446728 | 6.250925e-03 | 2.204 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.842304e-03 | 2.165 | 1 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.157714e-03 | 2.145 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.447819e-03 | 2.128 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.478847e-03 | 2.126 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.564082e-03 | 2.121 | 1 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 8.977972e-03 | 2.047 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.977972e-03 | 2.047 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.977972e-03 | 2.047 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.722560e-03 | 2.059 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 8.991288e-03 | 2.046 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.516668e-03 | 2.070 | 1 | 1 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.000316e-03 | 2.046 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.512235e-03 | 2.022 | 1 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.016171e-02 | 1.993 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.018133e-02 | 1.992 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.018133e-02 | 1.992 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.020267e-02 | 1.991 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.028279e-02 | 1.988 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.028279e-02 | 1.988 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.079668e-02 | 1.967 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.123778e-02 | 1.949 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.123778e-02 | 1.949 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.152291e-02 | 1.938 | 1 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.162880e-02 | 1.934 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 1.218858e-02 | 1.914 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.232500e-02 | 1.909 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.244646e-02 | 1.905 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.350599e-02 | 1.869 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.312021e-02 | 1.882 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.309553e-02 | 1.883 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.330178e-02 | 1.876 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.298530e-02 | 1.887 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.356683e-02 | 1.868 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.449293e-02 | 1.839 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.449293e-02 | 1.839 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.449293e-02 | 1.839 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.465440e-02 | 1.834 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.530047e-02 | 1.815 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.685195e-02 | 1.773 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.563169e-02 | 1.806 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.573238e-02 | 1.803 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.689496e-02 | 1.772 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.725416e-02 | 1.763 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.826893e-02 | 1.738 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.858679e-02 | 1.731 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.065157e-02 | 1.685 | 1 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.138775e-02 | 1.670 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.151606e-02 | 1.667 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.229908e-02 | 1.652 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.314658e-02 | 1.636 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.277061e-02 | 1.643 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.387557e-02 | 1.622 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.260115e-02 | 1.646 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.554433e-02 | 1.593 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.611966e-02 | 1.583 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.622548e-02 | 1.581 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.891748e-02 | 1.539 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.820726e-02 | 1.550 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.820726e-02 | 1.550 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.820726e-02 | 1.550 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.820726e-02 | 1.550 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.834313e-02 | 1.548 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.714888e-02 | 1.566 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.868757e-02 | 1.542 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.891748e-02 | 1.539 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.891748e-02 | 1.539 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.850129e-02 | 1.545 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.924112e-02 | 1.534 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.054965e-02 | 1.515 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.103417e-02 | 1.508 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.103417e-02 | 1.508 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.210116e-02 | 1.493 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.233086e-02 | 1.490 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.745039e-02 | 1.427 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.745039e-02 | 1.427 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.745039e-02 | 1.427 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.485148e-02 | 1.458 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.489175e-02 | 1.457 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.682624e-02 | 1.434 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.489175e-02 | 1.457 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.745039e-02 | 1.427 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.485148e-02 | 1.458 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.444045e-02 | 1.463 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.385787e-02 | 1.470 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.773493e-02 | 1.423 | 1 | 0 |
| Lipophagy | R-HSA-9613354 | 3.783447e-02 | 1.422 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.783447e-02 | 1.422 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.783447e-02 | 1.422 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.783447e-02 | 1.422 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.826366e-02 | 1.417 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.951028e-02 | 1.403 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.951028e-02 | 1.403 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.136208e-02 | 1.383 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.981988e-02 | 1.400 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.981988e-02 | 1.400 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.981988e-02 | 1.400 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.907119e-02 | 1.408 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.017734e-02 | 1.396 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.151085e-02 | 1.382 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.051056e-02 | 1.392 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.043558e-02 | 1.393 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.212201e-02 | 1.375 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.561581e-02 | 1.341 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.731357e-02 | 1.325 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.765486e-02 | 1.322 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.799485e-02 | 1.319 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.815703e-02 | 1.317 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.012729e-02 | 1.300 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.188702e-02 | 1.285 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.188702e-02 | 1.285 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.188702e-02 | 1.285 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.971569e-02 | 1.224 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.957294e-02 | 1.225 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.420090e-02 | 1.266 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.252095e-02 | 1.280 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.762373e-02 | 1.239 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.855022e-02 | 1.232 | 1 | 1 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.391065e-02 | 1.268 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.252095e-02 | 1.280 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.391065e-02 | 1.268 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.322618e-02 | 1.274 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.363768e-02 | 1.271 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.971569e-02 | 1.224 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.943258e-02 | 1.226 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.971569e-02 | 1.224 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.398267e-02 | 1.268 | 1 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.420090e-02 | 1.266 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.027026e-02 | 1.220 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.431396e-02 | 1.192 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.444951e-02 | 1.191 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.860259e-02 | 1.164 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.860259e-02 | 1.164 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.003673e-02 | 1.155 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.140386e-02 | 1.146 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.153518e-02 | 1.145 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.175173e-02 | 1.144 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.297275e-02 | 1.137 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.635111e-02 | 1.117 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.655888e-02 | 1.116 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.125168e-02 | 1.090 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.178989e-02 | 1.087 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 9.604547e-02 | 1.018 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 9.604547e-02 | 1.018 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.742546e-02 | 1.058 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 8.742546e-02 | 1.058 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 8.742546e-02 | 1.058 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.742546e-02 | 1.058 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.496260e-02 | 1.071 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.995766e-02 | 1.046 | 1 | 1 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.424209e-02 | 1.026 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.424209e-02 | 1.026 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.611385e-02 | 1.065 | 1 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.575701e-02 | 1.019 | 1 | 1 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.636156e-02 | 1.064 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.458781e-02 | 1.073 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.694788e-02 | 1.013 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.815590e-02 | 1.008 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.862582e-02 | 1.006 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.002611e-01 | 0.999 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.014013e-01 | 0.994 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.015771e-01 | 0.993 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.035712e-01 | 0.985 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.073621e-01 | 0.969 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.073621e-01 | 0.969 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.076006e-01 | 0.968 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.081545e-01 | 0.966 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.081545e-01 | 0.966 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.081545e-01 | 0.966 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.081545e-01 | 0.966 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.107681e-01 | 0.956 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.295045e-01 | 0.888 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.295045e-01 | 0.888 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.326130e-01 | 0.877 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.326130e-01 | 0.877 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.156354e-01 | 0.937 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.269895e-01 | 0.896 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.269895e-01 | 0.896 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.208430e-01 | 0.918 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.208430e-01 | 0.918 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.208430e-01 | 0.918 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.265384e-01 | 0.898 | 1 | 1 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.265384e-01 | 0.898 | 1 | 1 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.263015e-01 | 0.899 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.218278e-01 | 0.914 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.199338e-01 | 0.921 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.208430e-01 | 0.918 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.148566e-01 | 0.940 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.305706e-01 | 0.884 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.347713e-01 | 0.870 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.305706e-01 | 0.884 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.305706e-01 | 0.884 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.347874e-01 | 0.870 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.154847e-01 | 0.937 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.145550e-01 | 0.941 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.349977e-01 | 0.870 | 1 | 1 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.875298e-01 | 0.727 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.875298e-01 | 0.727 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.875298e-01 | 0.727 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.875298e-01 | 0.727 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.875298e-01 | 0.727 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.875298e-01 | 0.727 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.875298e-01 | 0.727 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.875298e-01 | 0.727 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.676698e-01 | 0.572 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.676698e-01 | 0.572 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.676698e-01 | 0.572 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.676698e-01 | 0.572 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.676698e-01 | 0.572 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.676698e-01 | 0.572 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.676698e-01 | 0.572 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.676698e-01 | 0.572 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.676698e-01 | 0.572 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.676698e-01 | 0.572 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.651589e-01 | 0.782 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.651589e-01 | 0.782 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 1.651589e-01 | 0.782 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 1.651589e-01 | 0.782 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 1.651589e-01 | 0.782 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.022508e-01 | 0.694 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.399092e-01 | 0.469 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.399092e-01 | 0.469 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.399092e-01 | 0.469 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.399092e-01 | 0.469 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.399092e-01 | 0.469 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.399092e-01 | 0.469 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.399092e-01 | 0.469 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.399092e-01 | 0.469 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.399092e-01 | 0.469 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.399092e-01 | 0.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.399092e-01 | 0.469 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.544459e-01 | 0.811 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.544459e-01 | 0.811 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.544459e-01 | 0.811 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.544459e-01 | 0.811 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.401503e-01 | 0.620 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.795508e-01 | 0.746 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.378941e-01 | 0.860 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.378941e-01 | 0.860 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.378941e-01 | 0.860 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.056597e-01 | 0.687 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.056597e-01 | 0.687 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.056597e-01 | 0.687 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.783377e-01 | 0.555 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.783377e-01 | 0.555 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.783377e-01 | 0.555 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.783377e-01 | 0.555 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.050266e-01 | 0.393 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.050266e-01 | 0.393 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.050266e-01 | 0.393 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5688399 | 4.050266e-01 | 0.393 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.050266e-01 | 0.393 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.050266e-01 | 0.393 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.050266e-01 | 0.393 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.050266e-01 | 0.393 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.050266e-01 | 0.393 | 0 | 0 |
| Defective ABCA3 causes SMDP3 | R-HSA-5683678 | 4.050266e-01 | 0.393 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.325547e-01 | 0.633 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.325547e-01 | 0.633 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.325547e-01 | 0.633 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.325547e-01 | 0.633 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.325547e-01 | 0.633 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.325547e-01 | 0.633 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.325547e-01 | 0.633 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 1.973686e-01 | 0.705 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.163878e-01 | 0.500 | 1 | 1 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.163878e-01 | 0.500 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.462055e-01 | 0.835 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.462055e-01 | 0.835 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.462055e-01 | 0.835 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.462055e-01 | 0.835 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.406252e-01 | 0.619 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.539564e-01 | 0.451 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.637236e-01 | 0.334 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.637236e-01 | 0.334 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.637236e-01 | 0.334 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.637236e-01 | 0.334 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 4.637236e-01 | 0.334 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.637236e-01 | 0.334 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.159575e-01 | 0.500 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.907685e-01 | 0.408 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.907685e-01 | 0.408 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.440684e-01 | 0.463 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.036032e-01 | 0.691 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.801890e-01 | 0.553 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.560746e-01 | 0.592 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.000187e-01 | 0.523 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.000187e-01 | 0.523 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.319879e-01 | 0.479 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.720747e-01 | 0.429 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 3.720747e-01 | 0.429 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.720747e-01 | 0.429 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.266079e-01 | 0.370 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.266079e-01 | 0.370 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.266079e-01 | 0.370 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.266079e-01 | 0.370 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.166330e-01 | 0.287 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.166330e-01 | 0.287 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.166330e-01 | 0.287 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.166330e-01 | 0.287 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.087273e-01 | 0.510 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.087273e-01 | 0.510 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.263864e-01 | 0.645 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 3.402472e-01 | 0.468 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.613084e-01 | 0.336 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.613084e-01 | 0.336 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.493958e-01 | 0.603 | 1 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.605238e-01 | 0.443 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.447899e-01 | 0.462 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.272586e-01 | 0.369 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.272586e-01 | 0.369 | 1 | 1 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.272586e-01 | 0.369 | 1 | 1 |
| mRNA Splicing | R-HSA-72172 | 1.378189e-01 | 0.861 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.247222e-01 | 0.372 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.947459e-01 | 0.306 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.947459e-01 | 0.306 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.643252e-01 | 0.248 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.643252e-01 | 0.248 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.643252e-01 | 0.248 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.643252e-01 | 0.248 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.643252e-01 | 0.248 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.643252e-01 | 0.248 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.110811e-01 | 0.507 | 1 | 1 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.475098e-01 | 0.349 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.176669e-01 | 0.379 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.806292e-01 | 0.318 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.948234e-01 | 0.404 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.948234e-01 | 0.404 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.595492e-01 | 0.444 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.700060e-01 | 0.328 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.268320e-01 | 0.278 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.067573e-01 | 0.391 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.613128e-01 | 0.336 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.921551e-01 | 0.308 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.921551e-01 | 0.308 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.717502e-01 | 0.326 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.717502e-01 | 0.326 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.131748e-01 | 0.384 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.131748e-01 | 0.384 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.139073e-01 | 0.289 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.139073e-01 | 0.289 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.139073e-01 | 0.289 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.315295e-01 | 0.274 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.315295e-01 | 0.274 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.575079e-01 | 0.254 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.073142e-01 | 0.217 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.073142e-01 | 0.217 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.073142e-01 | 0.217 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.073142e-01 | 0.217 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.073142e-01 | 0.217 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 6.073142e-01 | 0.217 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.352189e-01 | 0.271 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.352189e-01 | 0.271 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.352189e-01 | 0.271 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.559026e-01 | 0.255 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.320500e-01 | 0.274 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.867394e-01 | 0.232 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.867394e-01 | 0.232 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.581799e-01 | 0.253 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.514056e-01 | 0.259 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.763725e-01 | 0.239 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.763725e-01 | 0.239 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.563148e-01 | 0.255 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.750518e-01 | 0.240 | 1 | 1 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.750518e-01 | 0.240 | 1 | 1 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.904552e-01 | 0.229 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.895157e-01 | 0.230 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.022877e-01 | 0.220 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.022877e-01 | 0.220 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.022877e-01 | 0.220 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.145131e-01 | 0.211 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.460637e-01 | 0.190 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.460637e-01 | 0.190 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.460637e-01 | 0.190 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.460637e-01 | 0.190 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.460637e-01 | 0.190 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.460637e-01 | 0.190 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.460637e-01 | 0.190 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.222262e-01 | 0.206 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.340129e-01 | 0.198 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.408318e-01 | 0.193 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.408318e-01 | 0.193 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.408318e-01 | 0.193 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.433466e-01 | 0.192 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.521717e-01 | 0.186 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.520575e-01 | 0.186 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.737185e-01 | 0.172 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.656121e-01 | 0.177 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.657124e-01 | 0.177 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.657124e-01 | 0.177 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.657124e-01 | 0.177 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.809916e-01 | 0.167 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.809916e-01 | 0.167 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.809916e-01 | 0.167 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.809916e-01 | 0.167 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.613128e-01 | 0.336 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.914028e-01 | 0.718 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.139073e-01 | 0.289 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.352189e-01 | 0.271 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.004555e-01 | 0.301 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.794462e-01 | 0.319 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.689834e-01 | 0.570 | 1 | 1 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.806292e-01 | 0.318 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.331378e-01 | 0.199 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.767152e-01 | 0.753 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.763725e-01 | 0.239 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.731326e-01 | 0.762 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.384503e-01 | 0.269 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.067141e-01 | 0.217 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.383016e-01 | 0.623 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.626831e-01 | 0.250 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.022877e-01 | 0.220 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.806157e-01 | 0.167 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.189537e-01 | 0.496 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.153738e-01 | 0.211 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.377860e-01 | 0.624 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.720747e-01 | 0.429 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.315295e-01 | 0.274 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.717502e-01 | 0.326 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.100658e-01 | 0.215 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.022508e-01 | 0.694 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.878898e-01 | 0.541 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.159575e-01 | 0.500 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.907685e-01 | 0.408 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.256310e-01 | 0.647 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.263864e-01 | 0.645 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.266922e-01 | 0.486 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.017051e-01 | 0.396 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.017051e-01 | 0.396 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.643252e-01 | 0.248 | 1 | 1 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.559026e-01 | 0.255 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.272586e-01 | 0.369 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.545170e-01 | 0.811 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.947459e-01 | 0.306 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.213206e-01 | 0.375 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.630142e-01 | 0.580 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.315295e-01 | 0.274 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.433466e-01 | 0.192 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.597633e-01 | 0.797 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.056597e-01 | 0.687 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.056597e-01 | 0.687 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.056597e-01 | 0.687 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.325547e-01 | 0.633 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.539564e-01 | 0.451 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.166330e-01 | 0.287 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.909394e-01 | 0.536 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.984019e-01 | 0.702 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.987982e-01 | 0.702 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.643252e-01 | 0.248 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.258159e-01 | 0.371 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.867394e-01 | 0.232 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.460637e-01 | 0.190 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.809916e-01 | 0.167 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.850112e-01 | 0.164 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.611196e-01 | 0.251 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.413911e-01 | 0.266 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.544459e-01 | 0.811 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.406252e-01 | 0.619 | 1 | 1 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.087941e-01 | 0.510 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.560746e-01 | 0.592 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.070190e-01 | 0.295 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.441189e-01 | 0.264 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.453560e-01 | 0.190 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.153738e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.423808e-01 | 0.847 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.893821e-01 | 0.230 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.719810e-01 | 0.326 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.043593e-01 | 0.690 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.022508e-01 | 0.694 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.401503e-01 | 0.620 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.163878e-01 | 0.500 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.166330e-01 | 0.287 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.808310e-01 | 0.419 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.638758e-01 | 0.439 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.064212e-01 | 0.295 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.575079e-01 | 0.254 | 1 | 1 |
| Hydrolysis of LPE | R-HSA-1483152 | 6.073142e-01 | 0.217 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.904552e-01 | 0.229 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.927675e-01 | 0.227 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.460637e-01 | 0.190 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.460637e-01 | 0.190 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.460637e-01 | 0.190 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.242450e-01 | 0.205 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.242450e-01 | 0.205 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.242450e-01 | 0.205 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.408318e-01 | 0.193 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.408318e-01 | 0.193 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.809916e-01 | 0.167 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.809916e-01 | 0.167 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.085731e-01 | 0.511 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.719810e-01 | 0.326 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.581799e-01 | 0.253 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.453560e-01 | 0.190 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.545470e-01 | 0.811 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.202673e-01 | 0.657 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.692510e-01 | 0.771 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.604006e-01 | 0.795 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.445675e-01 | 0.840 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.629774e-01 | 0.440 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.520575e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.656121e-01 | 0.177 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.268320e-01 | 0.278 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.247222e-01 | 0.372 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.147232e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.377860e-01 | 0.624 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.692510e-01 | 0.771 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.539564e-01 | 0.451 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.159575e-01 | 0.500 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.643252e-01 | 0.248 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.894834e-01 | 0.310 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.319839e-01 | 0.274 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.763725e-01 | 0.239 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.808310e-01 | 0.419 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.935774e-01 | 0.713 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.871964e-01 | 0.312 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.406156e-01 | 0.852 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.401503e-01 | 0.620 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.907685e-01 | 0.408 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.352472e-01 | 0.628 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.008350e-01 | 0.697 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.064212e-01 | 0.295 | 1 | 1 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.850112e-01 | 0.164 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.560515e-01 | 0.255 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.777311e-01 | 0.423 | 1 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.224599e-01 | 0.653 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.903085e-01 | 0.409 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.688347e-01 | 0.329 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.390884e-01 | 0.621 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.808310e-01 | 0.419 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.140761e-01 | 0.212 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.272586e-01 | 0.369 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.728822e-01 | 0.172 | 1 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.226049e-01 | 0.652 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.994556e-01 | 0.399 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.384087e-01 | 0.859 | 1 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.226966e-01 | 0.374 | 1 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.145131e-01 | 0.211 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.964076e-01 | 0.304 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.414021e-01 | 0.355 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.808310e-01 | 0.419 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.872228e-01 | 0.412 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.651589e-01 | 0.782 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.399092e-01 | 0.469 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.399092e-01 | 0.469 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.399092e-01 | 0.469 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.399092e-01 | 0.469 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.050266e-01 | 0.393 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.050266e-01 | 0.393 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.050266e-01 | 0.393 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.187079e-01 | 0.660 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.878898e-01 | 0.541 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 4.637236e-01 | 0.334 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.637236e-01 | 0.334 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 4.637236e-01 | 0.334 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.440684e-01 | 0.463 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.319879e-01 | 0.479 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.266079e-01 | 0.370 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.819893e-01 | 0.550 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.613084e-01 | 0.336 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.447899e-01 | 0.462 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.643252e-01 | 0.248 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 5.643252e-01 | 0.248 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.643252e-01 | 0.248 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.643252e-01 | 0.248 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.213206e-01 | 0.375 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.475098e-01 | 0.349 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.972744e-01 | 0.401 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.268320e-01 | 0.278 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.268320e-01 | 0.278 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.921551e-01 | 0.308 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.073142e-01 | 0.217 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.867394e-01 | 0.232 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.961542e-01 | 0.225 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.460637e-01 | 0.190 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.460637e-01 | 0.190 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.453560e-01 | 0.190 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.694975e-01 | 0.174 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.657124e-01 | 0.177 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.219677e-01 | 0.654 | 1 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.101117e-01 | 0.508 | 1 | 1 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.705414e-01 | 0.244 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.898359e-01 | 0.229 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.139073e-01 | 0.289 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.433466e-01 | 0.192 | 1 | 1 |
| Gene expression (Transcription) | R-HSA-74160 | 5.591369e-01 | 0.252 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.048315e-01 | 0.689 | 1 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.867394e-01 | 0.232 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.867394e-01 | 0.232 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.748481e-01 | 0.426 | 1 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.566653e-01 | 0.340 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.532661e-01 | 0.344 | 1 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.867394e-01 | 0.232 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.430976e-01 | 0.192 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.340129e-01 | 0.198 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.998438e-01 | 0.398 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.998438e-01 | 0.398 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.064544e-01 | 0.685 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.542166e-01 | 0.343 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.520575e-01 | 0.186 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.613128e-01 | 0.336 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.319839e-01 | 0.274 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 2.056212e-01 | 0.687 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.923384e-01 | 0.534 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.622731e-01 | 0.441 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.064212e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.064212e-01 | 0.295 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.087397e-01 | 0.680 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.087397e-01 | 0.680 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.687896e-01 | 0.773 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.682605e-01 | 0.774 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.822983e-01 | 0.317 | 1 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.692510e-01 | 0.771 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.539564e-01 | 0.451 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.000187e-01 | 0.523 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.213206e-01 | 0.375 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.700060e-01 | 0.328 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.073142e-01 | 0.217 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.453560e-01 | 0.190 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.696737e-01 | 0.770 | 1 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.536102e-01 | 0.257 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.226049e-01 | 0.652 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.440684e-01 | 0.463 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.000187e-01 | 0.523 | 1 | 1 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.674335e-01 | 0.776 | 1 | 1 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.036796e-01 | 0.691 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.622852e-01 | 0.790 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.817664e-01 | 0.317 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 2.022508e-01 | 0.694 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.401503e-01 | 0.620 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.783377e-01 | 0.555 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.163878e-01 | 0.500 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.600293e-01 | 0.585 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.947459e-01 | 0.306 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.643252e-01 | 0.248 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.230677e-01 | 0.491 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.004555e-01 | 0.301 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.961542e-01 | 0.225 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.460637e-01 | 0.190 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.460637e-01 | 0.190 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.429591e-01 | 0.192 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.809916e-01 | 0.167 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.964076e-01 | 0.304 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.905892e-01 | 0.720 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.909394e-01 | 0.536 | 1 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.894834e-01 | 0.310 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.951488e-01 | 0.710 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.125021e-01 | 0.290 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.765206e-01 | 0.170 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.410679e-01 | 0.618 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.909394e-01 | 0.536 | 1 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.017051e-01 | 0.396 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.268320e-01 | 0.278 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.472527e-01 | 0.189 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.542166e-01 | 0.343 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.414021e-01 | 0.355 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.538485e-01 | 0.343 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.750518e-01 | 0.240 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.829323e-01 | 0.417 | 1 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.676698e-01 | 0.572 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.022508e-01 | 0.694 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.399092e-01 | 0.469 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.544459e-01 | 0.811 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.795508e-01 | 0.746 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.864576e-01 | 0.729 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.539564e-01 | 0.451 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.637236e-01 | 0.334 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.630142e-01 | 0.580 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.224599e-01 | 0.653 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.390884e-01 | 0.621 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.087941e-01 | 0.510 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.266079e-01 | 0.370 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.166330e-01 | 0.287 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.166330e-01 | 0.287 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.166330e-01 | 0.287 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.909394e-01 | 0.536 | 1 | 1 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.152101e-01 | 0.667 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.613084e-01 | 0.336 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.272586e-01 | 0.369 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.643252e-01 | 0.248 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.643252e-01 | 0.248 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.176669e-01 | 0.379 | 1 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.268320e-01 | 0.278 | 1 | 1 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.064212e-01 | 0.295 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.004829e-01 | 0.397 | 1 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.575079e-01 | 0.254 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.575079e-01 | 0.254 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.073142e-01 | 0.217 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.022877e-01 | 0.220 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.460637e-01 | 0.190 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.747922e-01 | 0.171 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.509602e-01 | 0.821 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.808310e-01 | 0.419 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.491005e-01 | 0.260 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.597340e-01 | 0.252 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.017177e-01 | 0.221 | 1 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.163878e-01 | 0.500 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.793318e-01 | 0.421 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.139073e-01 | 0.289 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.085731e-01 | 0.511 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.570588e-01 | 0.804 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.189933e-01 | 0.208 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.064223e-01 | 0.295 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.050266e-01 | 0.393 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.907685e-01 | 0.408 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.414021e-01 | 0.355 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.810102e-01 | 0.318 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.559026e-01 | 0.255 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.320500e-01 | 0.274 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.658511e-01 | 0.247 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.656121e-01 | 0.177 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.159575e-01 | 0.500 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.610348e-01 | 0.793 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.234774e-01 | 0.281 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.895767e-01 | 0.409 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.783377e-01 | 0.555 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.783377e-01 | 0.555 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 2.783377e-01 | 0.555 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.050266e-01 | 0.393 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.163878e-01 | 0.500 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.163878e-01 | 0.500 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.878898e-01 | 0.541 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.637236e-01 | 0.334 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.159575e-01 | 0.500 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 3.907685e-01 | 0.408 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.166330e-01 | 0.287 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.643252e-01 | 0.248 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.643252e-01 | 0.248 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.643252e-01 | 0.248 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.538485e-01 | 0.343 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.315295e-01 | 0.274 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.352189e-01 | 0.271 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.794992e-01 | 0.237 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.145131e-01 | 0.211 | 1 | 1 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.145131e-01 | 0.211 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.460637e-01 | 0.190 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.460637e-01 | 0.190 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.100658e-01 | 0.215 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.863382e-01 | 0.163 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.521717e-01 | 0.186 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.453560e-01 | 0.190 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.809916e-01 | 0.167 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.656121e-01 | 0.177 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.656121e-01 | 0.177 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.440684e-01 | 0.463 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.453560e-01 | 0.190 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.226049e-01 | 0.652 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.907685e-01 | 0.408 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.100658e-01 | 0.215 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.244914e-01 | 0.372 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.266079e-01 | 0.370 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.268320e-01 | 0.278 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.867394e-01 | 0.232 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.655840e-01 | 0.177 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.593035e-01 | 0.181 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.638896e-01 | 0.439 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.542166e-01 | 0.343 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.413911e-01 | 0.266 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.593035e-01 | 0.181 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.187079e-01 | 0.660 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.166330e-01 | 0.287 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.643252e-01 | 0.248 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.073142e-01 | 0.217 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.794992e-01 | 0.237 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.460637e-01 | 0.190 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.187079e-01 | 0.660 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.947459e-01 | 0.306 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.545886e-01 | 0.450 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.600293e-01 | 0.585 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.927675e-01 | 0.227 | 1 | 1 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.473044e-01 | 0.459 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.306342e-01 | 0.637 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.560515e-01 | 0.255 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.414167e-01 | 0.617 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.643252e-01 | 0.248 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.867394e-01 | 0.232 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.947459e-01 | 0.306 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.874881e-01 | 0.541 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.454808e-01 | 0.190 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.622731e-01 | 0.441 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.268320e-01 | 0.278 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.904552e-01 | 0.229 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.595492e-01 | 0.444 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.475098e-01 | 0.349 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.064212e-01 | 0.295 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.533162e-01 | 0.257 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.907685e-01 | 0.408 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.909394e-01 | 0.536 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.418603e-01 | 0.848 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.447899e-01 | 0.462 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.809916e-01 | 0.167 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.408318e-01 | 0.193 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.605091e-01 | 0.584 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.882998e-01 | 0.162 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.891823e-01 | 0.162 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.891823e-01 | 0.162 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.891823e-01 | 0.162 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.925872e-01 | 0.160 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.925872e-01 | 0.160 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.941830e-01 | 0.159 | 1 | 0 |
| DNA Replication | R-HSA-69306 | 6.949264e-01 | 0.158 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.963149e-01 | 0.157 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.963149e-01 | 0.157 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.991579e-01 | 0.155 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.991579e-01 | 0.155 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.025406e-01 | 0.153 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.035561e-01 | 0.153 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.035561e-01 | 0.153 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.035561e-01 | 0.153 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.035561e-01 | 0.153 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.043403e-01 | 0.152 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.075049e-01 | 0.150 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.112776e-01 | 0.148 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.112776e-01 | 0.148 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.112776e-01 | 0.148 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.112776e-01 | 0.148 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.112776e-01 | 0.148 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.112776e-01 | 0.148 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.112776e-01 | 0.148 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.124744e-01 | 0.147 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.124744e-01 | 0.147 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.124744e-01 | 0.147 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.124744e-01 | 0.147 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.124744e-01 | 0.147 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.124744e-01 | 0.147 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.124744e-01 | 0.147 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 7.124744e-01 | 0.147 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.124744e-01 | 0.147 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.124744e-01 | 0.147 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.124744e-01 | 0.147 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.124744e-01 | 0.147 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.124744e-01 | 0.147 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.124744e-01 | 0.147 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.124744e-01 | 0.147 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.169596e-01 | 0.145 | 1 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.181402e-01 | 0.144 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.181402e-01 | 0.144 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.181402e-01 | 0.144 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.181402e-01 | 0.144 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.212546e-01 | 0.142 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.212546e-01 | 0.142 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.212546e-01 | 0.142 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.212546e-01 | 0.142 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.232620e-01 | 0.141 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.245844e-01 | 0.140 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.280245e-01 | 0.138 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.319634e-01 | 0.136 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.320410e-01 | 0.135 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.320410e-01 | 0.135 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.320410e-01 | 0.135 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.320410e-01 | 0.135 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.320410e-01 | 0.135 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.320410e-01 | 0.135 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.320410e-01 | 0.135 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.320410e-01 | 0.135 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.320410e-01 | 0.135 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.320410e-01 | 0.135 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.320410e-01 | 0.135 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.328107e-01 | 0.135 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.329822e-01 | 0.135 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.331274e-01 | 0.135 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.342605e-01 | 0.134 | 1 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.381185e-01 | 0.132 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.383513e-01 | 0.132 | 1 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.408519e-01 | 0.130 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.408519e-01 | 0.130 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.408519e-01 | 0.130 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.408519e-01 | 0.130 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.408519e-01 | 0.130 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.408519e-01 | 0.130 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.408519e-01 | 0.130 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.408519e-01 | 0.130 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.408519e-01 | 0.130 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.408519e-01 | 0.130 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.408519e-01 | 0.130 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.448667e-01 | 0.128 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.448667e-01 | 0.128 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.450526e-01 | 0.128 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.460125e-01 | 0.127 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.475070e-01 | 0.126 | 1 | 1 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.479822e-01 | 0.126 | 1 | 1 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.504786e-01 | 0.125 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.515201e-01 | 0.124 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.515201e-01 | 0.124 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.515201e-01 | 0.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.515201e-01 | 0.124 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.541628e-01 | 0.123 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.541628e-01 | 0.123 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.554870e-01 | 0.122 | 1 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.565257e-01 | 0.121 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.576635e-01 | 0.121 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.595821e-01 | 0.119 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.600909e-01 | 0.119 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.612860e-01 | 0.118 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.612860e-01 | 0.118 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.612860e-01 | 0.118 | 1 | 1 |
| G alpha (s) signalling events | R-HSA-418555 | 7.623943e-01 | 0.118 | 1 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.664302e-01 | 0.116 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.664302e-01 | 0.116 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.664302e-01 | 0.116 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.664302e-01 | 0.116 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.664302e-01 | 0.116 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.664302e-01 | 0.116 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.664302e-01 | 0.116 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.664302e-01 | 0.116 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.664302e-01 | 0.116 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.664302e-01 | 0.116 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.664302e-01 | 0.116 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.664302e-01 | 0.116 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.680724e-01 | 0.115 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.694056e-01 | 0.114 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.694056e-01 | 0.114 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.694056e-01 | 0.114 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.694402e-01 | 0.114 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.694402e-01 | 0.114 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.697660e-01 | 0.114 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.697660e-01 | 0.114 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.697660e-01 | 0.114 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.697660e-01 | 0.114 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.697660e-01 | 0.114 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.728618e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.785269e-01 | 0.109 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.799200e-01 | 0.108 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.838673e-01 | 0.106 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.838673e-01 | 0.106 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.838673e-01 | 0.106 | 1 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.868325e-01 | 0.104 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.868325e-01 | 0.104 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.883152e-01 | 0.103 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.883152e-01 | 0.103 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.891450e-01 | 0.103 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.891450e-01 | 0.103 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.894853e-01 | 0.103 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.894853e-01 | 0.103 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.894853e-01 | 0.103 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.894853e-01 | 0.103 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.894853e-01 | 0.103 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.894853e-01 | 0.103 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.894853e-01 | 0.103 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.894853e-01 | 0.103 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 7.894853e-01 | 0.103 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.894853e-01 | 0.103 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.894853e-01 | 0.103 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.894853e-01 | 0.103 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.894853e-01 | 0.103 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.894853e-01 | 0.103 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.894853e-01 | 0.103 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.905372e-01 | 0.102 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.910905e-01 | 0.102 | 1 | 0 |
| HIV Infection | R-HSA-162906 | 7.925587e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.926731e-01 | 0.101 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.926731e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.959175e-01 | 0.099 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.969798e-01 | 0.099 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.975024e-01 | 0.098 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.975024e-01 | 0.098 | 1 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.975703e-01 | 0.098 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.975703e-01 | 0.098 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.975703e-01 | 0.098 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.975703e-01 | 0.098 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.010832e-01 | 0.096 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.027745e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.027745e-01 | 0.095 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.027745e-01 | 0.095 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.027745e-01 | 0.095 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.027745e-01 | 0.095 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.027745e-01 | 0.095 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.042248e-01 | 0.095 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.043125e-01 | 0.095 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.047293e-01 | 0.094 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.061778e-01 | 0.094 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.077115e-01 | 0.093 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.102658e-01 | 0.091 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.102658e-01 | 0.091 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.102658e-01 | 0.091 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.102658e-01 | 0.091 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.102658e-01 | 0.091 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.102658e-01 | 0.091 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.102658e-01 | 0.091 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.102658e-01 | 0.091 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.102658e-01 | 0.091 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.102658e-01 | 0.091 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.102658e-01 | 0.091 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.102658e-01 | 0.091 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.102658e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.102658e-01 | 0.091 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.102658e-01 | 0.091 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.102658e-01 | 0.091 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.102658e-01 | 0.091 | 1 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.102658e-01 | 0.091 | 1 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.102658e-01 | 0.091 | 1 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.102658e-01 | 0.091 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.102658e-01 | 0.091 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.102658e-01 | 0.091 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.102964e-01 | 0.091 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.105384e-01 | 0.091 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.105384e-01 | 0.091 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.105384e-01 | 0.091 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.105384e-01 | 0.091 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.105960e-01 | 0.091 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.105960e-01 | 0.091 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.107855e-01 | 0.091 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.107855e-01 | 0.091 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.107922e-01 | 0.091 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.171018e-01 | 0.088 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.176477e-01 | 0.087 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.176477e-01 | 0.087 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.176477e-01 | 0.087 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.176477e-01 | 0.087 | 1 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.176477e-01 | 0.087 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.200755e-01 | 0.086 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.227968e-01 | 0.085 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.289962e-01 | 0.081 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.289962e-01 | 0.081 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.289962e-01 | 0.081 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.289962e-01 | 0.081 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.289962e-01 | 0.081 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.289962e-01 | 0.081 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.289962e-01 | 0.081 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.289962e-01 | 0.081 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.289962e-01 | 0.081 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.289962e-01 | 0.081 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.289962e-01 | 0.081 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.289962e-01 | 0.081 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.289962e-01 | 0.081 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.289962e-01 | 0.081 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.289962e-01 | 0.081 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.289962e-01 | 0.081 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.289962e-01 | 0.081 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.289962e-01 | 0.081 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.289962e-01 | 0.081 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.289962e-01 | 0.081 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.292165e-01 | 0.081 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.296496e-01 | 0.081 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.305042e-01 | 0.081 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.315077e-01 | 0.080 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.315077e-01 | 0.080 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.315077e-01 | 0.080 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.315077e-01 | 0.080 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.315077e-01 | 0.080 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.315077e-01 | 0.080 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.330358e-01 | 0.079 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.330358e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.330358e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.330358e-01 | 0.079 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.330358e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.330358e-01 | 0.079 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.332951e-01 | 0.079 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.343713e-01 | 0.079 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.343713e-01 | 0.079 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.343713e-01 | 0.079 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.349269e-01 | 0.078 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.397868e-01 | 0.076 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.418452e-01 | 0.075 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.418452e-01 | 0.075 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.418452e-01 | 0.075 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.420595e-01 | 0.075 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.420595e-01 | 0.075 | 1 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.420595e-01 | 0.075 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.442038e-01 | 0.074 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.444095e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.444095e-01 | 0.073 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.444095e-01 | 0.073 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.458785e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.458785e-01 | 0.073 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.458785e-01 | 0.073 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.458785e-01 | 0.073 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.458785e-01 | 0.073 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.458785e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.458785e-01 | 0.073 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.458785e-01 | 0.073 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.458785e-01 | 0.073 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.458785e-01 | 0.073 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.458785e-01 | 0.073 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.458785e-01 | 0.073 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.458785e-01 | 0.073 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.458785e-01 | 0.073 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.458785e-01 | 0.073 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.470024e-01 | 0.072 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.506776e-01 | 0.070 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.521375e-01 | 0.069 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.547581e-01 | 0.068 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.553925e-01 | 0.068 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.555752e-01 | 0.068 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.555752e-01 | 0.068 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.555752e-01 | 0.068 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.555752e-01 | 0.068 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.564072e-01 | 0.067 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.564072e-01 | 0.067 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.564072e-01 | 0.067 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.564072e-01 | 0.067 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.568783e-01 | 0.067 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.568783e-01 | 0.067 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.580565e-01 | 0.066 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.581771e-01 | 0.066 | 1 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.583185e-01 | 0.066 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.601759e-01 | 0.065 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.610950e-01 | 0.065 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.610950e-01 | 0.065 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.610950e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.610950e-01 | 0.065 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.610950e-01 | 0.065 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.610950e-01 | 0.065 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.610950e-01 | 0.065 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.610950e-01 | 0.065 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.610950e-01 | 0.065 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.610950e-01 | 0.065 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.610950e-01 | 0.065 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.610950e-01 | 0.065 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.610950e-01 | 0.065 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.610950e-01 | 0.065 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.617474e-01 | 0.065 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.646184e-01 | 0.063 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.651297e-01 | 0.063 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.652585e-01 | 0.063 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.652585e-01 | 0.063 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.652585e-01 | 0.063 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.663096e-01 | 0.062 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.670115e-01 | 0.062 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.672517e-01 | 0.062 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.672517e-01 | 0.062 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.675535e-01 | 0.062 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.675535e-01 | 0.062 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.675535e-01 | 0.062 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.678761e-01 | 0.062 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.686402e-01 | 0.061 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.686402e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.686402e-01 | 0.061 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.709318e-01 | 0.060 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.739694e-01 | 0.059 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.743652e-01 | 0.058 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.743652e-01 | 0.058 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.748100e-01 | 0.058 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.748100e-01 | 0.058 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.748100e-01 | 0.058 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.748100e-01 | 0.058 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.748100e-01 | 0.058 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.748100e-01 | 0.058 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.748100e-01 | 0.058 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.748100e-01 | 0.058 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.748100e-01 | 0.058 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.748100e-01 | 0.058 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.748100e-01 | 0.058 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.748100e-01 | 0.058 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.766599e-01 | 0.057 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.766599e-01 | 0.057 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.770025e-01 | 0.057 | 1 | 1 |
| S Phase | R-HSA-69242 | 8.777246e-01 | 0.057 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.778995e-01 | 0.057 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.778995e-01 | 0.057 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.778995e-01 | 0.057 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.787802e-01 | 0.056 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.806200e-01 | 0.055 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.811706e-01 | 0.055 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.816924e-01 | 0.055 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.829221e-01 | 0.054 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.842520e-01 | 0.053 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.871485e-01 | 0.052 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.871715e-01 | 0.052 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.871715e-01 | 0.052 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.871715e-01 | 0.052 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.871715e-01 | 0.052 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.871715e-01 | 0.052 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.871715e-01 | 0.052 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.871715e-01 | 0.052 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.871715e-01 | 0.052 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.871715e-01 | 0.052 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.871715e-01 | 0.052 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.871715e-01 | 0.052 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.871715e-01 | 0.052 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.871715e-01 | 0.052 | 1 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.871715e-01 | 0.052 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.871715e-01 | 0.052 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.874945e-01 | 0.052 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.874945e-01 | 0.052 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.914336e-01 | 0.050 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.938165e-01 | 0.049 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.963860e-01 | 0.048 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.963860e-01 | 0.048 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.963860e-01 | 0.048 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.971092e-01 | 0.047 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.982215e-01 | 0.047 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 8.982215e-01 | 0.047 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.982215e-01 | 0.047 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.983131e-01 | 0.047 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.983131e-01 | 0.047 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.983131e-01 | 0.047 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.983131e-01 | 0.047 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.983131e-01 | 0.047 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.983131e-01 | 0.047 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.983131e-01 | 0.047 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.983131e-01 | 0.047 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.983131e-01 | 0.047 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.983131e-01 | 0.047 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.983131e-01 | 0.047 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.983131e-01 | 0.047 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.983131e-01 | 0.047 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.993748e-01 | 0.046 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.036500e-01 | 0.044 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.046193e-01 | 0.044 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.046193e-01 | 0.044 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.055540e-01 | 0.043 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.055540e-01 | 0.043 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.055540e-01 | 0.043 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.055540e-01 | 0.043 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.083551e-01 | 0.042 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.083551e-01 | 0.042 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.083551e-01 | 0.042 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.083551e-01 | 0.042 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.083551e-01 | 0.042 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 9.083551e-01 | 0.042 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.083551e-01 | 0.042 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.083551e-01 | 0.042 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.083551e-01 | 0.042 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.083551e-01 | 0.042 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.083551e-01 | 0.042 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.085009e-01 | 0.042 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.086439e-01 | 0.042 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.121692e-01 | 0.040 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.121692e-01 | 0.040 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.121692e-01 | 0.040 | 1 | 1 |
| Somitogenesis | R-HSA-9824272 | 9.121692e-01 | 0.040 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.121692e-01 | 0.040 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.122376e-01 | 0.040 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.122376e-01 | 0.040 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.122376e-01 | 0.040 | 1 | 1 |
| RSV-host interactions | R-HSA-9833110 | 9.131999e-01 | 0.039 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.136603e-01 | 0.039 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.163902e-01 | 0.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.174059e-01 | 0.037 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.174059e-01 | 0.037 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.174059e-01 | 0.037 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.174059e-01 | 0.037 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.174059e-01 | 0.037 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.174059e-01 | 0.037 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.179683e-01 | 0.037 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.183603e-01 | 0.037 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.183603e-01 | 0.037 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.183603e-01 | 0.037 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.183603e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.192821e-01 | 0.037 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.192821e-01 | 0.037 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.192821e-01 | 0.037 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.192821e-01 | 0.037 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.217687e-01 | 0.035 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.220885e-01 | 0.035 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.241506e-01 | 0.034 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.255633e-01 | 0.034 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.255633e-01 | 0.034 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.255633e-01 | 0.034 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.255633e-01 | 0.034 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.255633e-01 | 0.034 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.255633e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.255633e-01 | 0.034 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.255633e-01 | 0.034 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.257918e-01 | 0.033 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.257918e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.257918e-01 | 0.033 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.257918e-01 | 0.033 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.257918e-01 | 0.033 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.257918e-01 | 0.033 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.268344e-01 | 0.033 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.295621e-01 | 0.032 | 1 | 1 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.295621e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.311934e-01 | 0.031 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.316026e-01 | 0.031 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.318035e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.318035e-01 | 0.031 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.318035e-01 | 0.031 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.318035e-01 | 0.031 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.318035e-01 | 0.031 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.322567e-01 | 0.030 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.329155e-01 | 0.030 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.329155e-01 | 0.030 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.329155e-01 | 0.030 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.329155e-01 | 0.030 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.329155e-01 | 0.030 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.329155e-01 | 0.030 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.329155e-01 | 0.030 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.329155e-01 | 0.030 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.329155e-01 | 0.030 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.341697e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.341697e-01 | 0.030 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.341697e-01 | 0.030 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.373521e-01 | 0.028 | 1 | 1 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.373521e-01 | 0.028 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.373521e-01 | 0.028 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.387727e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.395420e-01 | 0.027 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.395420e-01 | 0.027 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 9.395420e-01 | 0.027 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.395420e-01 | 0.027 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.395420e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.421209e-01 | 0.026 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.424704e-01 | 0.026 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.424704e-01 | 0.026 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.424704e-01 | 0.026 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.430732e-01 | 0.025 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.433040e-01 | 0.025 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.442658e-01 | 0.025 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.455142e-01 | 0.024 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.455142e-01 | 0.024 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.455142e-01 | 0.024 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.455142e-01 | 0.024 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.455142e-01 | 0.024 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.455142e-01 | 0.024 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.455142e-01 | 0.024 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.455142e-01 | 0.024 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.471892e-01 | 0.024 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.471892e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.471892e-01 | 0.024 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.478379e-01 | 0.023 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.478379e-01 | 0.023 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.508968e-01 | 0.022 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.508968e-01 | 0.022 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.508968e-01 | 0.022 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.508968e-01 | 0.022 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.508968e-01 | 0.022 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.508968e-01 | 0.022 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.508968e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.508968e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.515376e-01 | 0.022 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.516607e-01 | 0.022 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.523380e-01 | 0.021 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.531870e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.536974e-01 | 0.021 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.549483e-01 | 0.020 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.552207e-01 | 0.020 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.555425e-01 | 0.020 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.555425e-01 | 0.020 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.555425e-01 | 0.020 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.557479e-01 | 0.020 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.557479e-01 | 0.020 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.557479e-01 | 0.020 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.557479e-01 | 0.020 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.567046e-01 | 0.019 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.572044e-01 | 0.019 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.588166e-01 | 0.018 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.592295e-01 | 0.018 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.592295e-01 | 0.018 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.592295e-01 | 0.018 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.592295e-01 | 0.018 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.592295e-01 | 0.018 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.601200e-01 | 0.018 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.601200e-01 | 0.018 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.601200e-01 | 0.018 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.601200e-01 | 0.018 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.616162e-01 | 0.017 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.626222e-01 | 0.017 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.626222e-01 | 0.017 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.626222e-01 | 0.017 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.626222e-01 | 0.017 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.626222e-01 | 0.017 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.633894e-01 | 0.016 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.633894e-01 | 0.016 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.633894e-01 | 0.016 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.640604e-01 | 0.016 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.640604e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.640604e-01 | 0.016 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.640604e-01 | 0.016 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.640604e-01 | 0.016 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.640604e-01 | 0.016 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.651151e-01 | 0.015 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.654439e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.657428e-01 | 0.015 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.657428e-01 | 0.015 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.671386e-01 | 0.015 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.671453e-01 | 0.015 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.671453e-01 | 0.015 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.676117e-01 | 0.014 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.676117e-01 | 0.014 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.676117e-01 | 0.014 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.676117e-01 | 0.014 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.676117e-01 | 0.014 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.686118e-01 | 0.014 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.691857e-01 | 0.014 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.696191e-01 | 0.013 | 1 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.696191e-01 | 0.013 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.696191e-01 | 0.013 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.704755e-01 | 0.013 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.708122e-01 | 0.013 | 0 | 0 |
| Phosphate bond hydrolysis by NTPDase proteins | R-HSA-8850843 | 9.708122e-01 | 0.013 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.708122e-01 | 0.013 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.708122e-01 | 0.013 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.708122e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.719160e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.725840e-01 | 0.012 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.730765e-01 | 0.012 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.736710e-01 | 0.012 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.736967e-01 | 0.012 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.736967e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.736967e-01 | 0.012 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.736967e-01 | 0.012 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.736967e-01 | 0.012 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.740477e-01 | 0.011 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.742066e-01 | 0.011 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.742169e-01 | 0.011 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.744621e-01 | 0.011 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.758956e-01 | 0.011 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.760251e-01 | 0.011 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.762962e-01 | 0.010 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.762962e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.762962e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.762962e-01 | 0.010 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.774089e-01 | 0.010 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.775132e-01 | 0.010 | 1 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.779378e-01 | 0.010 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.779378e-01 | 0.010 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.779399e-01 | 0.010 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.786390e-01 | 0.009 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.786390e-01 | 0.009 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.786390e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.786390e-01 | 0.009 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.786390e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.795066e-01 | 0.009 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.795878e-01 | 0.009 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.798120e-01 | 0.009 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.798120e-01 | 0.009 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.804126e-01 | 0.009 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.807504e-01 | 0.008 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.807504e-01 | 0.008 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.808614e-01 | 0.008 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.811801e-01 | 0.008 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.819001e-01 | 0.008 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.820128e-01 | 0.008 | 1 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.823303e-01 | 0.008 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.826531e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.826531e-01 | 0.008 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.828091e-01 | 0.008 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.839413e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.839413e-01 | 0.007 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.843347e-01 | 0.007 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.843347e-01 | 0.007 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.843679e-01 | 0.007 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.845539e-01 | 0.007 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.845539e-01 | 0.007 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.845539e-01 | 0.007 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.847830e-01 | 0.007 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.850604e-01 | 0.007 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.851908e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.859133e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.859133e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.859133e-01 | 0.006 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.859133e-01 | 0.006 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.859133e-01 | 0.006 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.859133e-01 | 0.006 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.864395e-01 | 0.006 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.870665e-01 | 0.006 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.870665e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.870931e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.873060e-01 | 0.006 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.874076e-01 | 0.006 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.874157e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.884041e-01 | 0.005 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.884041e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.885610e-01 | 0.005 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.885610e-01 | 0.005 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.885610e-01 | 0.005 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.886297e-01 | 0.005 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.892238e-01 | 0.005 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.892238e-01 | 0.005 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.895780e-01 | 0.005 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.896921e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.896921e-01 | 0.004 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.896921e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.896921e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.896921e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.907113e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.907113e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.909407e-01 | 0.004 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.912461e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.916299e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.916299e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.916299e-01 | 0.004 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.916604e-01 | 0.004 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.916604e-01 | 0.004 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.917626e-01 | 0.004 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.918466e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.924576e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.924576e-01 | 0.003 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.925054e-01 | 0.003 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.927987e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.931589e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.931589e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.931589e-01 | 0.003 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.932036e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.932907e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.934389e-01 | 0.003 | 1 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.934685e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.938758e-01 | 0.003 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.938758e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.938758e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.939023e-01 | 0.003 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.942092e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.942295e-01 | 0.003 | 1 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.943029e-01 | 0.002 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.943029e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.943876e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.945099e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.948024e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.949485e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.950169e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.950274e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.950274e-01 | 0.002 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.950274e-01 | 0.002 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.953648e-01 | 0.002 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.953648e-01 | 0.002 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.955193e-01 | 0.002 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.955193e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.955193e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.955193e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.955193e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.959626e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.959626e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.960567e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.965239e-01 | 0.002 | 1 | 1 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.967220e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.967220e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.967223e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.968224e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.968224e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.968224e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.969629e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.970463e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.973386e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.973386e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.975188e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.976020e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.976199e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.976507e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.977393e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.978393e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.979090e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.980547e-01 | 0.001 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.980946e-01 | 0.001 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.980946e-01 | 0.001 | 1 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.983048e-01 | 0.001 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.985323e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.985759e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.985759e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.987100e-01 | 0.001 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.987169e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.987412e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.988439e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.990271e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.990473e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.990615e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.990615e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.992382e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.992382e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.992382e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.992562e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.992644e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.993816e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.993849e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.994428e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.994980e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.995123e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995925e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996227e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996329e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.996500e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.997132e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997316e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997328e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997386e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997484e-01 | 0.000 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997484e-01 | 0.000 | 1 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997582e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.997659e-01 | 0.000 | 1 | 1 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997821e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.997821e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998243e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998243e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998420e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998475e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.998550e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998550e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998707e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998835e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999104e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999422e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999544e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999704e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999746e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999798e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999840e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999883e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999892e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999895e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999899e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999904e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999952e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999953e-01 | 0.000 | 1 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999964e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999970e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999971e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999982e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999984e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999989e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999990e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999995e-01 | 0.000 | 1 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 1 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.000000e+00 | 0.000 | 1 | 1 |